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ABSTRACT 

The main goal ofthis study was to discover polymer candidates which can cross­
link and as an imprinted template with quadruplex structures for nucleic acid applications 
such as recognition and transfection. Nucleic acids are classified as macro-biopolymers 
which are central to the functioning oforganisms. Nucleic acid polymers have many 
applications in different fields such as biotechnology, medicine and nanomaterials. One 
application, gene therapy, can provide great opportunities for treating diseases from 
genetic disorders to cancer. Polymers are one non-viral delivery vector for gene therapy. 
Cationic polymers have advantages in gene delivery and appear to have promising 
potential in the treatment ofdiseases. 
Polyethylenimine (PEl), a commercial cationic polymer, is available in bulk 
quantities. PEl has been widely used for non-viral transfection in vitro and in vivo and 
also been proven to be an efficient vector for use in gene delivery and other biological 
areas. lsophthalaldehyde, a cross-linker, was found to be effective in use with PEl. In an 
attempt to make cross-linked PEl nanoparticles for nucleic acid gene delivery, we cross­
linked branched (25K) PEl with isophthalaldehyde. In situ IH NMR, QELS light 
scattering and UV -Vis data are in agreement with the cross-linking of polyethylenimine 
with isophthalaldehyde and could form either inter- or intra-molecular cross-links. In a 
relatively dilute solution, the cross-linking reaction condenses the polymer molecules 
only by intra-molecular cross-linking. 
I 

There are growing interests in quadruplex DNA research. Quadruplex DNA is a 
higher order DNA structure found in guanine rich chromosome end (telomere) regions 
and in promoter regions. Interest in quadruplex DNA has advanced considerably due to 
its utilization in cancer treatments. We looked for polymers which can bind to 
quadruplex DNA without disrupting the quadruplex structure. The 
d(T4G4) repeated sequence can fold into quadruplex structure in its telomere region and 
has been found in a living organism (sty/onychia). The synthetic DNA sequence of 
(TTTTGGGG)4, (32-bps), was used in this study. We have studied the interaction ofPEl 
with quadruplex T 4G4 DNA by circular dichroism, UV, and NMR. 
It is known that the PEls (cationic polymers) were shown to interact with 
.quadruplex DNA. Our CD spectroscopy results suggested that PEl might disrupt the 
quadruplex DNA and converted it into a hybrid or unknown structure. However, it is 
currently unclear what the structure of the quadruplex DNA was. 
Our ultimate aim is to be able to find the suitable polymer for our imprinted model 
in DNA researches. Porphyrins are known to successfully bind to quadruplex structures. 
Toward this goal, we have used cationic tetrapyridyl porphyrin (TMPyP4) as a probe to 
screen the interaction of the quadruplex DNA with different categories ofpolymers. 
Here, we have found that the UV-Vis binding interaction ofporphyrin, polymers and 
quadruplex DNA have shown that the Soret bands of the porphyrins changed drastically 
upon addition ofquadruplex DNA, with bathochromic shifts (to longer wavelength). By 
addition ofpolymers into porphyrin I quadruplex complex, the Soret band was observed 
to shift to different position as a function ofpolymer structure. 
2 

Our UV -Vis data have revealed that the cationic polymer (e.g. PEl) might disrupt 
quadruplexes DNA or alter it to an unknown or hybrid structures; the neutral polymers 
might associate with quadruplex DNA without structural disruption. However, the 31p 
NMR studied showed only a weak binding or non·binding interaction for poly (4· 
vinylpyridine N-oxide) and poly (N.vinylpyrrolidone) with quadruplex DNA. These 
results motivate us for further investigation of the neutral polymers. 
3 

Dissertation Structure 
This dissertation is organized in the following order: An introduction to the research 
is presented in Chapter 1; an historical overview is given in Chapter 2; the theory ofthe 
methodologies are given in Chapter 3; materials and experimental methods are in Chapter 
4, results and discussion are given in Chapter 5; and Chapter 6 is comprised of the 
conclusion and possible future work, followed by references. 
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CHAPTER 1 INTRODUCTION 
1.1 Polymers as non-viral nucleic acid vehicles 
Cancer has become the number one killer in developing countries and is moving 
toward being the number one cause ofdeath in industrialized countries. 1 Because of the 
aggressive growth of tumor cells, and the complex mechanism in cancer developments, 
standard treatments are not sufficiently effective in many cases.2 Therefore, the search 
for new anticancer strategies becomes urgently required. In this regard, a better 
understanding of the relationship between growing cancer cells and genes led researchers 
to search for new approaches for treatments. The growing interest in gene therapy has 
become an attractive concept in recent years because it provides a promising tool for 
treating the tumor cells.34 
In past decades, gene therapy has emerged as a powerful, new therapeutic 
intervention for gene-related diseases and has gained increasing attention in medicine, 
biotechnology and the pharmaceutical sciences. S DNA is the hereditary material in all 
living organisms. An efficient gene carrier is required to be able to deliver the genetic 
material into target cells. The efficiency and safety for a specific delivery of therapeutic 
genes remains an important bottleneck for the development ofgene therapy. To date, 
developing a stable and efficient delivery system is still a major challenge. The key 
considerations for the development ofgene therapy strategies are to improve the 
efficiency and safety of genes after their administration into the body. Gene delivery 
systems are currently under investigation for both viral and non-viral carriers.6 
The limitations ofviral vectors and cellular barriers (extracellular/ intracellular) are 
the critical issues for gene delivery. There is a need for development of an appropriate 
5 

delivery system to enhance efficiency.7-9 The viral carriers can produce efficient gene 
expression but have high immunogenicity issues.10 The virus gene carrier also has 
drawbacks in the size capacity of therapeutic DNA and difficulty in targeting specific cell 
types. Although virus carriers are efficient gene delivery agents, a high death toll in 
clinical trials has been reported over the past decades. 11·12 The attempt to achieve 
successful gene therapy has led to the evaluation and development of alternative vectors. 
Synthetic non-viral systems have showed an interesting pharmaceutical profile with 
18potential advantages for certain applications. l3' The non-viral delivery systems have 
become one of the alternative methods because of their favorable gene delivery 
characteristics such as low immunogenicity, less size limitation, increased cost efficiency 
and facility ofmodification.19 
Non-viral carriers are mainly found in three categories: naked DNA delivery, lipid­
based delivery, and polymer-based delivery.2o A wide range of polymeric vectors, most 
22ofa cationic nature, have been utilized to deliver therapeutic genes in vivO.2I - The 
cationic polymers have been used as possible alternative vectors for viral and liposomal 
carriers in a gene delivery system.23-24 The advantage of using cationic polymers is that 
cationic polymers have many different structural elements which can self-assemble with 
negatively charged nucleic acids via electrostatic interactions to condense the string-like 
nucleic acids into compact nanoparticles. 25 
DNA molecules are large domains which can have a wormlike random coil 
structure. The DNA condensation will decrease the size of the DNA chains into compact, 
orderly structures by which the genetic information is packaged and protected. DNA 
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condensation processes enable DNA easily to transfer into the target cells for gene 
therapy applications. The dominant forces ofthe DNA condensation are attractive 
(counterion, cross-linking) forces, hydration forces and repulsion (electrostatics) forces. 
The multivalent cation condensation process can provide the free energy which can 
then stabilize the condensed state of DNA molecules. 26 The electrostatic attraction 
between positively charged cationic polymers and negatively charged DNA results in the 
formation of the polyplex. In swnmary, the cationic polymers are known to receive the 
most attention as potential non-viral gene carriers. 
1.2 Polymers and Quadruplex DNA Interaction 
James Watson and Francis Crick were the first to discover right-handed double 
helical DNA structures. 27 After a few decades, more polymorphic natural DNA 
structures have been reported. There is an increasing interest in a number ofother DNA 
forms and their role in biological activities. Four-stranded helical guanine-rich DNA 
structures, joined by hydrogen bonds through Hoogsteen base pairing to form a planar 
structure, are ofparticular interest among the various DNA structures. 28 
The human telomere with a long 3' overhang of a G-rich strand can adopt an unusual 
four-stranded structure called a G- quadruplex?9 This quadruplex DNA displays a 
significant role in the regulation oftelomerase activity; due to the inhibition of the 
enzyme telomerase, the G- quadruplex structures have been considered as a target design 
33for anticancer drugS.30­
Monovalent cations play an important role in the formation of the quadruplex 
structures. G-quadruplex formation varies with the cation species. The binding preference 
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ofmonovalent cations for G-quadruplex structures is K+>Na+>Cs+>Li+. 34 Potassium has 
significant binding preference over other alkali metal ions due to the following reasons: 
(A) Ionic radius: potassium has an ionic radius of approximately 1.3 Awhich fits well in 
the guanine tetrads' cavities. (B) Physiological concentrations: physiological conditions 
provide optimal stability for potassium ions. The potassium ion can induce the formation 
ofthe G-quadruplex structure by a slow unfolding reaction.35 
The original concept of this research was designed to investigate the possibility for 
applying polymers using an imprinting model. Traditionally, a polymerization in the 
presence of a cross-linker is performed to prepare this architecture. This was done by 
cross-linking the polymer to form a template which interacts with the nucleic acid (DNA) 
and formed a complex. The imprinted template is removed from the polymer by melting 
or dialysis of the DNA and leaves behind the specific binding site to serve as a "lock and 
key',.36-37 
Cationic polymers are well documented in many studies for binding to anionic DNA 
to provide the control release of DNA polyplexes.38-40 We examined polycationic 
polymers as potential candidates because the electrostatic interactions between the 
negative charge of the nucleic acid and positive charge of the polycation will attract each 
other. Our interest has focused on one of the cationic polymers- polyethylenimine (pEn. 
PEl has been used as a non-viral gene delivery system for many years. 41 
Our experiments identified that one of the cross-linkers, isophthalaldehyde (an 
aromatic dialdehyde), was able to cross-link with PEl to form nanoparticles. The 
interaction between polymers and DNA has been studied by many researchers. 37-38,42 
We are interested in how the polyethylenimine condensed with the quadruplex DNA, and 
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any confonnational changes of the DNA induced by the interaction with the quadruplex 
DNA. 
Structure of Isophthalaldehyde 
r0pOHC~CHO 
Cationic porphyrins have been noted for their ability to bind and to stabilize the G· 
quadruplex DNA. 43 We utilized cationic porphyrins as a probe to screen the interaction 
ofthe quadruplex DNA with different categories ofpolymers. The aim in this research is 
to explore the infonnation ofthe potential polymer candidates which can be used for the 
DNA binding and apply the resulting infonnation in nucleic acid research. 
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CHAPTER 2 HISTORICAL 
2.1 Polymers 
Polymers are molecules that are composed ofa large number of repeated units 
(monomers) which are linked by covalent bonds to form macromolecules. The large 
number ofdifferent building blocks ofmonomers can be constituted into a wide variety 
ofmacromolecules which allows for a great diversity of macromolecules. These 
structures can lead to a wide range ofproperties, allowing polymers to play an essential 
role in everyday life. 44 
The types ofpolymers range from synthetic plastics (thermoplastic or thermoset), 
films, and elastomers to natural biopolymers. The varieties ofnatural biopolymers 
include carbohydrates, lipids, proteins and nucleic acids which are composed ofdifferent 
monomers and serve different functions. Synthetic polymers are one of the largest fields 
in materials science including synthetic rubber, nylon, PVC, polystyrene, polypropylene, 
etc.45 There are three classes oforganic synthetic polymers by charge; these are cationic 
polymers, anionic polymers and neutral polymers. In the present study, we attempted to 
investigate some of the neutral and cationic polymers for their interaction with the 
G-quadruplex DNA. 
2.1.1 Neutral polymers 
Some neutral polymers have shown the ability to interact or bind with DNA.46 
There are many non-ionic neutral polymers including polyvinylpyrrolidone (PVP), 
polyvinylpolypyrrolidone (PVPP) and poly (4-vinylpyridine-N-oxide) which are able to 
interact with DNA through non-condensing mechanisms. 
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Polyvinylpyrrolidone (PVP) is a water- soluble homopolymer made from the 
monomer N-vinyl pyrrolidone. PVP is a non-compacting but interactive polymer which 
is used in many applications such as excipients or solubilizers in the pharmaceutical 
industry. The interaction between DNA and PVP is based on hydrogen bonding with the 
base-pair in the DNA major groove. Unlike polycationic polymers, PVP is a non-
condensing polymer which does not condense DNA into a polyplex.47 PVP binds to 
DNA through hydrogen bonding between DNA and PVP, which makes the DNAlPVP 
complex have less negative charge density, shielding the charged DNA from the aqueous 
environment, and becoming more hydrophobic than DNA alone. The formation of 
DNAlPVP complexes may lead to improved cellular uptake of DNA and enhance the 
transfection efficiency.48 
Figure 2.1: Chemical Structure of the Polyvinylpyrrolidone 
Poly (N-Vinylpyrrolidone) 
~o
(f 
Polyvinylpolypyrrolidone (PVPP), a cross-linked form ofPVP, is a water-insoluble 
polymer. PVPP is considered as a non-condensing agent which can be used in 
biochemical techniques such as DNA extraction. 
( 
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Poly (4-vinylpyridine-N- oxide) (PVPyNO), the N oxidation product ofpoly 
(vinylpyridine), is a water soluble polymer. Poly (4-vinylpyridine-N-oxide) has a charge 
separation across the N+-+O- bond with a large dipole moment which can fonn a partial 
complex with water to transfonn the N-O group into a weak acid. Holt presented 
evidence suggesting that poly (4-vinylpyridine-N-oxide) and other non-ionic polymers 
are able to inhibit cytotoxic activity in cell cultures. 49 Figure 2.2 shows the structure of 
some polymers which are covered in the study. 
Figure 2.2: Structure of Polymers in the Study 
Poly (2-vinylpyridine-N-oxide) Poly (4-vinylpyridine-N-oxide) 
Poly (2-vinylpyridine) Poly (4-vinylpyridine) 
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2.1.2 Cationic Polymers 
There are examples ofpolyanionlpolycation interactions in many biological systems. 
The cationic polymers have been investigated intensively as non-viral gene delivery 
systems.50 Due to their ease ofmodification, ready synthesis, and robust properties, 
cationic polymers have proven to be more efficient gene delivery systems than other 
cationic vectors (such as cationic lipids). 
Although many cationic polymers can condense DNA spontaneously, they still have 
limited efficiency for in vitro and in vivo gene delivery. 51 The chemical modification of 
polymers and the use of specific cell-targeting ligands may be alternative solutions for 
improving transfection efficiency and gene expression. Many chemically different 
cationic polymers have been investigated.22 However, most polymeric vectors have 
lower gene transfer efficiency than viral carriers. To improve the efficiency, there is a 
need for a better understanding of the intracellular trafficking and polymer 
structure/activity relationships in order to design an optimal polymer with virus-like 
qualities for gene delivery.52 
Poly (4-vinyl-I-methylpyridinium bromide) (PVMP Br) is a cationic water soluble 
polymer with ion-exchange properties. Polyethylene glycol (pEG), a polyether 
compound, is a low-toxicity hydrophilic polymer with unique physicochemical properties 
such as high water-solubility, high flexibility and large exclusion volume. PEG can be 
used in many areas from industrial to medicinal and is also FDA-approved as a 
component of various pharmaceutical formulations. PEG conjugates with other 
(cationic) polymers have been demonstrated to have the ability to improve the 
transfection efficiency. 53-54 
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Poly (4-vinyl-I-methylpyridinium) bromide and PEG are among the polymers 
included in this investigation. 
Figure 2.3: Chemical Structure ofPoly(4-Vinyl-l-methylpyridiniumbromide) and 
Polyethylene glycol (pEG) 
P4VMPBr PEG 
2.1.3 Polyethylenimine (PEl) 
Among the various synthetic polycationic vectors, polyethylenimines have shown 
particular advantages in delivery system applications. Polyethylenimine (PEl), one of 
the cationic polymers, has been investigated and widely employed for the design of non­
57
viral gene delivery vectors by many researchers for decades.55- The benefits ofusing 
polyethylenimine (pEl) as a non-viral transfection system are due to the fact that it has 
strong DNA compaction capacity with an intrinsic endosomolytic activity. 58-59 
The structurally different PEls are categorized into linear or branched types with a wide 
range ofmolecular masses. Different molecular weights and degrees of branching of 
PEls have been synthesized and evaluated for their in vitro or in vivo use. 
Branched PEl is made from an acid-catalyzed aziridine ring opening reaction. 
Commercially available branched PEl with molecular masses around 25 kDa is the most 
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frequently study polymers. The linear PEl polymers are made by the hydrolysis of poly 
(2-ethyl-2-oxazoline). Most of the amines in linear PEl are secondary amines, only the 
terminal groups are primary amines. In the recent revision by the van Harpe group, they 
have updated the previous information about the ratio of the primary, secondary and 
tertiary amino groups in branched PEls from the ratio of 1:2:1 (previous information) to 
closer to 1: I : I. 60 Boussifet al reported that non-protonated amino groups in PEl 
provided a high buffering capacity.41 The significant buffering capacity of the PEls 
makes an attractive feature for proton sponge applications. 
The phenomenon known as the "proton sponge effect" is the binding ofcationic 
polymers to lipid groups on surface membranes, which then enter an endosome resulting 
in large buffering capacity. Once these cationic nanoparticles enter into an acidifying 
lysosomal compartment, the non-protonated amino groups (proton acceptor) are capable 
of sequestering protons that are supplied by a proton pump enzyme in the membrane. 
As protons enter the endosome, this process keeps the pump functioning and leads to the 
retention ofone cr ion and one water molecule per proton. This influx of water causes 
the endosome to burst, releasing the delivery vectors into the cytosolic space. 
PEI is considered one of the most densely charged polymers due to the primary, 
secondary and tertiary amino groups, which exhibit this protonation property. Every 
third or fourth nitrogen atom carries a positive charge at physiological pH conditions 
therefore the nitrogens are able to buffer the relatively large number ofprotons in the 
endocytotic vesicles and keep the acidic lysosome balanced in pH. 
The buffering capacity ofPEl leads to osmotic swelling and rupture ofendosomes, 
resulting in the release of the vector into the cytoplasm. Researchers also found that 
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linear (PEI-22K) and branched (PEI-25K) resulted in similar transfection efficiencies but 
a different effect with liposome complexes. 60 The transfection efficiency of PEl 
depends on both buffering sponge effects and molecular weight.61 -62 Generally~ both 
branched and linear PEls are considered good candidates for non-viral vectors in vitro 
and in vivo.63 The interaction between the positively charged polymer backbone and 
negatively charged DNA leads to the formation ofpolyplexes.64 
The positive charges of PEl are balanced by an influx of counter ions~ which will 
protect DNA from degradation, such as osmotic swelling, bursting, and release into 
cytoplasm. PEls show excellent ttansfection efficiency in many types of cells.6s With a 
strong DNA condensation capacity and intrinsic endosomolytic activity, PEl is 
considered one of the most effective polymer-based non-viral gene carriers over other 
68polycations.66­
Studies on the interaction between quadruplex DNA and polycationic polymers have 
attracted much attention in the past decades.69 Sun and co-workers 70 have reported that 
PEl can be used with G-quadruplex ligands, which could stabilize and regulate intra­
72
molecular G- quadruplexes and condense DNA to form a compact structure.71 ­
Figure 2.4 shows the structure of the polyethylenimine, denoting the primary, 
secondary and tertiary amine sites. Figure 2.5 shows the branched PEl structure. 
\
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Figure 2.4: General Structure of PEl with Primary, Secondary and Tertiary 
Amines 
/Tertlary amiD". 25% 
H2N-(CH2CH27>X-(CH::PH2,H).vt 
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Primary 
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Figure 2.5: Branched Polyethylenimine 
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Adopted from Kulkarni, R Petal., PNAS 2005, 102, 7523·7528 
PEl can induce the formation of a G-quadruplex structure via electrostatic 
interaction and condensation effect. Figure 2.6 shows the formation of G-quadruplex by 
PEl condensation via negatively charged DNA and positively charged PEl through 
electrostatic interaction. 
Figure 2.6: Condensation of Anionic DNA with Cationic PEl 
DNA PEl PEIIDNA 
Adopted from Sun, H. et aI, Bioorganic & Medicinal Chemistry letters. 2009, 19,4669-4672 ( 
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2.1.4 Cross-Linking 
Cross-linking, one of the useful techniques for polymer structure modification, is a 
process by which long chains of polymers are linked together (usually at random sites in 
the middle of the chains), increasing the molecular mass and forming network polymers. 
Cross-linking reactions may occur by chemical or physical processes which are possible 
in natural or synthetic polymers. Physical cross-linking is a reversible reaction and 
occurs on the surface of the polymers. Chemical cross-linking, an irreversible and 
typically stable reaction, can be done by joining the chemically reactive groups within the 
polymer structure to form cross-links with other polymer molecules. 
For the chemically reactive groups, specific chemical processes are the basic 
elements for the cross-linking reaction. Amine, carboxyl, sulfhydryl, aldehyde or 
hydroxyl groups are some of the typical chemical reactive groups which are required for 
cross-linking. Covalent bonds, ionic bonds or hydrogen-bonds can all be used in the 
formation ofcross-links. 
The properties of the polymer can be modified by the degree of cross-linking. For 
example, polymers with a higher degree of cross-linking will produce stiffer and more 
rigid materials which will increase the polymer strength, improve the resistance to 
chemicals, etc. 
2.1.5 Cross-Linking Polymers 
High molecular weight cationic polymers possess low gene transfection efficiency 
74
and often high cytotoxicities.73- In the efforts to develop a safe and efficient polymeric 
gene vector, modification of the polymeric vectors has been widely used. 75-76 Cross­
(
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linking, copolymerization, grafting and conjugation are common practices of the polymer 
modification processes which can be applied to polymers to improve the gene delivery 
c: h' h c:. ill' d I .. 577·78system lor 19 er gene translectlon e IClency an ower tOXICIty. ' 
2.1.6 Amine-Aldehyde Reaction 
Isophthalaldehyde has two carbonyl groups which can react with the primary amine 
(from PEl) to form cross-links. The primary amines (R-NH2 or ArNH2), can undergo 
nucleophilic addition in which the carbonyls can react with primary amines to form stable 
imine bonds, creating cross-linked nanoparticles. Aromatic aldehydes, such as 
isophthalaldehyde, usually make stable imines with either aliphatic or aromatic amines, 
unlike aliphatic aldehydes, where the imines readily hydrolyze in water. 
2.1.7 Pre-Screening Polymer Candidates for Nucleic Acid Delivery System 
Cationic porphyrins are known to have a high affmity for binding to quadruplex 
DNA by intercalation or outside stacking to DNA.79 In the present work; we used 
porphyrins as a probe to investigate the binding interaction between DNA and polymers. 
The porphyrin contains four pyrrole rings with conjugated double bonds and four methyl 
pyridinium groups at the meso positions. This metal-free tetra-cationic porphyrin 
structure has similar molecular dimensions as the G- tetrad; thus it has a good fit for 
intercalation or stacking with the quadruplex structure.80-81 Porphyrins are also known 
to bind and stabilize different types of G-quadruplex structures and form DNA-porphyrin 
complexes. 82-87 Electronic spectroscopy is used to evaluate the binding ofporphyrin to 
quadruplex DNA with selected polymers. Free porphyrin has a Soret band with a A.max of 
422 nm; in the presence ofquadruplex DNA, the porphyrin binds and the Soret 
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absorption maximum shifts to longer wavelength (Amax =433 nm). When binding of 
DNA and porphyrin is disrupted - by stronger binding between quadruplex DNA and 
polymers, for example - the Soret Arnax will shift back to the free porphyrin wavelength. 
This data can provide us with information on strength and mode ofbinding by the 
polymer candidates. 
Structure of Porphyrin 
2.2 DNA Structure and Function 
2.2.1 Nitrogen Bases, Nucleosides, and Nucleotides 
Purine and pyrimidine derivatives are the nucleobases which are required for 
formation of nucleosides and nucleotides. Purine is a bicyclic base which consists of a 
six-membered and a five-membered nitrogen containing rings fused together, with four 
nitrogens in the position of 1,3, 7, and 9. The naturally occurring purine bases are 
adenine (A) and guanine (G). The monocyclic bases are pyrimidines. Thymine (T), 
uracil (U), and cytosine (C) are the most common pyrimidine bases. Uracil has a 
structure similar to thymine but lacks a methyl group-uracil is found in RNA, thymine is 
in DNA. 
Pyrimidine and purine bases have at least one N-H position which can be linked to a 
sugar to form the basic building blocks for nucleic acids. In the nucleic acids and 
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polymers, the adenine and guanine (purine bases) are complementary with thymine/uracil 
9O
and cytosine (pyrimidine bases) to form different structures.88'
Figure 2.7: Major Purine and Pyrimidine Bases 
Purine Base 
Adenine (A) Guanine (G) 
6-amino urine 2-amino-6-oxy urine 
o 
N 
HN I ' :):~NAN > 
Pyrimidine Base 
Cytosine (C) Thymine (T) 
(2-oxy-4-amino pyrimidine) (2, 4-dioxy-5-methyl pyrimidine) 
o 
HN I ~N 
H 
Uracil (U) 
(2, 4-dioxy pyrimidine) 
I 
I 
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Nucleosides are glycosylamines consisting ofthe sugar (ribose or deoxyribose) and 
nitrogenous base. The nitrogen base joins together with sugar component via a 
~.glycosidic linkage which is attached to the N-9 position of a purine base or to the N·l 
position of a pyrimidine base. Nucleotides are the basic monomer building blocks 
which, when joined together, make up the structural units of nucleic acids. The only 
difference between the nucleosides and the nucleotides is that the nucleotide contains one 
or more phosphates linked to carbon 51 ofthe sugar through a phosphate ester linkage. 
The alternating sugar and phosphate groups link together in a long chain to form the 
backbone ofa nucleic acid. Figure 2.8 shows the formation of a polynucleotide. 
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Figure 2.8: The Formation of Polynucleotide 
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Adapted from www.click4biology.info: DNA Structure 
2.2.2 Deoxyribonucleic Acid (DNA) 
2.2.2.1 History of the DNA 
Nucleic acids are polynucleotides, a polymeric compound, consisting ofa number of 
nucleotide monomers covalently bonded in a chain. DNA (deoxyribonucleic acid) and 
RNA (ribonucleic acid) are the most common polynucleotides. Deoxyribonucleic acid 
(
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(DNA) is the unit ofheredity which is associated with the transmission ofgenetic 
information in almost all activities ofcells. 
In 1869, scientist Johann Friedrich Miescher was the first person who isolated DNA. 
In 1919, the major components of DNA were identified by a Russian-American 
92biochemist, Phoebus Levene.91 • The first DNA sequences were confirmed by William 
Astbury, who used X-ray diffraction to disclose DNA patterns in 1937.93 The fact that 
DNA carried genetic information was proved in 1952 by Alfred Hershey.94 James 
Watson and Francis Crick applied Chargarrs rule to modeling the DNA structure; the 
famous DNA double helix structure was proposed in 1953.95 
2.2.2.2 Base Pairing Role in Nucleic Acid Structures 
Nucleic acid base pairings are very important for the formation ofa variety ofDNA 
structures. The structure of DNA depends upon the nitrogen bases which join together 
through hydrogen bonds. Nucleotide base pairing follows rules during replication, 
transcription, and translation. Base pairings are important in sequence-specific 
recognition for nucleic acid. Hydrogen bonding plays a role in maintaining the stability of 
the molecular structure. The base-pairing rules govern the appropriate geometry 
relationships for hydrogen bonding which allow only the correct pairs to form in a stable 
structure. For example: DNA structures with high GC content are more stable than 
structures with less GC content. Adenine and guanine (the purine bicyclic molecules) 
pairs are energetically unfavorable since the larger rings are too close to each other which 
lead to molecular overlapping and repUlsion. The cytosine and thymine (also uracil) have 
a single-ring (pyrimidine) small molecular structure. Cytosine and thymine pairs or 
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pairing with uracil are also an energetically unfavorable due to the two bases being too 
far apart. The only favorable pairings are the GC pairings or AT (AU) pairings which are 
energetically favorable for a stable molecular structure. 
The G'C pairing and A-T pairing are usually arranged in "Watson-Crick" base 
pairing where maximally three hydrogen bonds are formed between G'C pair and two 
hydrogen bonds are formed between A'T pair. (Figure 2.9) These conformations are 
involved in the cis hydrogen bonding pattern and is symmetrical to the C l'---C I ' vector 
of the two bases. 96 
Some other alternate hydrogen bonding patterns between base pairs can also occur 
in the nucleic acids, such as the wobble base pair and Hoogsteen base pair. Base pairing 
is a mechanism which can provide messages for molecular recognition. The Hoogsteen 
base-pairing model is different from the Watson and Crick model. using the N7 atom of 
the purine instead of the Nt atom to form the hydrogen bonding. Figure 2.10 show the 
difference between Watson-Crick and Hoogsteen base pairing models. 
{ 

\
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Figure 2.9: 	Watson-Crick Base Pairing- A: T and G: C fonned by hydrogen 
bonding A-T base pairing fonn two hydrogen bonds and G-C base 
pairing fonns three hydrogen bonds. 
A:T Base Palmg 
G:C Base PairiDg 
! 
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Figure 2.10: Difference between Watson -Crick and Hoogsteen Base Pairing 
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Adapted from Mathews, C.K.; Van Holde, K.E., Biochemistry 2/e. 1990,The Benjamin/Cummings 
Publishing Co., Inc. 
2.2.2.3 Tautomerization of DNA Bases 
The four DNA bases are all polyfunctional bases, and may exist in tautomeric fonns. 
Tautomers are isomers of organic compounds that interconvert by a chemical reaction 
(tautomerization) usually migration of a proton and the shifting of bonding electrons. 
Tautomerism, the equilibrium between two such different structures, can play an 
important role in non-canonical base pairing in nucleic acids and might have biological 
significance. In DNA, the nucleotide bases nonnally are in the keto fonn. However, the 
keto and enol fonns exist in dynamic equilibrium. Adenine and cytosine are cyclic 
amidines which exist in either amino or imino fonns. Guanine and thymine can have 
alternate molecular structures based on different locations of a particular proton. The 
cyclic amide structures ofguanine and thymine can exist in either lactam (keto) or lactim 
(enol) tautomeric fonns. The keto fonn occurs when the proton bonds to a nitrogen atom 
\
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in the ring. An enol fonn occurs when the proton bonds to the exocyclic oxygen. Both 
guanine and thymine can switch easily between tautomers. The tautomeric fonns change 
shape which can affect the three-dimensional structure of the molecule. The tautomeric 
fonns exist in equilibrium but the amino and lactam tautomers are more stable and 
therefore predominate inside most cells under physiological conditions.97 Figure 2.11 
shows the tautomers ofnucleobases (A, C, G, T) in imino or lactim fonn. 
( 
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Figure 2.11: Tautomers of Nucleobases 
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2.2.3 DNA Structure 
DNA is a highly polymorphic molecule. The structures ofDNA have a variety of 
conformation and structural motifs, including primary, secondary, tertiary and other 
higher order structures. The terms primary, secondary, tertiary, and quaternary structure 
were first defined in 1951 by Kaj Ulrik Linderstrem-Lang, a Danish protein scientist.98 
Primary structure is the raw sequence ofnucleotide bases in each ofthe complementary 
DNA strands. The secondary structure is how the strands ofDNA are arranged. This can 
involve two or more strands, hydrogen-bonding in a highly specific way determined by 
the primary structure. Most ofthe DNA in cells occurs in double helix structures. 
However, other arrangements are also possible in the genome. The double helix DNA 
under certain conditions can accommodate a third strand in its major groove to form a 
triple helix structure (such as Hoogsteen triplexes). The three-stranded helical DNA has 
been observed and studied by some researchers.99 In addition to three-stranded DNA, 
the four-stranded tetraplex structures also have been shown to exist; they have been 
found in some of the multiple folded protein or coiling protein molecules in a multi­
subunit complex or in higher order DNA structures. Quadruplex DNA has been found in 
a variety of organisms particularly in telomeric repeats units. 
( 
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Figure 2.12: Typical Double Strand Formation- The two strands are anti-parallel (one 
strand is 5' to 3' direction, the other strand is 3' to 5' in opposite direction). 
Adapted from Horton, R.A., Principles ofBiochemistry, 4/e, 2006 Pearson Prentice Hall, Inc. 
2.2.3.1 Alternative DNA Conformation 
DNA is usually a double helix with the two strands running in opposite directions. 
DNA can adopt other secondary structures which form various possible conformations 
and shapes. Each structural conformation is found to be dependent on the specific base 
sequence patterns in which each plays its different biological role. lOO Under different 
applied forces such as twists or hydration conditions, DNA duplex can adopt many 
helical conformations that include the well- known A- DNA, B- DNA and Z-DNA, 
although this does not cover all conformations. Only B-DNA and Z-DNA have been 
directly observed in functional organisms. Z -DNA has been difficult to study because it 
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does not exist as a stable feature of the double helix structures. Instead, it is a transient 
structure that is occasionally induced by biological activity and then quickly 
disappears. IO! Z-DNA occurs in a dynamic state, forming transitions between left­
handed Z-DNA (during the physiological processes) and right-handed B-DNA (relaxing 
state) with the formation of the BZ-junctions.102 
BFormDNA 
The most common DNA double helix structure in solution is known as B-DNA. B 
form DNA is a right-hand double helix structure which usually occurs in a high humidity 
and low salt condition. In this structure, two single strands are antiparallel and 
intertwined together to form a helix. The B-DNA structures are very similar to Watson 
and Crick's modeL However, there are still numerous variations in the structure and the 
individual base pairs. Many bases are not exactly planar but are slightly twisted 
(propeller twist) in B-DNA. 
Figure 2.13: B-DNA Base Angle Orientation 
B·DNA Base Orientation· Propeller Twist 
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Adapted from www.biochem.arizona.edu 
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B-fonn DNA has all its bases in the anti-confonnation; the intertwined strands are 
organized with the bases which create two grooves in different size: a major (wider) 
groove and a minor (narrow) groove. The wider major groove is easily accessed by 
proteins. The stability of the B-DNA double helix is detennined by hydrophobic base­
stacking interactions (van der Waals forces) between adjacent base pairs and hydrogen 
bonds fonning between the base-pairs and grooves.I03-104 
A FonnDNA 
A-DNA occurs only in a dehydrated condition and usually is observed in RNA and 
RNA-DNA duplexes. When B- DNA undergoes an applied force such as a high salt or 
alcohol solutions, the DNA structure may change to A- DNA. A-DNA is a right-handed 
compact structure; its helix is shorter and wider than B-DNA. A-DNA has a deep and 
narrow major groove so it is not easily accessible to proteins. However, the wide and 
shallow minor groove allows proteins to stack inside. I os 
Z Fonn DNA 
It was not unti11970s, that the first single- crystal x-ray revealed the structures of 
the left-handed double helix DNA fragment. The alternating pyrimidine-purine 
sequences (especially poly (dGh) in alcohol or high salt solutions tend to have Z fonn 
structure. Transition from the right-handed B fonn to the left-handed Z fonn is due to the 
upside-down flip of the base pairs through a rotation ofevery other purine from the anti 
to the syn confonnation. The two anti-parallel chains wind to the left which causes the 
backbone to fonn a zigzag pattern by Watson-Crick base pairs.106 Z-DNA has a 
(
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narrower, more elongated helix than A form or B form DNA. Z-DNA can form a 
junction with B-DNA in a structure which involves the extrusion of a base pair. \07 
Z-DNA is a higher energy form of the double helix structure which is stabilized by 
negative supercoiling.108 
It has been proposed that A- form DNA (low humidity) is considered to be more 
hydrophobic and results in the different packing modes of DNA. 109-1 10 Table 1 is the list 
of comparison of the A, B, Z forms ofDNA. 
Table 1: A-Form, B-Form and Z-Form Geometry Comparison 
Geometry 
Attribute 
A-form B-form Z-form 
i 
Helix sense right-handed right-handed left-handed 
Repeating unit I bp 1 bp 2bp 
Rotationlbp 33.6° 35.9° 60°/2 
Mean bp/turn 11 10.5 12 
Inclination of bp 
to axis 
+19° -1.2° -9° 
Rise/bp along axis 2.4 A(0.24 urn) 3.4 A{0.34 
urn) 
3.7 A(0.37 urn) 
Rise/turn of helix 24.6 A(2.46 urn) 33.2 A {3.32 
nm) 
45.6 A(4.56 urn) 
Mean propeller 
twist 
+18° +16° 0° 
Glycosyl angle anti anti pyrimidine: anti, 
purine: svn 
Sugar pucker C3'-endo C2'-endo C: C2'-endo, 
G: C2'-exo 
Adapted from reference 109-110 
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Figure 2.14: Band Z Form DNA Double Helix Conformations 
The major difference between B-DNA and Z-DNA is that B-DNA possesses 
a minor and major groove. Z- DNA only has minor grooves 
Band Z Form DNA 
Adapted from: http://bioinf.mpi-inf.mpg.de 
Triplex DNA 
Three stranded helical DNA structures have been observed and have been studied 
intensively by some researchers. The formation of the triplex DNA occurs when 
pyrimidine or purine bases occupy the major groove of the DNA double helix forming 
Hoogsteen pairs with purines of the Watson-Crick base pairs. The purine bases ofDNA 
have hydrogen bonding donors and acceptors that are able to form two additional 
hydrogen bonds (Hoogsteen base pairs) in the major groove. 111 
As a pre-requisite, the DNA duplexes must contain only purine bases in one strand 
and only pyrimidines in the complementary strand. These duplexes are capable of 
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forming a triplex with a third pyrimidine strand in a homopyrimidine/homopurine region 
ofDNA. Thus, the triple-helical DNAs using Hoogsteen pairings consist of two homo-
pyrimidines and one homo-purine and the homo-pyrimidine third strand is parallel to the 
homo- purine strand. Triple helices consisting of one pyrimidine (T, C) and two purine 
113(A, G) strands were also proposed. For example: A * AT or G*GC. ll2­
Figure 2.15: Triplex DNA 
A third strand of DNA can fit in the major groove ofduplex DNA to form triplex DNA. 
Duplex DNA (grey) interacts with the third DNA strand to form a triplex (blue). 
a) 
b) Example of the Chemical Structure of triplex DNA 
C.-GC T-AT 
Adapted from www.atdbio.com!contentJ13/oligonuleotides-as-drug 
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2.3 DNA, Telomeres and Telomerase 
2.3.1 Mechanism of Gene Delivery System 
Since the mid-l 960s there has been interest in using gene therapy applied to the 
possible treatment of genetic disorders. In 1990, the first phase I gene therapy clinical 
trial was reported with promising results. I 14 Genes, the basic units of heredity, have 
specific sequences ofbases that encode instructions for the production ofproteins. 
When gene sequences are altered, the encoded proteins are not able to perform their 
normal functions, which create genetic disorders. Gene therapy is a technique which has 
the potential to correct the defective genes and treat the genetic disorder disease. 
From the years 1989 to 1994, many gene-based therapy protocols were approved 
worldwide for treatment of the inherited genetic disorders. I IS There are many different 
methods of gene delivery which have been developed for a variety of cell types and 
tissues, ranging from bacterial to mammalian.116-117 Gene carriers need to overcome 
many obstacles ofboth intra and extracellular barriers to reach the target site. The intra 
and extracellular barriers include crossing the plasma membranes, escape from 
endocytosis vesicles, migration to the nucleus, then release of the genetic information at 
the appropriate location. 
Typically gene delivery methods can be divided into viral and non-viral systems. 
A virus is capable of transferring its genetic materials into host cells. Although viral 
vectors are highly efficient in gene delivery, there are still problems with safety and other 
limitations. The disadvantages have encouraged researchers to focus on alternative 
systems - non viral methods. 118-119 Non-viral synthetic vectors are able to interact with 
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negatively charged DNA through electrostatic interactions and condense DNA particles; 
therefore allowing transfer of the genetic materials into target cells. 120-121 
Figure 2.16 illustrates the formation of the polyplex and cellular uptake via an endocytic 
pathway in the following steps. 
Step one: DNA is condensed with a mixture ofpoly cations-ligand (for receptor-
mediated uptake) to form a polyplex. Step two: Receptor-mediated uptake of the 
polyplex into the endosomal vesicles. Step three: Acid-triggered deshielding and 
exposure of the positive inner polyplex core. 122 
Figure 2.16: Cellular Uptake via an Endocytic Pathway 
DNA _~_ complexation 
_~ of DNA • 
_ --.........--.... binding to the 

polycation _ ~+.~ lI!" =--. receptor 
wIth ligand  _ • ~j::=;;;;=--'.) ~~  ~••-':''''r'('i 
endocytosis Ji. endo;orn" 
Image adapted from website: nano-lifescience.com 
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2.3.2 DNA Replication 
In all living organisms. DNA replication is the basic process for passing down 
biological inheritance. Before cell division. a copy of DNA must be made for the 
daughter cells. This process is called DNA replication. 
The replication begins with the "unzipping" of the parent molecule and uses the 
original double-stranded DNA molecule as a template for the reproduction of the 
complementary strand. Hence, following DNA replication. two identical double stranded 
DNA daughter molecules have been produced from each original double-stranded DNA 
molecule. Figure 2.17 gives the explicit structure of the DNA replication fork. 
Figure 2.17: DNA Replication Fork 
Jmagine adapted from http://notesforparkistan.blogspot.com 
When completing the replication processes; two DNA molecules are formed 
identical to each other and identical to the parent strand. DNA polymerase and other 
proteins work together to initiate the elongation of DNA.123-124 These two strands serve 
(
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as the templates in which one is called the leading strand and the other is called the 
lagging strand. The DNA polymerase can read the template and continuously adds 
complementary nucleotides to the template. The leading strand template is oriented in a 
3' to 5' direction. The lagging strand is oriented 5' to 3' but will create DNA fragments in 
the 3' to 5' direction. DNA has a ladder-like structure with hydrogen bonds holding two 
DNA strands together. When the hydrogen bonds are broken, the resulting structure can 
form a fork shape which is made up from two single strands DNA. The replication fork is 
a structure that forms within the nucleus during DNA replication.125 
A problem that occurs during the replication process is that on one strand the 
replication process creates discontinuous fragments of daughter strand DNA. This is 
because, DNA synthesis can only occur in one direction (5' to 3'). The original DNA 
strand must be read from 3' to 5' to produce a 5' to 3' nascent strand. One of the daughter 
DNA molecules must synthesize in a discontinuous manner. The resulting 
polynucleotide segments (called Okazaki fragments) are then stitched together into the 
lagging strand by DNA ligase I. 
127Figure 2.18 illustrates the process of the DNA replication.126• Step 1 is the 
unwinding process. Step 2 is preparation for replication. Step 3 is elongation of the 5'-3' 
template and the 3'-5' template. Step 4 is a connection step (join DNA fragments). In the 
lagging strand the DNA polymerase I (exonuclease) reads the fragments and removes the 
RNA primers. The gaps are closed with the action of the DNA polymerase and DNA 
ligase. 
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Figure 2.18: The Steps of the DNA Replication 
Step3 
Step I SI..,,2 
S' ,.. 
S' TAC,," .. ~TACA 
;a' ATGT 
" 
AT•• -r- cC> 2' A"'fG'I' ",_', 
S' .. ~-::-..? .. 
Step 4 
S' 
_ ~"" ""11:(­
.. 
Imagine adapted from www.DNAReplication.Info 
2.3.3 Telomeres and Telomerase 
In 1938 Hermann J. Muller, a remarkable scientist, was the first to discover and 
name the telomeres. Muller found that telomeres served as protective caps that could 
protect DNA from damage when the DNA replication cycle took place. 128 In the past 
few decades, telomeres have gained attention for many researchers because ofmany 
interesting topics relating to cellular aging and cancer. Telomeres have been shown to 
form a variety ofG-quadruplex structures. 129 G-quadruplex structures are now being 
considered as targets for drug design.130 
Telomeres are structures located at the ends of the chromosomes which protect 
chromosomal DNA from degradation and recombination, and is part of the complex 
133cascade oforganism aging. 131 • The chromosomes are a long strand of coiled DNA, 
located inside the nucleus. The structure of the telomere consists of simple tandem repeat 
135DNA sequences, Human telomeres have the sequence (TTAGGG)n.134• These 
(
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repeating sequences make up a portion of the double-strand telomeric DNA with a piece 
of single-strand tail overhanging the G-rich 3' end DNA which contributes to the 
secondary structure of the telomere. The human overhanging sequence consists of 100­
137200 telomeric repeating units which could form G-quadruplex structures. 136. 
The chromosomes shorten at the ends in every cycle of cell division, eventually 
impacting needed genetic material. Telomeres play an important role in preventing the 
140degradation of the chromosomes.138. The known biological function of telomeres is 
to protect the chromosome ends from fusion, degradation and to maintain the integrity of 
the genetic material in the chromosomes. 141·143 
In 1940, Barbara McClintock discovered the behavior of the ruptured chromosomes 
which resulted in fusion and adhesion of the end of the chromosome. Barbara 
McClintock demonstrated that the telomere had the ability to repair the damage to the end 
of the chromosomes.l44oI45 In 1973 Alexey Olovnikov, a Soviet biologist, hypothesized 
that the telomere is critical in the understanding of aging and cancer. 146 It was not until 
1978 that Elizabeth Blackburn and Joseph Gall discovered that a reverse transcriptase 
enzyme, telomerase, plays a key role in normal cell functions as well as in cell aging or 
cancers. Elizabeth Blackburn. Carol Greider and Jack Szostak were awarded the Nobel 
Prize in 2009 for resolving the end replication problem. 147 Telomerase has the ability to 
elongate the G- rich strand oftelomeric DNA. Thus telomeres and telomerase may be 
proposed as attractive targets for the discovery ofnew anticancer drugs. 148 
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2.3.4 Telomerase and Aging 
There is increasing evidence to indicate that telomerase plays an important role 
during the replication of mammalian telomeres. 149 During a life span, cells divide over 
and over to keep the body alive, but the telomeres grow shorter with each division. To 
address the consequences of incomplete replication, nearly all eukaryote cells have the 
ability to employ a telomere at the ends of chromosome. In the absence of a special 
telomere maintenance mechanism, telomeres wi1l10se or damage some essential parts of 
DNA sequences during the cell replication cycles; which is due to the inability ofDNA 
polymerase to fully replicate the chromosome ends. The length ofthe telomeres over time 
is connected to cell aging and lifespan. 
In 1987, Blackburn and her coworkers made the astounding discovery that 
telomerase (a ribonucleoprotein reverse transcriptase) activity might be able to extend 
telomeric sequences. ISO Telomerase can synthesize telomeric repeats units and add them 
onto the ends of chromosomes. A variety ofpremature aging syndromes are associated 
with short telomeres. lsl However, the premature aging can be reversed by telomerase 
enzyme that can prevent the shortening at the ofchromosomes.1 52 In 2000, Geron 
Corporation revealed a study results that addressed the telomerase-based therapies could 
not only prevent but also reverse the aging process in humans. IS3 
2.3.5 Telomerase and Cancer 
Telomerase enzymes were found active in most human tumor cells and the 
telomerase activity is found to be involved in about 85% to 90% ofhuman cancers.154.IS6 
Cancer is a condition in which certain cells in the body are growing and dividing 
uncontrollably. Most cancers are the result of "immortal" cells which have ways of ! 
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evading this programmed destruction. IS7 Normally telomeres shorten significantly and 
will lead to cell death or sustain damage that can cause cancer,lSS Every living system 
should maintain a balance of the cells replicating and dying. If there are too many of the 
same types of cell gathering together this wi111ead to cell abnormality or cancer,IS9-162 In 
about 90% ofcancer cells telomerases have been found,163.166 For this reason, many 
researchers believe that part of forming an abnormal cell in cancer is the activation of 
telomerases. These cells use telomerase to overcome the incomplete end-replication 
problems. Te10merase will extend the leading strand of DNA to elongate the telomere. 
Telomerase inhibition has been identified as a new approach to cancer therapy. I 67·174 
Dr. Michael Fossel has suggested that telomerase therapy may be used not only to 
combat cancer but also to have an anti-aging effect and extend the lifespan significantly 
in the human body. 175 This assumption has inspired a number ofpotential therapeutic 
strategies. The inhibition of telomerase has become an attractive strategy for anticancer 
therapy since the first demonstration of telomerase inhibition by a G-quadruplex 
interactive compound in 1997.176 The formation ofG- quadruplex complexes by 
l78telomeric DNA has become a new direction cancer therapeutics. l77•
2.3.6 Quadruplex DNA 
G-quadruplex structures are a class ofDNA structures that may be useful in 
targeting telomeres. Quadruplexes are four stranded higher order nucleic acid structures. 
That guanine-rich oligonucleotides can form a quartet structure was recognized more 
than forty years ago. Gellert et al. proposed that guanine base sequences could form a 
quartet structure through hydrogen bonding. 179 A G-quartet is formed by four guanine 
! 
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bases in a square planar arrangement which provides a central cavity where each guanine 
acts as both donor and acceptor for hydrogen bonds. The oxygen lone pair of the carbonyl 
groups within the G-quartet can associate with the metal cation in the cavity site. G­
quartets can arise between G-rich strands (intermolecular) or within G-rich nucleic acid 
sequences (intramolecular). 
The level of interest in the G-rich structures have increased markedly in the past 
decade due to the fact that guanine-rich single-stranded overhang structures can be folded 
into quadruplex structures under certain physiological conditions.180 These guanine-rich 
quadruplex structures were found in G-rich eukaryotic telomere ends as well as in non­
telomere genomic regions including gene promoter regions,18I immunoglobulin switch 
region,182 and sequences associated with disease. IS3 There are studies on some naturally 
occurring eukaryotic telomere repeat DNA sequences which all contain a 3' single strand 
overhang to form quadruplex structures such as d(ITAGGG)n (found in vertebrate 
chromosome including Homo sapiens), 184 d( ITITGGGG)n (from Stylonychia), 
d(ITTAGGG)n (from Arabidopsis), and d(TGGGGT)n (from Tetrahymena) 
G-quadruplex DNA displays an amazing structural polymorphism, and different 
typologies of G-quadruplex may be associated with different cellular processes. The 
polymorphism of the G-quadruplex structure may provide insight for achieving 
therapeutic selectivity for drug design. ISS 
2.3.7 Quadruplex Structure 
G-rich four-stranded structures can form in different ways, by folding and base­
pairing ofone, two, three, or four DNA strands. In particular, the number ofstructures 
involving guanine tetrads has been an area of increasing interest in the past few decades. 
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It is well known that DNA oligomers containing repeating guanine bases can form 
specific motifs. The fundamental structural units of the quadruplex consist of a planar 
arrangement of four guanines connected by hydrogen bonds for each side (tetrad), with a 
central channel formed by stacking of guanine tetrads that can accommodate selectively 
certain cations. 186 These planar G-quartets will stack on each other to form a higher-
order DNA structure, which is called a G_quadruplex.187-188 Figure 2.19 illustrates the 
forming of the G-tetrads and G-quadruplex structures. 
Figure 2.19: G-tetrads and G-quadruplex Structure. 
Structure of tetrad shows hydrogen bonds between four guanines and the 
a cation (M) located in the center. 
xl 
... 1'-"'+-"" 
G-quadruplex
G-tetrad 
Numerous studies have been shown that G-quadruplex structures are biologically 
important in both in vivo and in vitro systems.189-1 90 The structural polymorphism of 
G-quadruplex DNA has been proven to affect the cellular functions. 191 The biological 
relevance of the G-quadruplex may be involved in many areas: regulation of telomerase 
activity, controlling biological phenomena, functional molecules, and nano-materials. 
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The polymorphic nature of the G-quadruplex structure might also explore the promising 
future for using as a building block ofthe novel nanomaterials.192 
2.3.8 G-Quadruplex Architectures 
G-quadruplex structures have a rich structural diversity which can align through 
mismatch, triple, triad, tetrad ~d hexad alignments, resulting in unique DNA 
architectures, that differ in the number and orientation of strands and pairing 
alignments. 193 The organization ofthe chain direction gives rise to a large number of 
possible topologies. The possible structural folding topologies of the quadruplex have 
multiple conformations which can be described as parallel, antiparallel or mixtures of 
these two forms. The Viglasky group has reported how protruding nucleotides can 
destabilize the G-quadruplex structure, and the overhanging sequences can influence the 
folding of the quadruplex.136 
The topologies ofdifferent G-quadruplexes are affected by the orientation ofthe G-
quartet core, the synlanti conformation ofguanine residues, the association ofmetal 
cations, and the types of linking 100ps.I94-2oo The possible orientation of the G­
quadruplex architectures may exist as unimolecular, bimolecular or tetramolecular 
structures which connect their backbones with a variety ofloop types to build different 
conformations of the G-quadruplexes. 201 In recent review articles of G-quadruplex 
structures, 26 possible topologies have been reported. 202 However, only a few 
topologies have been proven to exist in vitro 203, and there is even less knowledge of in 
vivo architectures. 
I 
f 
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The G- quadruplex structure appears to be stabilized by a hydrogen-bonding 
network which comprises a stack of two or more G-quartets linked by the phosphodiester 
backbone and stabilized by a specific monovalent ion. The structural diversity and 
stability of G-quadruplex structures depend on many factors: strand stoichiometry, 
connecting loops, strand polarity, glycosidic torsion angle, and coordinated cations. 
Strand stoichiometry: Strand stoichiometry allows G-quadruplexes to be formed from 
one, two, three or four strands from unimolecular to quadrimolecular structures. 204-206 
Figure 2.20: Examples of Various Strand Stoichiometries of 
G-Quadruplex Structures 
(A) One-stranded: a unimolecular G-quadruplex. 
(B) Two strands: a bimolecular G-quadruplex. 
(C) Four separate strands: a quadrimolecular G-quadruplex. 
A B c 
Loop connectivity: A loop can connect guanines in a variety ways to form 
unimolecular or bimolecular G- quadruplexes.207 Figures 2.21 and 2.22 show 
examples of loop connectivity ofguanine tetrads. 
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Figure 2.21: Unimolecular: Different way of Strand Loop Connectivity for 
Guanine Tetrad Structure (A, B, C) 
A B c 
Figure 2.22: Bimolecular: Strand Loop Connectivity to form Various Guanines 
Tetrad Structures (A, B, C, D, E). 
A B c o E 
Strand Polarity: Strand polarity can induce the various sequences and different 
structures arrangement in G-quadruplex. For example: all parallel, mixed parallel and 
antiparallel, adjacent parallel or alternating antiparallel.208-21I 
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Figure 2.23: Strand Polarity Arrangements in G-Quadruplex Structures: 
(A) all parallel, (B) three parallel and one antiparallel, (C) adjacent 
parallel and (D) alternating antiparallel. Arrows indicate 5' to 3' 
polarity 
A B c o 
Torsion Angle: The glycosidic torsion angle is the key factor to determine the G­
quadruplex structure's orientation for paraUel or anti-parallel strands. The glycosidic 
conformation changes the relative orientations of the bases in contiguous guanine tetrads 
and affects the stacking energy. Parallel strands have the same glycosidic torsion angle. 
Antiparallel strands have the opposite glycosidic torsion angle. Rotation around the 
glycosidic bond enables the guanine base to interconvert between the syn and anti 
conformations. The stacking of the guanine tetrads for parallel and antiparallel 
conformations will produce different spaces in the grooves. A parallel strand will create 
four medium sized grooves; an antiparallel strand will create three types of grooves: 
wide, medium and narrow grooves.212-215 
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Figure 2.24: Example of the syn/anti conformation structure by the rotation 
of the glycosidic bond 
The bond rotation can convert syn into anti or reverse conformations. 
fI 
o N ~ N~N 
M~o 

o 
3' 
The presence of cations is an essential element for the formation of G- quartets. The 
nature of the cation can induce the conformational changes (parallel or anti-parallel) in 
G-quadruplex structure. For example, the potassium ion (K) will often induce a parallel 
structure. 216 Venczel and Sen reported that divalent cations (Mg2+, Ba2) are also 
present in a parallel G-quadruplex structure. The sodium ion (Na) usually induces an 
anti-parallel conformation. The calcium ion (Ca2) can induce a structural transition ofG­
quadruplex from the antiparallel to parallel conformation.217 
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Figure 2.25: Depiction of the G-Quadruplex DNA Structures: Example of the 
Parallel and Anti-Parallel 
Parallel Structure 
d(TGGGGT) d(ATGOOUTAGGGT) 
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four stranded parallel structure external loops, propeller type structure 
Anti-Parallel Structure 
d(GGTIGGTGTGGTTGG) d(GGGGTTTIGGGG) 
( 
lateral loops, chair type structure diagonal loops, basket type structure 
Adapted from Paramasiva, S. et ai, Method 2007, 43(4), 324-331 
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Groove Effect: Groove dimension is controlled by the glycosidic torsion angles (syn 
lanti) and strand polarities. The space between the glycosidic torsion angles and strand 
polarity of the quadruplex can be classified as wide (w), medium (m) or narrow (n) size 
of the grooves. J99 Figure 2.26 and 2.27 show the examples of the groove effect. 
Figure 2.26: Two pairs of adjacent Parallel Strands·create two 

Medium Grooves 

Medium 
Figure 2.27: 	 The alternating Anti·Parallel Strands: generate two 
Medium and two Narrow Grooves 
Wide 
G-quadruplex DNA displays an amazing structural polymorphism; different 
topologies of G-quadruplex may be associated with different cellular functions. 
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Therefore, the polymorphism ofthe G-quadruplex can provide insight for achieving 
therapeutic selectivity for drug design. As shown in Figure 2.28 and 2.29, the overall 
topologies available to G-quadruplex structures depend on the combination of 
antiparalleVparallel orientation ofguanine tracks and arrangement of the loop. 
Figure 2.28: Structures of G-Quadruplexes. Schematic representation of G­
quadruplex structure: (a) G-quadruplex with three stacked quartets, (b) A 
tetramolecular parallel G-quadruplex and antiparallel (c) intermolecular antiparallel G­
quadruplexes (d) intramolecular fold over G-quadruplex. 
(a) G-quadruplex, linked bytbe DNA backbone (b) Parallel and Antiparallel quadruplex 
ParaDe. ADtlpa raUel Tbree stacked qartets 
G~.adra:pleJ: 
(c) Intermolecular antiparaUel (d) Intramolecular foldover 
G-quadruplex G-quadruplex 
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Figure 2.29: Examples of inter-and intramolecular quadruplex DNA conformation 
(a) Tetramolecular parallel. (b) Bimolecular antiparallel. (c) Unimolecular antiparallel. 
(d) Unimolecular antiparallel. (e) Unimolecular parallel. Many sequences can also form 
mixed structures or are polymorphic 
Tetramolecular parallel Bimolecular antiparallel 
a b 
Unimolecular antiparallel Unimolecular antiparallel 
d 
Unimolecular parallel 
e 
Adapted from Huppert, IL., Phil. Trans. R. Soc. A, 2007,365, 2969-2984 
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2.3.9 The Stability of Quadruplex Structures 
The quadruplex DNA structures are considered as compact and resistant to DNAses, 
preventing the cleavage ofphosphodiester linkages in the DNA backbone. The 
quadruplex structures are more stable than duplex DNA due to the presence ofmore 
hydrogen bonding between the guanine bases. Quadruplex DNA has higher melting 
temperatures than duplex DNA, which could also be due to the presence of the G-quartet 
stacks stacking. 199 There have been a large number ofpublications on structure and 
other properties of the quadruplex structures since the late 1980s.202.203 However, there 
is still insufficient understanding of their basic physical properties. 
The stability of the quadruplex structures are determined by the following factors: 
the base stacking, hydrogen bonding, van der Waals forces, electrostatic interactions, the 
nucleotide sequence, ionic strength, cations and temperature. Hydrogen bonding is one 
of the important factors which can control the formation ofboth secondary and tertiary 
structures. The hydrogen bonds, van der Waals forces, ionic interactions, and 
hydrophobic interactions are intermolecular or intramolecular attractions which can 
influence the nature of the biological structure. 
The structure and stability of intramolecular quadruplexes are profoundly influenced 
by the length and composition ofthe 100pS.218 Increasing the loop length will increase 
the binding affinity of the quadruplex DNA. The loop length will influence the 
quadruplex conformation; short loops favor parallel conformations. With increasing loop 
length, quadruplex conformations prefer intra-molecular and anti-parallel 
conformation.219 
56 

The ion-binding site is a cavity between two G-quartets that is lined with eight 
0-6 atoms from guanines participating in the coordination of cations. The negatively 
charged cavities located between the G-tetrads can be stabilized by the coordination of 
cations (monovalent or divalent) present in the center of the cavity. With the presence of 
the monovalent or divalent cations in the center, the size of the ion will affect the 
interaction with the G_quartet.220 In general, the ionic radius is a parameter that decides 
how well guanine tetrads are stabilized by various cations. 
Kang and coworkers, using X-ray, studied the d (G4T4G4) and reported that 
pocket stacking stabilized the quadruplex structure by forming the stacking in the 
adjacent G-quartet.221 The switching between various conformations can be induced by 
the presence ofdifferent cations and difference in temperature. Miyoshi's group had 
found that, in low concentration, divalent cations can destabilize the anti parallel G­
quartet ofd(G4T4G4) structure in the following order Zn2+>C02+>Mn2+>Mi+>Ca2+. 222 
Particularly, higher concentrations ofdivalent cations can induce structural transition 
from antiparallel to parallel structure. 223 Chen reported that divalent cation induced 
quadruplex structural change such as self-assembly (Mg+2) and formation ofquadruplex 
(Sr+2).224-225 Monovalent as well as divalent cations are an integral part ofG­
quadruplex structure, and without these cations, G-quadruplexes are unstable.226 
2 .3.10 The Biological Role of the G-quadruplex DNA 
Rising interest in G-quadruplex structures has been evident in the large number of 
publications, books and articles. The biological functions ofquadruplex DNA were a 
relatively unexplored area for decades. In the last few years, the biological significance 
57 

of these G-quadruplex structures has been explored. Evidence has been found that 
227quadruplex structures may be involved in many different biological phenomena.

G-quadruplex DNA has been studied in vitro and in vivo for some biological species. 

The studies have indicated that G-quadruplex DNA might play important roles in cellular 

functions such as control of gene expression,228 regulation of gene transcription, and 

genomic stability.229-234 

The unusual conformation of G- rich quadruplex-forming sequences have led to 
'd bl' b .. . h cancers, ce 11 . 235-238 d a so IconSI era e mterest y aSSOCIatIOn WIt agmg processes an 
participation in gene regulation and telomere maintenance.239-245 The G- quadruplex 
structures were described as playing a role in the inhibition oftelomerase activity by 
negatively regulating through the G-quadruplex, influencing multiple cellular processes 
(transcription, translation, and replication).246-247 
G-quadruplexes have been considered as a potential therapeutic target for human 
cancer because they can inhibit telomerase activity, and some quadruplex-interacting 
drugs can induce senescence and apoptosis of cancer cells.248 Therefore, the use of 
specifically designed G- rich sequences has motivated scientists to develop new classes 
ofanticancer therapeutics, therapeutic interventions and as potential targets for the design 
and development ofnovel anticancer drugS.249-253 
2.3.11 Porphyrin Chemistry 
5,10, 15,20-tetra-(N-methyl-4-pyridyl)porphyrin (TMPyP4). a heterocyclic aromatic 
conjugated compound, is composed of four pyrrole subunits. These pyrrole rings with 
conjugated double bonds are connected so that electrons are delocalized over the 
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macrocyc1e, which induces intense absorption bands in the visible region. The 
stabilization of quadruplex DNA by TMPyP4 is in part due to x-x stacking interaction 
between the porphyrin ring and the guanine-tetrad. A porphyrin with no metal ion in the 
central cavity is called a free base. There has been considerable interest in the synthesis 
of porphyrins with various substitution patterns in their ability related to the biological 
functions. 37 Cationic porphyrins have been known to interact with DNA and form 
DNA-porphyrin complexes. The interactions between porphyrins and their derivatives 
with DNA have been widely studied for potential applications in biological and medicine 
sciences.254-259 It has been reported that the cationic porphyrins can interact with native 
DNA and nuc1eotides through various binding modes including intercalation,260-262 
external binding,263-27J random binding,272-274 and self_stacking.275-279 
It has been proposed that the mode ofbinding to the quadruplex DNA is "face on", 
including the end stacking to G-tetrad or nearby diagonal loop. In the external stacking 
mode, the cationic side arms of the porphyrins probably stabilize the quadruplex structure 
by reducing the electrostatic repUlsion between the anionic phosphates of the backbone of 
the lateral or loops. In the external groove binding mode, the antiparallel quadruplex 
DNA structure, it has been found that the porphyrin binding might be located in the 
narrow or wide groove by outside stacking.180 The cationic porphyrin and derivatives 
(TMPyP2, TMPyP3, and TMPyP4) have been reported to be G-quadruplex-interactive 
agents that demonstrated selective binding behavior with different G-quadruplex 
conformations.281 
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The UV-Vis absorption spectra ofTMPyP4 have shown to be responsive to the 
quadruplex stabilization.282 However, it has been reported that this occurs through 
external stacking rather than intercalating with G-quadruplex structures. 
TMPyP4 is a potent inhibitor ofhuman telomerase. The interaction ofthe cationic 
porphyrin derivative with G-quadruplex DNA has the ability to inhibit telomerase due to 
stabilization of the telomere.283-284 In addition, porphyrins can be used as photo 
chemotherapy agents to treat cancer since they remain longer in cancer cells than in 
normal cells after injection.285-286 Porphyrins linked to oligonucleotides produce various 
types ofphoto-damage to the target site of DNA. Figure 2.30 shows the chemical 
structure of the porphyrin and its derivates. 
Figure 2.30: The Chemical Structure Porphyrin and derivates 
R1 = CH2~NJ 
R2=H 
R1 = CH2~N(CH3)3 
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R2 = CHlI'=N(CHah 
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CHAPTER 3 INSTRUMENTATIONS 

3.1 Spectroscopy 
Spectroscopy is the study of the absorption and emission of light with matter. The 
interaction between the matter and radiated energy depends on the process and is a 
function of wavelength. Light has particle-like or wave-like characteristics which can 
serve as the reference of electromagnetic radiation. The given frequency or wavelength 
oflight is associated with an energy (photon). Frequency (u) and energy changes are 
proportional to one another, but wavelength (A) as an inverse relationship to these 
quantities (u = ciA). Different regions of the electromagnetic spectrum provide different 
kinds of information about the structure of the atoms or molecules. The electromagnetic 
spectrum ranges from very short wavelengths (including gamma and x-rays) to very long 
wavelengths (including microwaves and broadcast radio waves). The following chart 
displays the important regions of the electromagnetic spectrum. 
Figure 3.1: The Electromagnetic Spectrum 
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3.1.1 Quasi-Elastic Light Scattering I Dynamic Light Scattering 
Dynamic Light Scattering (DLS), also known as Photon Correlation Spectroscopy or 
Quasi-Elastic Light Scattering (QELS), is widely used in determining the size distribution 
profile of small particles, diffusion coefficients, and molecular weights ofpolymers in 
solution. 
The incident light on the particle scatters in all directions, and one is able to 
determine the distribution of the particles' movement by measuring dynamic fluctuations 
intensity of scattered light. The intensities of the scattered light are determined by size, 
shape and molecular interactions in the scattering particles. Light scattering is a valuable 
tool for measuring molecular weight, radius of gyration, translational diffusion constant 
and so on. 287 
When the laser light strikes the dispersed particles or macromolecules suspension in 
a medium, it is interacting with randomly moving particles. The intensity of the 
fluctuating scattered light at a different angle and time will depend upon the size of the 
particles. The small particles move faster than the big particles. These fluctuations occur 
due to Brownian motion; analysis of the fluctuation will yield the velocity. The velocity 
ofBrownian motion is measured as the translational diffusion coefficient. This 
translational diffusion coefficient (D) can be related to particle size through the Stoke­
Einstein equation. Therefore, it is possible to estimate the size ofdistribution, diffusion 
coefficient and the hydrodynamic radius of a molecule from DLS measurements.288-290 
The molecular weight measurements are usually obtained by static light scattering; 
however, there are a few advantages for using dynamic light scattering techniques to 
determine the molecular weight. For example: (i) it can be used to analyze the broad 
\
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distributions of species of wide molecular masses; (ii) its high sensitivity allows detection 
of very low amounts « 0.01%) of higher mass species; (iii) there is no mass loss during 
the measurement (not like chromatography method, SEC); (iv) time saving due to a short 
experimental time; (v) automation; (vi) a modest development costs for using LS 
instrument. 
The major parts of the light scattering instrument include a monochromatic coherent 
laser as a light source, photon detector and auto-correlator (Figure 3.2). When a laser 
light beam passes through the sample, that light is scattered by particles at all angles. The 
scattering light passes through the photon detector which detects the scattered light at a 
given angle. The purpose for using the same scatter angle is to produce the identical 
mean size particles. The fluctuations of scattered light are converted into electrical 
pulses and pass the digital correlator. The auto-correlator generates the autocorrelation 
function for data analysis. 
Polydisperse samples (with a broad distribution ofparticle size) have shown a 
number of modes in DLS measurement, such as a main peak: and aggregation 
information. Measuring the intensity of fluctuations at a given scattering angle can 
provide information about the scattering particles hydrodynamic radius. When particles 
in a suspension diffuse through the suspending medium, the effective radius of an 
irregularly shaped particle is called the hydrodynamic radius of a particle. 
{ 

63 

I 
Figure 3.2: Schematic diagram of a conventionalt 900 dynamic light scattering 
Instruments 
A conventional dynamic light scattering instrument is including: 

A monochromatic coherent laser (light source) with a fixed wavelength of 

633nm; a focusing lens, one detector only detects the scattered light at one 

angle (usually 900 ), a digital correlator. 
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3.1.2 Theory 
As spherical monodisperse non-interacting particles are placed in a dust-free fluid; 
the scattering light will mutually interfere in different directions. In reality, all the scatter 
particles are undergoing Brownian motions and leads to fluctuations of the scattered 
intensity I (t). Dynamic light scattering is measuring the intensity of fluctuations which 
is recorded in the time domain via a time autocorrelation function. The scattered light 
intensity in time t is described as I (t); in a very short time, the intensity of the scattered 
light is described as I (t+t). As time goes on, the measured intensities will no longer 
correlate to the beginning state due to there is no similarity between the starting state and 
the current state. The light-scattering spectrum can be obtained from the autocorrelation 
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function of the scattering light intensity. A characteristic autocorrelation function (Eq.l) 
ofthe scattered light is shown below where intensity (I) can be detennined 
experimentally. 
As the particle moves through the beam the intensity reaches a maximum and then 
decays. The decay time of the correlation function is inversely proportional to the line 
width of the spectrum. The decay of the autocorrelation is described by an exponential 
decay function G (t) which relates the autocorrelation to the diffusion coefficient (D) and 
the measurement vector K. Therefore, the diffusion coefficient and either particle size or 
viscosity can be found by fitting the measured correlation function to a single exponential 
function. The decay of the autocorrelation is described by an exponential decay function 
in equation 2. 
Equation 1: Autocorrelation Function 
Equation 2 : Decay of Autocorrelation 
Equation 3 : Monodisperse Particles- Correlation Function 
G(r) =Aexp(-2fr) +B 
G (t): the sum ofall exponential decays contained in the correlation function 
A: baseline of the correlation function 
B: intercept of the correlation function 
r : decay constant proportional to the diffusion coefficient (D) 
I 
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Equation 4: Polydisperse Particles: Correlation Function 
gJ: Sum ofall exponential decays contained in the 
Correlation Function 
Equation 5: Decay Constant 
D: Translational Diffusion Coefficient 
q: (41t n/~) Sin (8/2) 
n: Refractive index ofsolution 
~: Wavelength ofLaser 
8: Scattering angle 
Diffusion coefficient: 
By fitting the points of the autocorrelation to the function G (t), the diffusion 
coefficient can be measured and related to the equivalent sphere ofdiameter d using the 
Stokes - Einstein equation (Equation 8). The diffusion coefficient (D) ofthe particles 
can be calculated in the following equation. 
Equation 6: Diffusion Coefficient (D) 
TKBD=-,;;;;.. 
3TCTJd 
T : Absolute temperature 

KB : Boltzmann constant 

17 : Viscosity 
I 
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Equation 7: Frequency of the Scattering Light 
2nn eK=- Sin (-]
A 2 
K is a constant related to the frequency of the scattering light (A) 
n: Refractive index of the medium 
.A.: Laser wavelength 
0: Scattering angle 
With the assumption that the particles are spherical and non-interacting, the 
hydrodynamic radius can be calculated from the Stokes-Einstein equation. The 
hydrodynamic radius is calculated based on an equivalent sphere with the same diffusion 
coefficient. 
Equation 8: Stokes-Einstein equation 
kT 
r= 
6n:1}d 
r hydrodynamic radius (m) 

k = Boltzmann constant (J1K=kg·m2/s2·K) 

T = temperature (K) 

'll = solvent viscosity (kg/m's) 

d = diffusion coefficient (m2/s) 
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Figure 3.3: Example of Autocorrelation Function ofthe scattered light 
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The dynamic scattering technique can be used to distinguish protein secondary 
structures. The advantage of using dynamic scattering is the possibility to analyze 
samples containing broad distributions of species of widely differing molecular masses 
(e.g. a native protein and various sizes ofaggregates), and to detect very small amounts 
of the higher mass species. Commercially, dynamic light scattering is a rapid, reliable, 
accurate and cost saving powerful tool for determining the size of particles and related 
information. Also, sample concentration is not a critical issue for obtaining the needed 
293information.291 - Actually, the main benefit is that the measurement doesn't require 
solution or multiple concentrations like MALLS. Data can be obtained at a single 
concentration. 
In the present study, we apply the light scattering technique to measuring the 
particle size of the cross-linked polymer nanoparticles and also studied the interaction 
and aggregation between the polymer (PEl) and cross-linker. 
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3.2 Nuclear magnetic resonance (NMR) 
Nuclear magnetic resonance spectroscopy (NMR) is a prominent technique that 
addresses many questions of structure and dynamics using the interaction ofradio 
frequency electromagnetic radiation with matter. NMR spectroscopy is widely used by 
chemists and biochemists to investigate the properties oforganic compounds and 
determine structure at the molecular level. Some isotopes are of particular interest to 
organic chemists e.g., IH, J3e, 19F and 31p, which have spin of i (1 Y2). The versatility 
ofNMR makes it pervasive in scientific research. NMR has the capability to perform 
multi-dimensional and multinuclear experiments. One-dimensional NMR spectroscopy 
is commonly used to elucidate simple chemical structure. Some advanced applications of 
NMR techniques can be used to assist scientists to investigate further details in the 
determination of molecular structure, such as multidimensional NMR, solid state NMR, 
and gradient enhanced spectroscopy. 
3.2.1 31 P NMR and IH NMR 
We will not attempt to discuss the basic theory of the IH or 31 P NMR. IH NMR and 
31 P NMR are important analytical tools for structure elucidation in chemistry, biology 
and medical science. The 31 p NMR spectroscopy has proven to be a useful technique in 
probing the secondary structure ofDNA and RNA in solution. The 31p nuclei, with 100% 
natural abundance and spin.!., are sensitive to the environment (such as o-p-o bond 
2 
angle and p-o torsional angle)?94-295 We have used 31p NMR to investigate the binding 
interaction between quadruplex DNA and polymers. 
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3.2.2 Diffusion NMR 
Many methods for structure elucidation ofsmall molecules and proteins have 
been well established for many years. The study of the solution behavior ofmolecules, 
proteins and nucleic acids for aggregation or interaction properties in solution are 
interesting fields for biochemical science. The intermolecular interactions, molecular 
recognition processes, and binding behaviors at the molecular level provide essential and 
important information for understanding the biological activities ofmolecules. Nuclear 
magnetic resonance spectroscopy is the method of choice for studying molecular 
dynamics in chemical and biological systems?96-298 
In the past years, diffusion NMR methods have become useful for measuring 
diffusion in solution. In principle, translational diffusion is one of the most basic forms 
oftransport in chemical and biological systems. When diffusion occurs in a 
homogeneous medium it will be a free and isotropic diffusion. The diffusion coefficient 
will reflect the shape and size ofa molecular species; which provides information on the 
molecular aggregation as well as size and structure oflabile systems. Diffusion NMR 
measurements are now widely used to explore and understand the interactions and shapes 
ofthe diffusion molecules.304-308 
Diffusion NMR spectroscopy is commonly used to examine closely separated 
mixtures, or to screen ligands for binding interactions. It can give unique insight as a 
reliable guide for measuring the apparent molecular weight, secondary and tertiary 
304-308 S .. d' . . I hr h' h d C'.structures. orne SCIentIsts accre It It as a specla c omatograp IC met 0 lor 
physical component separation. 
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The diffusion ordered spectroscopy, or DOSY, experiments provide a way to 
separate the different compounds in a mixture based on the differing translation diffusion 
coefficients. Diffusion is analyzed in the DOSY experiment by observing the exponential 
decay of the NMR signal due to the diffusion taking place between a coding and a 
decoding gradient. The pulse field gradients methods are used as a direct or indirect way 
to probe molecular dynamics in solutions. The diffusion measurement usually carries out 
by observing the attenuation of the NMR signals during a pulsed field gradient 
experiment. During the experiment, a series ofNMR diffusion spectra are acquired as a 
function of the gradient strength. The degree of attenuation is a function ofthe magnetic 
gradient pulse amplitude (G) and is proportional to the diffusion coefficient (D) of the 
molecule. The vertical axis shows the corresponding diffusion constants (D) of the 
molecules; the horizontal axis is encoded the chemical shift of the nucleus observed (such 
as IH). The molecular structural properties and size relationships can be obtained from 
the diffusion coefficient constant. 309 
3.2.3 IH NMR: Diffusion Experiment 
In proton diffusion experiments, there are two gradient pulses applied: one before 
the refocusing 1800 pulse and the other is after the 1800 pulse. These two gradient pulses 
are identical in amplitude (G) and width (d). They are separated by a time (0) and are 
placed symmetrically about the 1800 pulse. The first gradient pulse is to dephase 
magnetization according to its position in the NMR tube. During the subsequent 0 period, 
the spins are left to evolve and diffuse. Their chemical shift is refocused by applying the 
usual 180° pulse. At the end of the 0 period, the spins that have diffused to a new 
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location in the NMR tube will not be refocused by the second gradient and will therefore 
attenuate the signal. These gradient pulses have no effect on stationary spins. During the 
experimental process, the echo time is left constant while the gradient strength G is 
varied (usually along the z-axis). The loss of magnetization can be plotted against the 
gradient strength to extract the diffusion coefficient D. 
Figure 3.4: Example of the IH NMR: Diffusion Experiment 
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The self-diffusion coefficient for Brownian spheres is given by the Stokes-
Einstein equation. The Stokes-Einstein Equation (equation 8) relates the diffusion 
coefficient (D) ofa particle to its molecular shape via a friction coefficient (f) and 
temperature. 
Equation 9: Diffusion Coefficient (D) 
D=KT/f 
T : Temperature (Kelvin) 
K: Boltzmann constant I 

f : Fraction coefficient 1 
\ 
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lithe solute is considered as a spherical particle with the effective hydrodynamic 
radius (RD) in a solution of the viscosity (11); the friction coefficient (t) is given as the 
following equation. It should be noted that different theoretical descriptions are needed 
to describe the hydrodynamic frictional coefficient (t) for molecular species ofdifferent 
geometries. 310-312 
Equation 10: Friction Coefficient (t) 
f=62t 11 RD 
f: Friction coefficient 
RD: hydrodynamic radius 
11: solution viscosity 
Indeed, the diffusion coefficient factors are affected by molecular shape, size, 
solvent viscosity, and the solution properties such as salt concentration, pH, and 
temperature, etc. It is well known that molecular self-diffusion coefficients (D) are 
measured by a pulsed field gradient spin-echo NMR experiment. Three most practical 
gradient field methods are pulsed gradient spin echo (POSE), pulsed field gradient 
stimulated spin echo (PFO-SSE) and bipolar pulse longitudinal eddy current delay (BPP· 
LED). This technique is based on the application of the gradient field, which encodes 
and decodes the translational diffusion motion of the components in samples. To obtain 
the diffusion coefficient distribution from these experiments, the signal attenuation is 
detected and it depends on the gradient strength, the delay time between the pulse 
gradients and the diffusion coefficient of the molecules. Using the pulsed field gradient 
method, motion can be measured by evaluating the attenuation of the spin·echo signa1.313 
The attenuated signal (A) can be calculated by the following equation. 
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Equation 11: Attenuated Signal (A) 
A 22 ..2 d 
- = exp l G g a (T- - )] D 
Ao 3 
A: Measured peak intensity 
Ao: Maximum peak intensity 
D: Translational diffusion coefficient ~in cm2/s) 
g: Gyromagnetic ratio (2.675 I 97x 10 G-1S-1 for IH) 
d: Duration ofgradient 
T: Diffusion time (time between gradients) 
G: Gradient strength (G/cm) 
Data are plotted according to the following equation and D is calculated as the slope. 
Equation 12: 
The self-diffusion constant is measured in m2S·l. Smaller molecules have larger 
D values (diffuse faster); the larger molecules move more slowly with small D values. 
The Stokes-Einstein equation assumes spherical molecules that are much larger than the 
solvent molecules. 
3.2.4. Nuclear Overhauser Effect Spectroscopy (NOESy) 
The Nuclear Overhauser Effect (NOE) is the transfer of nuclear spin polarization 
from one nuclear spin population to another via cross-relaxation. The nuclear spins 
undergoing cross-relaxation are those which are close to one another in space, and the 
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effect decays at a rate of,-6 (r is the distance between the two nuclei). Thus, only atoms 
within a close distance (smaller than 5A) can give a nuclear Overhauser effect. The spin­
spin coupling can be observed by short-range dipolar couplings through close proximity 
in three-dimensional space. 
NOESY, two-dimensional nuclear magnetic resonance spectroscopy (20 NMR), 
is one of the widely used techniques to study the conformation ofmolecules. NOE's are 
observed as the cross-peaks between two coupled nuclei. NOESY cross peaks ofa 
spectrum indicate which protons are close in space. Thus, NOESY will allow for an 
estimation of the inter-nuclear distances and can provide precise molecular 
conformation.314-315 The NOESY spectrum can provide all possible correlations 
information such as the nuclear Overhauser effect, chemical exchange and 
conformational exchange to provide insight into molecular conformation and 
dynamics?15 
3.3 Ultraviolet-Visible Spectroscopy (UVNis) 
UVNis absorption spectroscopy (sometimes called electronic spectroscopy) covers 
the ultraviolet-visible region ranging from the near-UV to the near-IR. The absorption 
measures electronic transitions from the ground to the excited state as a function of 
frequency or wavelength due to its interaction with a sample. UVNis spectroscopy is 
commonly used in the quantitative determination of solutions of transition metal ions and 
highly conjugated compounds. The UV and visible wavelength ranges are from 190 to 
800 nrn. Figure 3.5 displays the visible spectrum ranges from 400 nrn to 800 nrn. 
Absorption ofultraviolet and visible (UV-Vis) radiation in both atoms and 
molecules is associated with excitation ofelectrons from low energy to higher energy 
75 

levels. The electron transition can either emit or absorb the energy. Most of the 
absorption in the UV-Vis spectroscopy occurs due to n-electron transitions or n-electron 
transitions within the molecules. Bonding to anti bonding (n - n*) and non-bonding to 
antibonding (n - n*) transition usually occur in UVNIS spectroscopy. The energy of 
light absorbed energetically is from the highest energy bonding n-orbital (HOMO) to the 
lowest energy antibonding n-orbital (LUMO). Figure 3.6 shows the diagram of the 
electron transition between the bonding, non-bonding and anti-bonding orbitals. 
Figure 3.5: Diagram of visible spectrum wavelength (400nm -800nm) 
Visible SpectrumHigher Lower 

Frequency Frequency 

uv 
I 
500 600 700 
IR 
Wavelength in nanometers 
Imagine adapted from www.oocities.org 
Figure 3.6: Diagram of the electron transition between the bonding, 
non-bonding and anti-bonding 
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UVNis can be used in a wide range of analytical applications to measure the 
absorptive behavior ofsubstances. The most routine measurement for UV-Vis is used as 
qualitative or quantitative analysis ofthe sample species. The qualitative measurement is 
served as identification for determining the molecular species, in which a given 
molecular species absorbs light in specific regions of the spectrum. For example, UVNis 
can be used in HPLC detector to identify the unknown analyte species. The quantitative 
analysis is measured the beam ofradiation through a sample and detects the intensity of 
radiation that passes through the sample. The Beer-Lambert law is often used as a 
quantitative method to determine concentrations of absorbing species in solution. The 
absorbance (A) is directly proportional to the concentration ofthe absorbing species in 
the solution and the path length. Thus, UVNis spectroscopy can be used to determine the 
concentration and molar absorptivity of the compound in dilute solution. 316 The molar 
absorption, known as molar extinction coefficient (s), is measured the molecule absorbs 
light at a particular wavelength. 
Equation 13: 	Beer -Lambert Law 
A= ebC 
A: absorbance (no units, since A = 10glO (10 I 1) 
s: molar absorptivity with units of L mor l cm") 
b: the path length of the cuvette (cm). 
c: concentration of the compound in solution, (mol L"I) 
I: Intensity 
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Figure 3.7: A Diagram of a Double Beam Spectrometer 
Diagram adapted from www. chemguide.co.uklanalysisluv-visible/spectrometer 
3.4 Circular Dichroism (CD) 
3.4.1 Basic Theory 
Circular dichroism (CD) is a chiroptical method which can be used to measure the 
differential absorption ofrotational plane-polarized light of optically active compounds. 
The interaction between the chromophores in the chiral field introduces the perturbations 
leading to optical activity. CD measures the difference of the absorption ofright- and 
left-handed circularly polarized light from chiral molecules. CD spectroscopy is used 
extensively to study higher order structures of chiral (asymmetric) macromolecules ofall 
types and sizes, particularly in proteins and DNA. The wavelength range of CD is 
included far UV, ultraviolet light as well as infrared light. The UV light range from180­
300 nm is most commonly used in CD for DNA measurement because the DNA bases 
absorb light in this range. 
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The majority of biological molecules are chiral compounds. CD is sensitive to 
the conformational changes, structure and stability of the secondary or tertiary structure 
ofproteins and DNA. CD spectroscopy can provide the representative structural 
information about the molecules, such as kinetic and thermodynamic information on 
macromolecules. Therefore, circular dichroism makes it an attractive and powerful tool in 
the biomolecule field.317 
The CD instrument measures the difference in left (L)and right (R)-handed 
absorbance of the circularly polarized light, (AA= AL-AR) A more convenient 
characterization of CD is the difference in the molar extinction coefficients, 8 E (Delta 
Epsilon) is a function of wavelength which typically corresponds to an ellipticity (9) and 
is expressed in millidegrees.318 
Circular dichroism (CD): M (A.) =AL (A.) - AR (A.), where A. is the wavelength. 
Molar circular dichroism (88): 8E =EL -ER (EL and ER is molar circular dichroism 
ofleft and right circularly polarized light) 
Molar extinction coefficients: EL : left circular polarized light (LCP) 
ER : right circular polarized light (RCP) 
Molar concentration: C (giL), C is concentration 
Path length: I (centimeters). 
!J. A= (EL -CR) CI, measured as degrees of ellipticity 
If a right (R) and a left (L) circularly polarized wave ofequal amplitude, are 
superimposed, the result is plane-polarized light. Figure 3.8shows how the E vector of 
each will sum up in part A. Similarly, plane-polarized light can be decomposed into R 
and L components. If the amplitudes of the two circularly polarized waves are not the 
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same, the resultant E vector will follow an elliptical path and such light is said to be 
elliptically polarized. Elliptical polarized light is composed ofunequal contribution ofER 
and EL circular polarized light. The degree ofellipticity (8) is defmed as the tangent ofthe 
ratio of the minor to major elliptical axis. Linear polarized light has 0 degrees of 
ellipticity. Figure 3.9 shows the examples ofthe left-handed and right-handed ellipticity. 
Degree ofellipticity [8] =3298.2 A E 
Figure 3.8: Elliptical Polarization 
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A 
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ER : magnitude of the electric field vector of right-circularly polarized light 

EL : magnitude of the electric field vector of left-circularly polarized light 
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Figure 3.9: Example of the left-handed and right-handed ellipticity (9) 
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A circular dichroism signal is defined as positive or negative, depending on 
whether L-CPL(circular polarized light) is absorbed to a greater extent than R-CPL (a 
positive CD signal) or to a lesser extent ( a negative CD signal). The CD instrument is 
quite sensitive and is capable of measuring with millidegree precision. 
CD is a particularly powerful technique for examining the conformational 
changes ofproteins and nucleic acids. CD is usually used in monitoring the structural 
changes due to changes in environmental condition, such as temperature, ionic strength, 
denaturants and pH.319 The advantages of using CD spectroscopy are as follows: (1) 
very little amount of sample is required in biological buffers (200~1 of0.5 mg/ml solution 
in standard cells), (2) CD will not destroy or decompose the compound and (3) CD can 
be monitored very accurately. One drawback of CD measurement is interference by 
solvent absorption in the UV region. For better performance in CD measurement, the 
sample is required to be in dilute solution with non-absorbing buffer for measurements 
below 200 nm. Figures 3.10 and 3.11 give examples of CD spectra to provide useful 
references for a variety of nucleic acid structures, ranging from single-stranded to 
quadruplex forms. Single strand has one positive peak at 276 nm and one negative peak 
at 250 nm. Duplex DNA has one negative at 246 nm and two positive peaks at 260 nm 
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and 285 run . Parallel quadruplex DNA has one negative peak at 236 run and one positive 
peak at 270 nm. The antiparallel quadruplex DNA show two positive peaks at 246 nm, 
300 nm and one negative peak at 260 nm. 
Figure 3.10: 	 Example of typical reference spectra of single strand and duplex DNA 
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Adapted from Bishop, G. R. et ai, Current Protocols in Nucleic Acid 
Chemistry,1003. 
Figure 3.11: 	 Typical reference spectra of parallel and anti-parallel quadruplex 
DNA 
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CHAPTER 4 MATERIALS AND METHODS 
4.1 Materials 
Polyethylenimine, high molecular weight, water -free polymer (Mw 25000 D, unit 
molecular weight 45 D) was purchased from Aldrich (St. Louis, MO, USA). The cross­
linking agent, isophthalaldehyde, 97% and D20 deuterium oxide 99.9 atom % D were 
also purchased from Aldrich. The phosphate buffer solution was prepared with 5 mM 
.KH2P04,5 mM K2HP04, 1 mM EDT A at pH 7.0. All the solid buffer chemical 
compounds were purchased from Sigma Chemicals. EDTA disodium salt was purchased 
from Fisher. Tris buffer solution was prepared and the pH adjusted with concentrated 
KOH to pH 7.1. TRIZMA BASE was purchased from Sigma-Aldrich. Tris HCl was 
purchased from J.T Baker. Potassium chloride was purchased from Fisher Scientific. 
Dichloromethane was purchased from PHARMCO-AAPER, HPLC grade. The 0.21lm 
filters were purchased from Millipore Corporation. The DNA primer TTTTGGGG was 
purchased from Invitrogen or Sigma Aldrich (St. Louis, MO) (custom primers, 5' to 3' 
TTTTGGGG). 5,10,15,20-tetrakis (l-methyl-4-pyridyl)2IH,23H-porphine,tetra-p­
tosylate salt -Porphyrin (HzTMPyP) was purchased from Aldrich. Polyvinylpyridine, 
polyallylamine, poly (L-lysine), polyethylene oxide (PEO), poly(4-vinylpyridinium 
bromide), poly( 4-vinylpyridine N-oxide), poly(N-vinylpyrrolidone); poly( ethylene 
glycol), Poly(L-omithine )HCl, poly(2-vinylpyridine), Poly( 4-vinylpyridine) were 
purchased from Polysciences. Metafectene Pro and Metafectene Easy are a gift of 
Biontex, poly (2-ethyl-2-oxazoline) with the MW200,000 and 50,000 were purchased 
from Alfa Aesar Company. The polymers were used without further purification. 
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4.1.1 Buffer Solutions 
Potassium phosphate buffer solution (KPBS): lOX KPBS was prepared and utilized 
as a stock solution to prepare subsequent working buffer solutions for samples. Table 2 
shows the KPBS 10X stock solution preparation. The reagents were weighted and 
transferred into the volumetric flask (IL) and Q.S with the milli Q distilled deionized 
water. The buffer solutions were mixed well and filtered through a 0.45 }11Il filter (stored 
at 4°C). 
Table 2: Potassium Phosphate Buffer (KPBS) lOX Stock Solution 
Reagent Molecular Weight Grams(g) Moles 
Monobasic KH2P04 136.09 5.716 0.042 
Dibasic K2HP04 174.18 10.102 0.058 
K2EDTA:2H2O 404.5 0.405 0.001 
Working solutions were prepared by transferring 100 mL ofthe KPBS stock 
solution (10X) into I L volumetric flask and QS to the volume. The buffer solution was 
then adjusted to pH 7.0 by adding KOH (1M) solution. 
Tris buffers were prepared by adding 2.9 g ofTris-HCI, 0.072 g ofTRIZMA BASE 
and 10.8 g of potassium chloride into one liter ofdistilled water. The buffer solutions 
were mixed well and adjusted with KOH to pH 7.1, then stored under 4°C condition. 
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4.2 Methods 
4.2.1 DNA Preparation 
4.2.1.1 Dialysis Procedure 
The purpose of the dialysis treatment of the DNA oligomers is to ensure the 
purification of the oligomers. Dialysis tubing from Spectro-Pro industries with a 1000 
molecular weight cutoff (MWCO) pore size was used for DNA dialysis. Pre-treatment of 
the dialysis tubing to remove the preservative before use is required. The dialysis tubing 
was placed in DI water and heated to boiling, and sodium carbonate was added, along 
with EDTA and boiling continued to one hour. After the solution was cooled, the 
solution was removed and replaced with a large amount ofdistilled water. The magnetic 
stirring bar was placed in the bottom of the beaker to keep the water agitated. This 
procedure needed to be repeated several times to ensure that all the preservatives were 
removed. After the pre-treatment, the dialysis tubing is stored at 4°C in the refrigerator 
for future use. 
If the DNA oligomers are not HPLC grade, the DNA must be purified by dialysis 
before use. The DNA samples were placed into dialysis tubing with a large amount ofDI 
water with continuing stirred during the procedures. The water was changed every 4 
hours and this was continued for 48 hours. These procedures were repeated several times 
to ensure the complete removal ofany unwanted salt from the oligomers. 
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4.2.1.2 Quadruplex DNA Preparation 
DNA stock solutions were prepared just prior to use by reconstitution of the 
oligomer in purified distilled water. The dry oligomers were reconstituted into a given 
volume of DI water depending on the DNA concentration needed. The oligomers were 
reconstituted into DI water, and then each sample solution was lyophilized at room 
temperature to remove the water. Unused portions of the stock samples were stored 
frozen at -20°C. The DNA concentration was determined by UV-Vis (CARY 100 Bio 
UV-Vis Spectrophotometer, Varian Company). The concentrated stock solution ofDNA 
was diluted before the measurement. The concentration of the T4G4was calculated 
spectrophotometrically using the Beer's Law (A= e be) equation. 
The milli-Q purified deionized water was used to prepare the buffer solutions. 
Appropriate amounts of the DNA stock solutions were aliquot for analysis, lyophilized, 
and reconstituted into buffer. In this experiment, the dry oligomers were reconstituted 
into 1 mL ofpotassium phosphate buffer (5 mM KH2P04. 5 mM K2HP04, 150mM KCI, 
pH 7.0) prior to quadruplex formation. The sample solution was treated in water bath at 
95°C in a Fisher Scientific, model 9100 water bath for 2 minutes and slowly cooled down 
to room temperature. This process was done by heating the samples in a dry water bath, 
then turning the power off after 2 minutes, and letting the samples cool to room 
temperature slowly within the heating block. Slow cooling is to ensure a slow annealing 
ofthe DNA and subsequent formation of stable quadruplex DNA. The samples were 
equilibrated for 48 hours at 4 °C prior to analysis. The formation ofquadruplex DNA 
structure was verified by circular dichroism measurement. The gel electrophoresis (SDS 
PAGE) also confirmed the formation of the quadruplex T4G4structure. 
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4.2.2 Polyethylenimine Intra-Molecular Cross-Linking 
4.2.2.1 Intra-molecular cross-linking (in solution) 
The stock solution of saturated isophthalaldehyde was prepared by adding the 
appropriate amount of the compound in water. This saturated solution was filtered 
through filter paper to remove any undissolved material. The PEl solutions were prepared 
with different concentrations. The PEl solution was added to a saturated 
isophthalaldehyde in a drop-by-drop manner. The resulting solution was stirred for two 
hours. After two hours reaction time, the solution was precipitated by adding 2-propanol. 
The precipitated solid was air dried and re-dissolved into D20 for NMR experiments. 
4.2.3 Cross-Linking Examined by NMR Experiment 
The VARIAN INOVA 500 MHz MNR Spectrometer System was used in IH in situ 
study. This NMR spectrometer is interfaced to a workstation that controls the NMR via 
the Varian software. 
4.2.4 In Situ Study 
The IH NMR in situ samples were prepared by adding a sufficient amount of 
isophthalaldehyde into D20 solution. Due to the low solubility of the isophthalaldehyde, 
the excess amount of the isophthalaldehyde was filtered through the filter paper. The 
clear solution was used to run IH NMR as isophthalaldehyde standard spectra. The 
polyethylenimine 1H NMR sample was prepared by transferring the sufficient amount of 
compounds into 5 mL ofD20. In order to identify the optimum PEIIisophthalaldehyde 
ratio in this study, the concentration ofthe corresponding polymer solution was adjusted 
to produce different ratios. The PEIIisophthalaldehyde ratio was prepared at 5, 15, 25,67 
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and examined by in situ IH NMR. The NMR spectra were recorded on GE 300 MHZ 
spectrometer at different time points. 
4.2.5 	 Identify the Intra- Molecular Cross-Linking by Organic Solvent Extraction 
and Examined by UV -Vis 
4.2.5.1 UV-Vis Experiment 
A Cary 300E Bio or Cary 100E spectrophotometer (Varian, Inc.), interfaced to a 
Windows based computer with CaryNarian Win UV Bio version 2.0 software, was used 
for studies. Both spectrophotometers are equipped with a Peltier thermoelectric heating! 
cooling system which include a multi-cell device and a sample compartment. The 
spectrophotometers have the capabilities of using either external probe to measure the 
temperature inside of sample cuvette or the ability to use the cell block to measure the 
temperature of the sample compartment. 
To effect the intramolecular cross-linking formation, the stock solution ofPEl was 
prepared at 0.0184 M. The isophthalaldehyde stock solution was prepared at 0.0012 M. 
The volume ratio of the PEl and isophthalaldehyde was prepared at 1: 1, 3: 1, 5: 1 and 16: 1. 
The equivalent mole ratio of the PEl (by monomer mass)/ isophthalaldehyde 
was 15,45, 75 and 240. 
The extraction samples were prepared by adding the dichloromethane into the cross­
linked sample with 1 to 1 ratios. The mixtures were shaken for 10 min and allowed to 
stand for 20 minutes to separate the top and bottom layers. The pure isophthalaldehyde 
extraction sample was used as a control sample. The PEIIisophthalaldehyde mole ratio 
at 75 and 240 were prepared in the same manner with the same volume of the 
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dichloromethane. All the samples were prepared with potassium phosphate buffer at pH 
7.0. The samples were analyzed using an Olis HP 8452 A Diode Array 
Spectrophotometer. 
4.2.5.2 Intermolecular Cross-Linked PEl: bulk preparation 
The bulk samples were prepared by transferring I g of water free 25 kD 
polyethylenimine into a beaker and adding 0.1 g of the isophthalaldehyde. The mixture 
was placed into a water bath and stirred for 15 minutes under 100°C temperature control. 
This process was to remove any remaining water from PEL The products of the PEl and 
isophthalaldehyde mixture turned into a yellow solid color. In order to test the solubility 
in water, a sufficient amount ofwater was added into the final products and stirred for 30 
minutes. The PEl and isophthalaldehyde cross-linked bulk samples remained solid yellow 
color materials. The bulk samples continued to stir overnight and the remaining 
compound was still insoluble in water. This observation provided the indications that the 
bulk PEIIisophthalaldehyde reaction formed intermolecular cross-linked PEL 
4.2.6 Characterization of Particle Size by Light Scattering (QELS) 
Light scattering spectroscopy was performed in a Wyatt Dawn EOS light scattering 
spectrometer (Wyatt Technology Corporation). The Wyatt spectrometry has provided the 
multi-angle light scattering (MALS) detector and the quasi-elastic light scattering 
detector (QELS) selection. The MALS-QELS system can be used to measure radius of 
gyration (rJ and radius of hydrodynamic (rh) at the same time; the radius of gyration is 
determined from the angular dependence of scattered light intensity. The radius of 
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hydrodynamic is measured the fluctuation of the light scattering of the diffusion 
molecules. MALLS utilized 18 detectors at various angles, ranging from 15° to 180°; 
each detector was nonnalized to the 90-degree detector using an isotropic scatterer 
standard. 
The molecular aggregation behavior was studied by dynamic light scattering. The 
measurements were performed at 4°C with an incident laser light beam of 685 nm at a 
scattering angle of 90°.320 Polyethylenimine solutions were prepared at concentrations of 
0.1 M and 1.8 M in phosphate buffer at pH 7.0. Water was pre-filtered through 0.02 Jlm 
Whatman nanotop filters before being used to prepare the solution. The sample solutions 
were filtered through 0.2 Jlm filters prior to use and stored at 4°C. The isophthalaldehyde 
solutions were prepared at 0.004M in a phosphate buffer solution. The solutions were 
filtered through 0.2 Jlm filters and stored under 4°C condition. The isophthalaldehyde 
was titrated into the PEl solutions. The mixing solution was stirred for 10 minutes 
followed by 2 minutes of sonication. The molecular cross-linking reaction was perfonned 
by dynamic light scattering to investigate whether the formation of inter-molecular cross­
links (aggregation) or intra-molecular cross-links. 
4.2.7 PEl I Quadruplex DNA Circular Dichroism Study 
Circular dichroism measurement was carried out using a 62 A DS AVIV CD 
spectropolarimeter (Aviv Associates, Lakewood, NJ) equipped with a multi-cell holder. 
The temperature ofthe Peltier heating/cooling device was assisted by an Isotemp water 
bath model 9100 (Fisher Scientific). A cold water supply circulates around the Xenon 
lamp to prevent overheating. The spectrophotometer was interfaced to a DOS-based 
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computer. The AVN version 3.14 software was used for data collection and processing. 
A nitrogen purge was used to eliminate any moisture on the optics. Cuvettes were 
scanned versus water prior to experiments to ensure that no CD active impurities 
remained in the cuvettes. CD measures the interaction ofcircularly polarized light with 
molecules. All CD spectra were read from 210-320 nm at 1.0 nm increments with a 
bandwidth of Inm and a time constant of 1.0 sec at 25°C. 
Samples were prepared by reconstituting lyophilized DNA oligomer into 100 mM 
phosphate (K+) buffer solution (PH 7.0). The experiment was performed by titration with 
pre-mixed DNAIIOx PEl solution. This procedure is designed to keep the DNA 
concentration constant. The DNA-PEl titration was conducted by adding the stock 
solution ofDNAIIOx PEl stepwise (aliquot of stock) directly to 250 ilL of starting 
volume ofDNA in solution. CD spectra were measured subsequently after the spectra 
were stabilized. The stock concentration of the quadruplex DNA was 47 11M. 50 ilL of 
DNA stock solution was transferred into 450 ilL buffer solution which was made up the 
final quadruplex DNA concentration at 4.7 11M. The stock solution ofPEl was 470 11M. 
The DNAIIOx PEl pre-mixed solution was prepared at 500 ilL for the titration purpose. 
The DNA pre-mixed solution was transferred 1 III and 20 III of the each aliquot into 
cuvette of250 III of DNA (4.7 11M) solution. This fixed quadruplex DNA concentration 
is used to more readily monitor changes in the structure. 
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4.2.8 Polymers Screen Using UV-Vis Spectroscopy Studies 
To investigate the interaction between polymers and quadruplex DNA, optical 
studies were carried out using the tetra (N-methylpyridyl) porphyrin as a probe. The 
polymers used in this study are the following: poly(2-vinylpyridine-N-oxide), 
polyallylamine, poly (L-Iysine), poly( 4-vinylpyridinium bromide), poly( 4-vinylpyridine 
N-oxide), poly(N-vinylpyrrolidone); poly( ethylene glycol), poly(L-omithine)HCI, 
poly(2-vinylpyridine), poly( 4-vinylpyridine), and the lipid agents Metafectence Pro, 
Metafectence Easy. All experiments, except where specifically indicated, were 
performed at 2SoC in potassium phosphate buffer at pH 7.0. The concentration of the 
polymer solutions was varied according to their solubility in phosphate buffer. A stock 
solution of the porphyrin was prepared at a concentration of S JlM and stored in 
phosphate buffer. The porphyrin solution must be protected from light to prevent 
degradation. The order of the experiment is as follows: 
1.) UV-Vis ofporphyrin solution used as a control spectrum. 
2.) Addition ofquadruplex DNA into porphyrin solution, measurement of the UV 
spectrum. 
3.) Addition ofpolymer into the DNA / porphyrin mixed solution, measurement ofthe 
UV spectrum. 
The porphyrin UV maximum peak (Soret band) is at 422 nm when it is a free 
porphyrin. The UV spectrum of the maximum peak of the quadruplex DNA/porphyrin 
complex was observed at 433 nm. When polymer is added to the DNA /porphyrin 
complex, the Soret band may stay at 433 nm (DNA-porphyrin complex intact) or shift 
back to 422 nm (DNA-porphyrin complex disrupted). 
92 

4.2.9 lip NMR Study: Binding Interaction of Quadruplex DNA I Polymer 
All 31p NMR experiments were carried out on a Bruker DPX400 NMR 
spectrometer equipped with a BBFO broad-band probe. The spectra were taken at 31p 
frequency of 161.975 MHz, with a spectral width of 40 ppm, a 90° pulse of 9.2 fl s. The 
spectra were referenced to an external 85% phosphoric acid sample (0 ppm). All spectra 
were processed using Bruker TopSpin 1.3 software. The quadruplex (T4G4) DNA was 
incubated in a saline solution at 150mM KCl at pH 7.0 (not in potassium phosphate 
buffer) to avoid signal from the buffer. The deionized water containing KCI would lower 
the buffer solution pH which will require the researcher to adjust the pH back to pH7.0 
with 1M KOH. All polymers (polyethylenimine, poly (4-vinylpyridine N-oxide) and poly 
(N-vinylpyrrolidone) were prepared with 98% D20. 
4.2.10 Diffusion NMR Experiment 
4.2.10.1 Sample preparation 
DNA quadruplex (T4G4) concentrations were adjusted to range from 0.5-1.0 mM in 
phosphate buffer (PH 7.0). Deuterium oxide (D20) was added to DNA samples prior to 
loading into NMR tube. NMR samples were prepared about 500 ilL for the experiment. 
Polymers preparation: The maximum concentration of the polymer depends on the 
solubility of the polymer. Poly (N-vinylpyrrolidone) was prepared at 4 mM. Poly (4­
vinylpyridine N-oxide) was prepared at 1 mM. PEl was prepared from 2 mM to 10 mM. 
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4.2.10.2 	 Experiment conditions 

All samples were prepared in 90%H20/1O% D20 in order to observe the 

exchangeable imino proton of the G nucleotides. The ID and 2D IH NMR spectra were 
obtained on a Bruker A vance 600 MHz spectrometer equipped with a triple-resonance 
Tel cryoprobe, operating at 600.11 MHz for the proton frequency and using the 
following parameters: 90°; pulse, 7.60-8.50 flS; 4-8 scans; recycle time 3-8 s; spectral 
width 6000 Hz and 16-32 k data points. 
The DOSY experiment spectra were recorded on Bruker A vance 700 MHz for 
proton equipped with a pulsed gradient unit. The experiments used a stimulated echo and 
bipolar gradient pulses for diffusion.321 The duration of the magnetic field pulse 
gradients (8) was optimized for each diffusion time (8) in order to obtain 1-5% residual 
signal with the maximum gradient strength. The gradient strength was varied linearly 
from 2% to 95% in 16 steps. The temperature was set and controlled to 300 K with an air 
flow of 670 L per hour in order to avoid any temperature fluctuations due to sample 
heating during the magnetic field pulse gradients. After Fourier transformation and 
baseline correction the diffusion dimension were processed and analyzed using Bruker 
Topspin 2.1 software. 
2D DOSY experiments with a IH detection for quadruplex (T4G4) DNA and Poly 
(N-vinylpyrrolidone) mixture sample were performed on a Bruker Avance 700 MHz 
using stimulated echo and bipolar gradient pulses for diffusion. 
2D DOSY experiments with 31p detection for quadruplex (T4G4) DNA and Poly (4­
vinylpyridine N-oxide) samples were performed on a Bruker DPX 400 MHz NMR 
spectrometer using the same pulse sequence as above. 
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4.2.11 PEl and Quadruplex DNA Complex Structural Transition Study by CD 
PEl samples were prepared at the concentration of3.76 mM and quadruplexes (T4 
G4) DNA was prepared at the concentration of0.7536 mM. The DNA concentration was 
detennined on the basis ofUV absorption at 260 nm of the sample measured in 
phosphate buffer (PH 7) at 95°C. The molar extinction coefficient (71400 cm·1M·I) was 
using the previous experiment data which was detennined by Beer Lambert law. The 
samples were prepared using 1 to 1 and 1 to 5 molar ratio of the quadruplex DNA and 
PEL The experiments were perfonned on Aviv Associates CD Spectropolarimeter Model 
62-ADS. The data were collected every 1 nm. with averaging time of3 sec and 
bandwidth of I in a 0.1 cm path length cuvette. 
The time interval profile was carried out at initial. two and half and four hour for 
quadruplex DNAIPEI complexes. The evaluations ofthe temperature influence on the 
structures were also included in the study. The incubation temperature at 4°C and 9°C 
were used to investigate the structural transition. All the experiment conditions are 
described as above. 
95 

CHAPTER 5 RESULTS AND DISCUSSION 

5.1 Molecular Cross-Linking Studies 
5.1.1 IH NMR investigates PEl cross-linking 
Polyethylenimine is a well-known macromolecule for binding DNA. 322·323 Several 
recent studies have been reported where the structure of PEl was altered to change the 
nature of the macromolecule and its binding properties.324 It was our intention to 
develop a cross-linker for PEl, which would alter the DNA binding and allow for 
molecular imprinting on specific DNA structures. 
Accordingly, we examined the reaction of isophthalaldehyde (I ,3-benzene 
dialdehyde) with PEl. Aldehydes and primary amines react to form imines. Purely 
aliphatic imines are unstable in the present ofwater. When either the aldehyde or amine 
is aromatic, such imines are relatively stable to hydrolysis. The cross-linking of PEl by 
isophthalaldehyde occurs when the two aldehydes react with two of the primary amine 
(-NH2) groups found in highly branched PEl. Cross-linking could be intra-molecular 
(both -NH2 groups on the same PEl molecule) or inter-molecular ( -NH2 groups on 
different PEl molecules). The cross-linking reactions were studied by a variety of 
techniques including NMR, UV-Vis, and QELS. 
First, cross-linking reactions were conducted in deuterium oxide and monitored by 
IH NMR. The proton NMR spectra revealed that the cross-linker (isophthalaldehyde) 
reacted with PEl very rapidly. We have found that the ratio ofthe PEIIisophthalaldehyde 
is a critical factor for the formation of the intra-molecular cross-linking. When the ratio 
of the PEIIisophthalaldehyde is low (high concentration ofisophthalaldehyde), the 
mixing solution immediately formed chunks of white precipitate. These white solids were 
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insoluble in D20. When the PEIIisophthalaldehyde ratio is too high (low concentration of 
isophthalaldehyde), few cross-links are fonned during the reaction. Table 3 showed the 
observation results of bulk quantity reactions ofPEl and isophthalaldehyde in different 
ratio. The resulting white precipitate compounds were re-dissolved in D20 and examined 
by proton NMR. The I H NMR spectra of isophthalaldehyde and polyethylenimine are 
shown in figure 5.1 and figure 5.2, respectively. Figure 5.3 shows the IH NMR spectrum 
ofan initial time point of the PEl cross-linking reaction. The CHO proton resonance can 
be observed at about 9.9 ppm. However, two hours after initiation of the PEl cross­
linking reaction, the CHO proton resonance can no longer be observed in the IH NMR 
spectrum (figure 5.4). Comparing figures 5.3 and 5.4, we have observed that the IH 
NMR peak for the isophthalaldehyde CHO proton disappeared after reacting with PEl for 
two hours. This indicates that the isophthalaldehyde has cross-linked the PEl molecules, 
while the broadening of the aromatic isophthalaldehyde peaks also supports cross-
linking. 
Table 3: Summary of tbe PEII Isopbtbalaldebyde Cross~linking Reaction 
Molar Ratio Comment 
PElIIsopbtbalaldebyde lI8 Large white precipitate, cross-linking 
reaction occurred immediately 
PElIIsopbtbalaldebyde 25 Cross-Linking Reaction occurred 
PElIIsopbtbalaldebyde 67 Cross-Linking Reaction occurred 
PElIIsopbtbalaldebyde 75 Cross-Linking Reaction occurred 
Note: The molar ratio in the experiment is mole PEl monomer/mole isophthalaldehyde 
not moles PEl polymer/moles isophthalaldehyde. 
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Figure 5.1: In NMR of Isophthalaldehyde 
.
i 
o 
l:-H 
'I 
1>10 
,.~., '~"4 i " ":~"'.~i' '~"'i~i"'i' 
Figure 5.2: InNMR of Polyethylenimine 
PEl 
I 
t 
98 

Figure 5.3: IH NMR of Isophthalaldehyde and Polyethylenimine immediately 
after Mixing 
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5.1.2 UV-VisfExtraction Experiments to Identify the Cross-linking Reaction 
To show that isophthalaldehyde is being chemically incorporated into the PEl as a 
cross-linker, the extraction studies were performed. The concept of the extraction 
experiment was to examine whether the isophthalaldehyde could be removed by 
extraction with dichloromethane. If isophthalaldehyde can be removed, the 
isophthalaldehyde is not cross-linking covalently. If isophthalaldehyde cannot be 
removed, this will support the cross-linking by covalent bonding. The UV -Vis spectra of 
isophthalaldehyde and PEl were recorded as reference standard spectra. 
PEl and isophthalaldehyde were prepared in stock solutions and aliquots were mixed 
in different ratios. In figure 5.5 (A) shows the isophthalaldehyde and PEl reference 
spectra ofUV-Vis absorption spectra. In figure 5.5(B) shows the UV-Vis absorption 
spectra ofdifferent ratios of isophthalaldehyde and PEl before extraction (PEl! 
Isophthalaldehyde from 1:1,3:1,5:1 and 16:1). From the spectra, we observed that 
increasing the volume ratio of the PEl I isophthalaldehyde resulted in decreasing the 
intensity of the PEIIIsophthalaldehyde (as expected with less isophthalaldehyde). 
Table 4 summarizes the pre-extraction (before added dichloromethane) of the PEl! 
isophthalaldehyde data in different ratios which were made by mixing stock solutions of 
the PEl and isophthalaldehyde in the volume ratios. Ifabsorptivity stays constant (no 
change due to cross-linking) then we should find the predicted results same as observed 
results. The volume ratio of the PEl and isophthalaldehyde was prepared from 1:1,3:1, 
5:1 and 16: 1; we observed the decrease in % ofrelative amount of the isophthalaldehyde 
at wavelength Amax (294 nm) from 42% to 6.3% (Table 4). When no PEl added, the Amax 
absorption was observed 0.8868 absorption unit which is equivalent to the 100% of the 
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relative amount of isophthalaldehyde. In I to I ratio ofPEI and isophthalaldehyde the 
results shows a 0.3737 absorption unit at Amax, which is corresponded to 42.1 % of 
relative amount of isophthalaldehyde (the expected value is 50%). In 16 to I ratio of 
PEIIlsophthaiaidehyde, the !.max is decreasing to 0.0565 absorption unit which is 
corresponded to 6.3% of isophthalaldehyde remaining in the solution mixtures (expected 
value is 5.9%). The predicted value and observed value of isophthalaldehdye (at Amax) are 
shown in table 4 as expected. 
Table 4: Summary the pre-extraction of PEl I Isophthalaldehyde from 1:1 to 16:1 
(lsophthalaldehyde l.mu:= 194nm) 
PEIIlsophthalaldehyde A=J...mn294nm 
Predicted % relative 
amount of 
Isophthalaldehyde 
Observed 0/_ 
relative amount of 
Isophthalaldehyde 
0:1 0.8868 100.0 100.0 
1:1 0.3737 50.0 42.1 
3:1 0.1781 25.0 20.1 
5:1 0.1572 16.7 17.7 
16:1 0.0565 5.9 6.3 
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Figure 5.5: PEII Isophthalaldehyde in Variety Ratio Study by UV-Vis 
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(A)UV-Vis Spectra ofpolyethylenimine and isophthalaldehyde. (B) 
UV-Vis Spectra ofpolyethylenimine and isophthalaldehyde in a 
different ratio from 1 to 1 up to 16 to 1 
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Figure 5.6 shows the UV-Vis spectra of the PElI isophthalaldehyde mixtures 
before and after extraction by dichloromethane (CH2Ch). The UV-Vis spectra ofPElI 
isophthalaldehyde mixtures were recorded before and after extraction with 
dichloromethane (DCM). The figure 5.6 spectra data shows that the isophthalaldehyde 
alone is extracted into dichloromethane with 98.1 % efficiency. If isophthalaldehyde is 
chemically incorporated into PEl, it cannot be extracted into dichloromethane. We 
compared the UV -Vis spectra of the PEIIIsophthalaldehyde at ratio of 5: 1 and 16:1 
before and after the dichloromethane extraction. From the DCM extraction data, we 
have observed the mixtures ofPElI isophthalaldehyde at a ratio of 5 to I; the 
isophthalaldehyde has 63.6% ofremaining in the mixtures. The PElIisophthalaldehyde at 
a ratio of 16 to I has 77.8% ofisophthalaldehyde remaining in the mixtures (Table 5). 
From these results, it can be concluded that the PElIisophthalaldehyde volume ratio 
of 16: I has smallest percentage of isophthalaldehyde removed from the mixture. The 
higher ratio ofPEl to isophthalaldehyde allows a greater proportion of the aldehyde to 
form cross-links. 
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Figure 5.6: Polyetbylenimine and isopbtbalaldebyde extracted by 
dichloromethane 
(a) ~(b_)____________ ~_, 
Isophthalaldehyde before and after ExtractionPo~ethyleninine (PEQ 
Wavelength (nm) Wavelength (nm) 
(d)(c) 
PEIIIso (5:1) before-after Extraction PElilso (16:1) before-after Extraction 
Wavelength (nm) Wavelength (nm) 
(a)UV spectrum ofPEl (b) UV spectra ofisopbthalaldehyde before and after 
extraction by CH2Ch (c) UV spectra of PEl and isophthalaldebyde mixture at 
ratio of 5 to 1 before and after extraction by CH2Ch (d) UV spectra ofPEl and 
isophthalaldehyde mixture at ratio of 16 to 1 before and after extraction by 
CH2Ch. 
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Table 5: 	 Summary UV-Vis absorption data: the isophthalaldehyde 
extracted by dichloromethane in different ratios of PEl I 
isophthalaldehyde. 
I PEJlIsophthalaldehyde A=A.max294nm 
PEl ( no 
isophthalaldehyde) 0 
• Isophthalaldehyde 0.8868 
Iso-Dichloromethane 
(extraction) 0.0173 
PEJlIso=5: 1 0.2824 
PEJlIso=5: 1 (extraction) 0.1797 
PEJlIso=16: 1 0.0967 
PEJlIso=16 :l(extraction) 0.0753 
Iso : an abbreviation of isophthalaldehyde 

o/. R .. Abs (after extraction) t000/.
70 emalnlng = 	 . X 70Abs (before extractIon) 
Abs : abbreviation of absorbance 
Table 6: Percentage Remaining of Isophthalaldehyde: the mixture of PEl 
and isophthalaldehyde after extraction by dichloromethane. 
PEIJ %of 
Isophthalaldehyde Isophthalaldehyde 
Remainin2 
Isophthalaldehyde 1.9 
(no PEl) 
PEI/Iso:::::: 5:1 63.6 
I PEI/lso = 16:1 77.8 
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Table 6 shows the percentage of isophthalaldehyde remaining from 1.9% to 77.8 
% with respect to the ratio ofPEJJIsophthalaldehyde from 0 to 16. In ratio 16 to 1 of 
PEJJIsophthalaldehyde, the 77 .8% of isophthalaldehyde remaining indicates that after 
removing any unbound or physically bound isophthalaldehyde, there is still 77.8% with 
covalent chemical bonding to form the cross-linking within the PEl molecules. These 
results are strongly supportive that PEl cross-linking reaction is a covalent, chemical 
cross-linking reaction. 
5.2 Light Scattering Analysis of Aggregation Behavior 
Polyethylenimine particle size was performed by using QELS light scattering 
techniques. The PEl molecular hydrodynamic radius as a function of concentration was 
determined by QELS light scattering analysis. Table 7 shows how with increasing 
concentration of PEl, we observed a decrease of the macromolecules' hydrodynamic 
radii. This indicated that the molecular repulsion force plays a role with shortening 
intermolecular distance as the cationic polymers are forced to be closer together; they 
shrink slightly from these ionic repulsions. 
Table 7: 	 Polyethylenimine (in water) Hydrodynamic Radius as a function of the 
concentration 
Polyethylenimine(M) Hydrodynamic Radius (nm) 
0.1 4.88 
0.4 4.76 
0.6 4.76 
1.0 4.68 
1.2 4.66 
1.4 4.54 
1.8 4.51 
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• • 
Figure 5.7: Polyethylenimine (in water) Radius in different Concentration 
PEl Radius as a function of Concentration 
I • Series1 j
-Unear(Series1
.. 
• • . ... 
4 .~------~------~--------~------~ 
o 0.5 1 1.5 2 
Polyethyleneimine (M) R2 = 0.9502 
Figure 5.7 shows the PEl radius (Y axis) as function of the concentration ofthe 
polyethylenimine (X axis). The results showed a slightly decrease in the 
polyethylenimine radius with increasing PEl concentration. PEl molecules, as 
polycationic polymers, are far apart from each other in very dilute solution. The PEl 
molecules are not repelled much by other molecules due to the long range distance. As 
the PEl concentration goes up, the molecules are closer to each other. The molecular 
charges repel, and as this force increase the radius of the molecules decreases. 
5.2.1 Cross-Linking Hydrodynamic Radius Measurement by QELS 
The molecular radius (r) of cross-linked PEl hydrodynamic radius was also 
investigated by light scattering analysis. The experiment was designed by studying the 
cross-linking reaction with two PEl concentrations (0.1 M and 1.8 M) titrated into a fixed 
concentration of the isophthalaldehyde (0.004 M). 
107 

From Table 8, we have observed the molecular radius of the cross-linked PEl 
decreasing from 5.82 nm to 3.89 nm as isophthalaldehyde solution (up to 1.8 mL) was 
added into the low concentration ofPEI (OJ M). This observation indicates that the 
cross-linking reaction was intra-molecular in low PEl concentration. At low 
concentration, once the isophthalaldehyde has reacted with one PEl molecule, it is much 
more likely to react again with a free NH2 from that same molecule. Collisions between 
the widely dispersed polymer chains are infrequent, so reaction of the second aldehyde 
with a different PEl molecule to from an intermolecular cross-link is unlikely. 
The aliquot volumes of the isophthalaldehyde (0.004 M) solutions were added into 
higher concentration of PEl (1.8 M) solution. Table 9 shows a similar reduced radius 
pattern (as seen in table 8) with addition of isophthalaldehyde, but the slope is much 
shallow in 1.8 M PEl. When adding an increasing amount of isophthalaldehyde into the 
PEl solution, the PEl molecular particle size decreased only slightly. This observation 
indicated that the PEl and isophthalaldehyde cross-linking reaction is still an intra­
molecular reaction (compact in size). The reduced slope occurs since the number of 
cross-links in each PEl molecule is smaller. No increase in radius - as would occur from 
intermolecular cross-linking - was observed. 
Our lH NMR, UV-Vis extraction, and light scattering studies results are strongly 
support that isophthalaldehyde acts as a cross-linker for PEl. The cross-linking reaction 
is primarily an intra-molecular cross-linking with PEl concentration up to 1.8M. 
In conclusion, whether inter or intra molecular cross-linking reaction occurred 
depends on the concentration of PEl. At very high concentrations ofPEl (reactions in 
bulk or pure PEl), we have observed the aggregation and insolubilization behavior which 
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indicated the inter-molecular cross-linking between the PEl molecules. However, in a 
low concentration of PEl, the cross-linking reaction is intra-molecules cross-links. 
The cross-linking experiments have suggest that the idea ofusing PEl as an imprinting 
medium for DNA seems viable- PEl is known to bind DNA and can be cross-linked with 
isophthalaldehyde. 
Table 8: Low concentration of PEl (0.1 M) Titrated with Isophthalaldehyde 
(0.004M) in Phosphate Buffer pH7.0 
Isophthalaldehyde 
added(mL) Radius (nm) Normalized Radius 
0.0 5.82 1.00 
0.1 5.62 0.97 
0.3 5.40 0.93 
0.5 5.13 0.88 
0.8 5.03 0.86 
1.0 4.71 0.81 
1.5 4.45 0.76 
1.8 3.89 0.66 
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Figure 5.8: Isophthalaldehyde (0.004 M) Titrated into Low Concentration of 
Polyethylenimine (0.1 M) 
PEl (O.1M) Titrated with lsophthalaldehyde(o.o04M) 
1.20 
• 1.10 
i::I 1.00 
II:: 0.90 
iIf 0.80 
i 0.70 
~ 0.60 
z 0.50 
0.40 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 
I • &riesl I 
IlOPhthalaldehyed Added(mL) -Un\'M(&riesl) . 
Table 9: High Concentration of PEl (1.8 M) Titrated with Isophthalaldehyde 
(0.004 M) (in phosphate buffer, pH 7.0) 
Isophthalaldehyde 
ImLl 
Hydrodynamic Radius 
(nm) Normalized Radius 
0.0 5.64 1.00 
0.2 5.53 0.98 
0.6 5.37 0.95 
0.8 4.86 0.86 
1.0 4.62 0.82 
1.5 4.53 0.80 
2.0 4.33 0.77 
3.0 4.16 0.74 
4.0 4.06 0.72 
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Figure 5.9: Isophthalaldehyde (0.004 M) Titrated into 1.8 M PEl (both prepared in 
Phosphate Buffer Solution at pH 7.0) 
Isophthalaldehyde(O.OO4m) Titrated into 1.8M PEl 
11.5 
i1.3! 1.1 
.!II 0.9 
~ 0.7 f 0.5 
~ 0.3 
::t 0.1 
5.00.0 0.5 1.0 1~ 2n 2S 3n 3S 4n 4~ 
Isophthalaldehyde added (mL) 
5.3 Binding Study of Polyethylenimine I Quadruplex DNA 
Figure 5.10 shows the CD spectrum ofG-quadruplex (T4G4) DNA. This CD 
spectrum displayed a positive maximum peak at near 265 nm and a negative minimum 
peak at 240 nm. These are the characteristic features of the parallel G-quadruplex DNA 
structure. 206 The quadruplex (T4G4) DNA has been reported to have a parallel G­
qUadruplex structure. 
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Figure 5.10: CD Spectrum of Quadruplex T4G4 DNA (parallel) 
Parallel Quadruplex T4G4 DNA 
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Figure 5.11 shows the CD spectrum of the polyethylenimine. CD is characteristic of 
the molecular and environmental asymmetrical effects. Because PEls has no significant 
CD signal within the UV region, we are not able to see any absorptivity in spectra. The 
CD spectrum of the PEl is simply showing the noise level. 
Figure 5.11: CD Spectrum of the Polyethylenimine 
CD Spectrum of Polyethylenimine 
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5.3.1 Circular Dichroism (CD) Titration Experiments 
In this work, we have used CD spectroscopy to monitor the quadruplex T4G4DNA 
conformational changes in PEIIT4G4quadruplex DNA complex solutions. A pre-mixed 
quadruplex DNA with PEl at a tenfold excess solution were prepared for use in our first 
titration study. DNA is included in the titrating solution to maintain a constant DNA 
concentration (and therefore a constant CD signal). PEl has no CD signal within the UV 
region. Hence, the observed signals recorded only from the quadruplex DNA molecules. 
Figure 5.12 shows the titration experiment, where the pre-mixed solution of lOX 
PEIJ quadruplex DNA was titrated into G-quadruplex DNA (250 ~l) solution. The 
titration began from the pre-mixed sample (PEIJquadruplex DNA) by additionally added 
I~L into G-quadruplex T 4G4 solution. As we observed from the CD spectra, quadruplex 
DNA conformation was changed by adding more PEl (a pre-mixed lOX PEIJDNA 
solution) into DNA solution. We observed a change in the positive maximum peak near 
265 nm, gradually changing to a negative peak near 285 nm. The CD spectra show that 
quadruplex DNA maximum positive peak in the vicinity of265-270 nm (parallel), then 
gradually decreased in intensity when more pre-mixed solution was added to the 
quadruplex DNA solution. 
From the observed changes in the CD spectra, there are a few possible 
interpretations: PEl might disrupt the quadruplexes (T 404) DNA conformations 
completely to single strand DNA or could change the conformation from a parallel 
orientation to different conformation - antiparallel, mixed, or some other transitional 
structure. 
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Figure 5.12: lOX PEIIQuadruplex DNA pre-mixed Solution with 1 ilL each 
addition titrated into Quadruplex T4G4 DNA Solution (250 ilL) 
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In order to gain further insight into the conformational changes, we have 
conducted additional titration profiles. Figure 5.13 shows the profile of the pre-mixed 
DNA/lOX PEl titrated into 250 !!L G-quadruplex DNA. The CD spectra show that 
quadruplex DNA maximum positive peak in the vicinity of265-270 nm (parallel), then 
gradually decreased in intensity when more pre-mixed solution was added to the 
quadruplex DNA solution. 
Table 10 summarizes the overall data from the quadruplex DNA and PEl titration. 
When the (T4G4),JPEI ratio is at 25, the positive peak - 265-270 nm showed a slightly 
change in conformation, compared with the quadruplex DNA alone. It was noted that the 
quadruplex DNA maximum peak decreased and gradually turned negative when higher 
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amounts of the pre-mixed DNAIPEI solution were added to the quadruplex DNA 
solution. These results indicated that the cationic polymer PEl might disrupt the 
quadruplex (T40 4) structure or change it in a complex manner. However, fully 
understanding of the (T 404)4 DNA and PEl interaction remained a challenge. 
Figure 5.13: Pre-mixed (T..G..).. IPEI Titrated into Quadruplex DNA (250pL) 
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Table 10: Parallel Quadruplex DNA (T4G4) (250"L) Titrated with Pre-Mixed 
(PEl/lOx DNA), A Positive Maximum Peak in the Vicinity of 265-270 nm 
Added Pre-Mix 
PEl/lOx DNA 
solution (JlL ) 
Overall ratio 
DNAIPEl 
Comment 
I 2511 Positive peak -265 nm ,12 mdeg, 
showed little change in confirmation 
3 -811 Positive peak -265 nm, now only 7 
mdeg 
8 -3/1 Positive peak -265 nm is lost, -I mdeg 
10 5/2 Negative peak -265 nm ,-2 mdeg 
20 -111 Negative peak -265 nm, 
-4mdeg 
Figure 5.14 shows stability of the (T4G4) quadruplex DNA! PEl complex solution. 
Quadruplex DNA solutions with added PEl solution were scanned by CD at initial, day I 
and day 7. The CD spectra of quadruplex DNA / PEl polyplex solutions showed only 
small changes from day 0 to day 7. This result suggested that the quadruplex (T4G4) 
DNAlPEI conformation is relatively stable at 4 °c condition for up to 7 days. 
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Figure 5.14: Quadruplex (T4G4) DNAIPEI Solution Stability 
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It had been our original intention to imprint PEl with the quadruplex DNA by 
cross-linking with isophthalaldehyde. The CD data shown above however, throws the 
viability of this approach into question. When mixed with PEl; the quadruplex DNA 
might change or disrupt the conformation and no longer be a parallel quadruplex 
structure (from the CD data). These results brought an uncertainty to our initial goal. 
We decided to study other polymers to find if a better candidate existed for our model of 
the imprinting with T 40 4quadruplex DNA. 
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5.4 Porphyrinl Quadruplex T4G4 DNA I Polymers Interaction Study by UV-Vis 
Porphyrins have a "ring of rings" structure of four pyrrole units, and are aromatic 
with an 18 1t-electron scaffold which allow for the ability to absorb visible light. 
Porphyrins are also known to be able to associate or intercalate with the anionic 
phosphate backbone ofDNA.28o,325 
We investigated the interaction ofpolycationic and neutral polymers with a 
quadruplex (T 4G4) DNA/ porphyrin complex; this acted as a screen for other polymers 
that will bind DNA. In screening the polymers, we have observed that the porphyrin 
Soret band shifts from 422 nm to 433 nm when quadruplex DNA is added into the 
porphyrin. On addition ofpolymer, the Soret band might shift back to 422 nm, as a result 
ofdissociation of the porphyrin from the DNA; or the Soret band might remain at 433 nm 
indicating an intact porphyrin-DNA complex. 
Figure 5.15 shows the UV spectra ofpolyethylenimine in the presence of the 
porphyrin-quadruplex DNA complex. When quadruplex DNA was added into 
porphyrin, the porphyrin maximum peak shifted to 433 nm, evidence of the formation of 
the DNA/porphyrin complex. After adding the polyethylenimine to the porphyrin-DNA 
complex, the porphyrin maximum peak shifted back to 422 nm. Figure 5.16 shows the 
interaction of the cross-linked PEl with the porphyrin! DNA complex, where the cross­
linked PEl demonstrated the same binding behavior as the non-cross-linked PEl 
Poly (4-vinyl-I-methylpyridinium bromide), an ionic polymer, also showed the 
same binding profile as PEl when porphyrin! quadruplex DNA complex was added 
(figure 5.17). Polyethylene glycol (pEG) is a nonionic neutral polymer which is often 
used as protein stabilizing agent. Figure 5.18 shows the polyethylene glycol (PEG) with 
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the porphyrin! T4G4 quadruplex DNA complex. The UV-Vis spectra have shown the 
porphyrin peak remains at 433 nm after addition of the PEG. This result might support 
hypothesis ofthe binding behavior as: (1) non-binding of the PEG and quadruplex DNA 
or (2) binding without the disruption of the quadruplex DNA with PEG. 
When poly (N-vinylpyrrolidone)was added to the porphyrin / quadruplex DNA complex, 
the absorption maximum remained at 433 nm which might indicate an intact of 
porphyrin-DNA complex (figure 5.19). Figure 5.20 shows poly (4-vinylpyridine N-
oxide) with porphyrin-quadruplex DNA complex. When poly (4-vinylpyridine N-oxide) 
interacted with porphyrin! quadruplex DNA complex, the maximum peak remained at 
433nm after polymers (PVNO) were added. 
Figure 5.15: Polyethylenimine interaction with porphyrin-quadruplex 
T4G4 DNA complex 
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Figure 5.16: 
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Figure 5.17: 	 Poly (4-vinyl-1-Methylpyridinium Bromide) interaction 
with PorphyrinlQuadruplex T 4G4 DNA Complex 
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Note: PVMP_ Br is the abbreviation of the Poly(4-vinyl-I-methylpydrdinium 
bromide) 
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Figure 5.18: Polyethylene glycol (pEG) interaction with 
PorphyrinlQuadruplex T .G. DNA Complex 
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Figure 5.19: Poly (N-vinylpyrrolidone) Interaction with porphyrin­
quadruplex T.G.DNA complex 
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Note: PVP is the abbreviation of the Poly (N-Vinylpyrrolidone) 
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Figure 5.20: Poly (4-vinylpyridine N-oxide) interaction with 

porphyrin-quadruplex DNA Complex 
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Table 11 summarizes the screening ofneutral and cationic polymers. The UV-Vis 
I spectra showed that the maximum peak of the porphyrin will shift back to 422 nm after j 
adding cationic polymers into the porphyrin and quadruplex DNA complex. WhenI 
i neutral polymers were added to the porphyrin and DNA complex, the porphyrinj 
1 
maximum peak remained at 433 nm. 
I 
i 
I 
I ~ 
I
. 
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Table 11: Porphyrin Probe Screening of Candidate Polymers 
Polymer 
C= Cationic 
N=Neutral 
Porphyrin 
(nm) 
A".,., 
Porphyrin A"..,. after Added 
DNA (nm) 
Porphyrin Amax after Added 
DNA and polymer (nm) 
Poly(2-vinyl pyridine) (C) 422 433 422 
PEl (C) 
422 433 422 
Poly( allylamine) 
20%wt(C) 
422 433 422 
Poly(L-lysine) (C) 
422 433 422 
Metafectene Easy(CJ 
422 433 422 
Metafectene Pro (C) 422 433 422 
Poly( 4-vinly-l­
methylpyridinium 
bromide) (C) 
422 433 422 
Poly(L-omithine) HCL 
(C) 
422 433 422 
Poly{N- vinylpyrrolidon) 
(N) 
422 433 433 
Ploy(4-vinylpyridine 
N-oxide) (N) 
422 433 433 
PEG (N) 422 433 433 
These screening results show that neutral polymers might be considerable 
candidates to further study for the binding of the quadruplex DNA with minimal 
disruption. We have assumed that neural polymer might bind to quadruplex DNA 
without disrupting the quadruplex structure based on the UV-Vis data. But, the porphyrin 
Arnax peak remaining at 433nm might also lead to a different answer: that there is no 
interaction of these neutral polymers with quadruplex DNA (no binding). To determine 
if the neutral polymers are binding to DNA, we have further investigated the polymer and 
DNA interaction by 2D NMR techniques. 
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5.5 31 P NMR Polymer - Quadruplex DNA Binding Study 
31p NMR is a powerful tool that has been applied to a wide variety of studies. 31p is a 
spin!h nuclei and has 100% natural abundance. All phosphorus species within a 
compound can potentially be detected by NMR spectroscopy. Due to the overlap and 
interference of the proton chemical shifts of DNA and poly(4-vinylpyridine-N-oxide) in 
the aromatic region, we cannot use I H NMR diffusion experiments to study the mixture 
of the (T4G4) quadruplex DNA with poly (4-vinylpyridine-N-oxide). The 31p NMR 
diffusion experiment is therefore a preferred method to examine the interaction of the 
quadruplex DNA and PVNO polymer. 
In figure 5.21, 31p NMR spectra show the binding interaction of the quadruplex 
DNA with the following polymers: poly(N-vinylpyrrolidone), poly(4-vinylpyridine N­
oxide) and polyethylenimine. The spectrum ofpolyethylenimine was observed to shift to 
the left (down field) compared with the free (T 4G4) quadruplex DNA. It is apparent that 
PEl has bound to quadruplex DNA from the change in the chemical shift. In figure 5.21, 
comparing with the free T4G4 quadruplex DNA pattern, we also observed no shift in peak 
maximum for the poly(N-vinylpyrrolidone) and poly(4-vinylpyridine N-oxide). This 
might indicate that there is a no binding relationship between the polymers and 
quadruplex DNA. However, other researchers' findings reported that poly(N­
vinylpyrrolidone) is known to interact with the quadruplex DNA.326 It might therefore 
be more appropriate to suggested that the PEl has a stronger binding interaction than PVP 
and PVNO, one that is centered on association of the negative phosphates of DNA and 
positive ammonium ions ofPEl. Another possibility is that PVP and PVNO do not 
interact with DNA phosphate backbone, but the interacting sites may close to the base. 
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This would have a maximum effect on the electron density and shielding at the P nuclei, 
resulting in a change in chemical shift. In comparing with the free (T4G4) quadruplex 
DNA, the PVNO and PNVP have shown the minor changes in contour line of spectra; 
however, there is still not sufficient evident for assessing whether these neutral polymer 
are binding with (T4G4) quadruplex DNA or not. 
In order to assess whether the poly(N-vinylpyrrolidone) would bind to quadruplex 
DNA or not, we examined the interaction by increasing the polymer concentration in the 
NMR. In figure 5.22, we have observed that the peak maximum of the 
poly(N-vinylpyrrolidone) shifted downfield (to the left side) relative to the previous 
experiment (figure 5.21). This result confirmed that the poly(N-vinylpyrrolidone) is 
bound to (T 4G4) quadruplex DNA; in addition, this result also suggested that the poly(N­
vinylpyrrolidone) has a stronger binding interaction with quadruplex DNA than poly (4­
vinylpyridine N -oxide). 
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I 
Figure 5.21: 	 31 P NMR Spectra of (TTTTGGGG)4, free and in the presence of 
Poly(4-vinylpyridine N- oxide), Polyethylenimine and Poly (N­
vinylpyrrolidone) 
freeQ.ON/I, 
Q-DNA+ 
Pofy(4-vinylpyridioe N-oxide) 
<HiNA+ 
Pofy(N-vin)'lp~rrolidone) 
1.0 	 0.0 
31p 
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Figure 5.22: 	31 P NMR Spectra of (TTTTGGGG)4, and with Poly(4-vinylpyridine 
N-Oxide), Polyethylenimine and Poly(N-vinylpyrrolidone) with 
increased concentration of Poly(N-vinylpyrrolidone) and Poly(4­
vinylpyridine-N-Oxide) 
Fleea·DNA 
Q-I)NA+ 
Polyethytenelmine 
1.0 0.0 
31p (ppm) 
5.6 DOSY: Diffusion NMR Experiments 
Diffusion-Ordered (DOSY) NMR spectroscopy provides a way to separate the 
spectra ofdifferent compounds in a mixture based on the different diffusion coefficients. 
noSy applies the diffusion analysis through the pulse-field gradient NMR methods. In 
noSy, the spectra are displayed in a 2D plot with chemical shift on one axis and the 
diffusion coefficient (often in a logarithmic scale) on the other.326 Compounds with the 
same diffusion coefficient will then appear correlated on the diffusion axis. Two 
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molecular species with different diffusion coefficients when measured alone show the 
different diffusion coefficients. If, when mixed together, they appear at the same 
diffusion coefficient, then it is reasonable to assume that the two molecules are bound 
into a single complex with a single diffusion coefficient. 
In this pseudo two dimensional NMR technique, one dimension (X axis) 
represents typical chemical shift information eH or 31 P (ppm» and the second dimension 
(Y-axis) distinguishes species by diffusion coefficient represent by the logarithm of 
diffusion constant (Log D). The size of the polymer is often much larger than (T4G4) 
quadruplex DNA (-10 kD) because the molecular weight of the polymer is much higher 
than (T4G4) quadruplex DNA. As a result, polymer displays a smaller diffusion 
coefficient and much broader peaks than T4G4 DNA does. In order to obtain stronger and 
more sensitive signal from diffusion NMR, we will need to monitor the DNA peaks 
rather than the polymer peaks. When DNA binds to polymer; the polymer diffusion will 
not change much - the diffusion rate will be dominated by the large polymer component. 
The DNA, on the other hand, will experience larger changes when it binds to polymer 
and diffuses the same as the polymer. In these diffusion experiments, we will examine the 
aromatic peaks from the quadruplex DNA portions. Figure 5.23 shows the DOSY 
diffusion experiment for (T4G4) quadruplex DNA and poly (N-vinylpyrrolidone) (PVP) at 
the ratio of 1 to I, 1 to 5 and 1 to 10, respectively. 
128 

Figure 5.23: 	 DOSY NMR Experiment Study Binding Relationship ofQuadruple x 
(T4G4) DNA alone (black) and with Poly(N-vinylpyrrolidone) (PVP) at 
the ratio of 1:1 (blue), 1:5 (red) and 1:10 (green) 
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In figure 5.23, the Y-axis represents ofthe logarithm ofdiffusion coefficient (Log D 
(m2 S·l». So spectra which occur nearer the top have slower diffusion. The X-axis 
represents 1H chemical shift (ppm). The different colors represent different ratios ofthe 
polymer with (T404) quadruplex DNA. The black color indicates (T404) quadruplex 
DNA only. The blue color, red, and green color represent the quadruplex (T404)1 PVP at 
ratio of 1 to 1, I to 5 and I to 10, respectively. We have observed that the DNA alone 
(black) and DNA:PVP 1 : 1 (blue )spectra are almost superimposed, which indicated the 
mixture of the quadruplex (T404) and PVP (1: I) and DNA alone might have nearly 
identical diffusion coefficients. This can be explained by the fact that polymer and 
129 

quadruplex DNA at I to I ratio did not have much effect on the diffusion (weak binding). 
On the other hand quadruplex (T4G4) and PVP at I to10 ratio gave multiple diffusion 
rates for small fragment species - faster diffusing than the intact quadruplex. These 
faster diffusing species might indicate that the Poly(N-vinylpyrrolidone) (PVP) begins to 
disrupt the quadruplex (T4G4) DNA into single strands or fragments at this high 
concentration. As we can see in the diffusion pattern, the quadruplex (T 4G4) and PVP at I 
to 5 ratio (red color) showed a slowing down of the diffusion, which indicates the 
polymer (PVP) was bound to (T4G4) quadruplex DNA. The diffusion analysis shows that 
interaction ofPVP and DNA is somewhat complex, with variability based on 
concentration. 
Figure 5.24: 31p Diffusion DOSY Experiment of Quadruplex T4G4 alone (black) 
and with Poly (vinylpyridine N-Oxide) (PVNO) (red) 
.­
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Figure 5.24 shows the diffusion pattern of the 31p DOSY NMR showing the 
binding interaction of the quadruplex (T4G4) DNA and poly(4-vinylpyridine N-oxide) 
(PVNO). In the simple chemical shift experiment, we did not see any significant change 
with PVNO as compared to the free quadruplex DNA. We had some doubts about the 
interaction ofPVNO with quadruplex DNA. Then we carried out a DOSY experiment for 
the further investigation. The overlap of the DNA and PVNO IH spectra required the use 
of 31 P NMR. The Y-axis represent logarithm of diffusion coefficient (Log D) and X-axis 
represents 31 P chemical shifts (ppm). The color codes again represent combination of 
the polymer PVNO and quadruplex DNA. The black color represents the quadruplex 
(T4G4) alone. The red color represents quadruplex (T4G4) DNA and PVNO at a ratio of I 
to 5. Quadruplex DNA log D is about -9.5, corresponding to a diffusion coefficient of 
3.2xlO-lO• For DNA with PVNO at a I to 5 ratio, the log D is about -9.8 which 
correspond to a diffusion coefficient of 1.6 X10-10, a factor of2 slower. We have 
observed the similar diffusion pattern for PVNO and quadruplex DNA as PVP and 
quadruplex (T4G4). However, the diffusion coefficient (D= (kT)/j) is related to friction 
coefficient (f= 6 1C 11 RH)' The effect of the viscosity (11) in solution will affect the 
diffusion constant. When polymer binds to DNA, the slight decrease in D might be due 
to the viscosity change in solution rather than the real binding interaction of the polymer 
and quadruplex DNA. We conducted another experiment to investigate the polymer 
viscosity effect in PVNO polymer. 
In this experiment, we took the viscosity condition into account and examined the 
binding relationship by 3Ip_DOSY techniques. A PEG concentration was prepared which 
had the same viscosity as the PVNO solution. The sample preparation was described in 
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-11.00 
the methods section. Figure 5.25 shows 31 p DOSY spectra of quadruplex DNA, mixture 
concentration ratios of the polyethylene glycol (PEG) / quadruplex (T4G4) DNA, and the 
PVNO / (T4G4)4 DNA are both 5 to 1. The red and blue color code are symbolized the 
(PEG) / quadruplex (T4G4) and PVNO / (T4G4)4, respectively. The black color represents 
the quadruplex (T4G4) DNA alone. 
Figure 5.25: 	31 P DOSY Experiment for Quadruplex DNA, (T4G4)4/ PVNO at 1:5 
ratio and quadruplex (T4G4) !PEG at 1 to 5 ratio 
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As observed in the spectra, the quadruplex (T4G4) alone displayed the log D about 
-9.6 which is corresponding to the diffusion coefficient of3.98 xlO-9• The mixture of the 
PVNO and quadruplex DNA had log D about -9.8. The corresponding diffusion 
coefficient for PVNOI (T4G4)4 complexes is 1.6 x 10-10 The PEG I quadruplex DNA 
solution has a diffusion coefficient of 5.0 x 10-11 (logD is -10.3). The spectra of the PEGI 
(T4G4)4 displayed a broadened diffusion profile which illustrated the distribution of 
environments for DNA mobility when increased viscosity is the main contributing factor. 
The PEG is a neutral polymer which has been found to have no binding affinity with the 
quadruplex DNA but has the molecular crowding effect for the stabilization of the 
DNA.344 We have observed that the mixture of the PVNOI (T4G4)4 spectra have a sharp, 
narrow diffusion profile, but the reduction in diffusion coefficient is slight. We note 
that the diffusion coefficient of PVNOI quadruplex DNA is only about 1.6 times higher 
than the quadruplex DNA alone, whereas a larger change would be expected for strong 
binding with the PVNO. The difference in diffusion profile with the viscosity agent PEG 
suggests a different mode of interaction than PEG. The nature of the association of DNA 
with PVNO remains ambiguous. 
Figure 5.26 shows the mixture of the PEl and (T4G4) quadruplex DNA in IH 
DOSY Experiment. The (T 4G4) quadruplex DNA in the experiment is used as the 
reference for the comparison for the PEl. The Y-axis represent logarithm of diffusion 
coefficient (Log D). The X-axis represents 1 H chemical shifts (ppm). The blue color 
code represented the combination of the polymer PEl and quadruplex DNA at a ratio of 5 
tol. The black color represents the (T4G4) quadruplex DNA alone. The quadruplex (T4G4) 
displayed the log D about -9.7 which is corresponding to diffusion constant at 5.01 xlO·9• 
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As observed in the spectra, the PEl and DNA at 5 to 1 ratio, the log D is about -10.3. The 
corresponding diffusion coefficient for PEl! (T4G4)4 complexes is 1.99 x 10-10• PEl with 
quadruplex DNA showed a lower diffusion coefficient and a shifted in the spectra. This 
data suggested that the polymer (pEl) bound to quadruplex DNA. 
Figure 5.26: IH DOSY Experiment for Quadruplex DNA (f..G..) alone (black) and 
DNAIPEI at Ratio of 1:5 (blue) 
T4G4~only 
T4G4 ONA/PEI 1:5 
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5.7 	 PEl Induced Conformational Changes in Quadruplex DNA (T4G4)4: 2D 
NOESY NMR and CD Experiments 
Figure 5.27 shows the 2D NOESY spectrum of the parallel G-quadruplex T4G4. 
The G-quadruplex T4G4 NOESY spectrum has several clear regions. The resonances 
from 10.5-12 ppm are denoted as the imino proton resonances (HI of the guanines). 
There are also amino protons from 8.0 - 10.5 ppm, aromatic protons from 6.8 -8.0 ppm, 
sugar protons from 4.0 - 6.5 ppm, and thymine methyl protons from 1.4-2.0 ppm. 
The imino protons (10-12 ppm) are characteristic ofguanine imino-H8 cross-peaks for G-
tetrads. The cross-peaks between the imino protons, between the imino and amino 
protons, and between the aromatic and sugar protons are characteristic of the G­
quadruplex structures. 
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Figure 5.27: A 2D NOESY spectrum of G-quadruplex T4G4 Parallel Structure 
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Figure 5.28 shows G-quadruplex (T4G4) DNA mixed with PEl at a 1 tol molar 
ratio. In this experiment, the spectra recorded did not show the proton resonances peaks 
in the region of the 10 to 12 ppm, which typically indicated the imino proton resonances. 
The amino peaks from 8.5 - 10 ppm are also absent. These unresolved peaks may appear 
as broadened signals as a result of the NMR time scale detection limit and therefore 
invisible in this NMR spectrum. The signals may be broadened due to the 
conformational exchange between structures. These results indicated that the protons 
might undergo an intermediate exchange. However, the cross-peaks and diagonal peaks 
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could clearly be seen from 5.5 to 8.5 ppm, the aromatic and amino proton chemical shift 
region. These cross-peaks are not necessarily determinative of any quadruplex structure. 
This result suggest that the G-quadruplex (T4G4) DNA and PEl at I tol ratio might have 
weak binding or be in eqUilibrium between multiple structures. 
Figure 5.28: 2D NOESY spectrum of G-quadruplex (T4G4) DNA and PEl at 1 t01 
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Figure 5.29 shows the 2D NOESY results for T4G4 quadruplex DNA and PEl mixed 
at a 1 to 5 molar ratio. Here two peaks can be observed in the diagonal region near 11.0 
ppm, where the guanine imino proton resonances occur (10.8-11.6 ppm). While no 
amino peaks appear on the diagonal, imino-amino cross peaks are observed, which 
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suggests that the G-quadruplex structure is intact. The NOESY spectrum shows other 
changes which are suggestive of a structural transition, further evidenced by the CD data 
provided below. 
Figure 5.29: 	2D NOESY Spectrum of G-quadruplex T4G4DNA and PEl at 1 to 5 
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Figure 5.30 shows the imino-imino and imino-amino regions of the NOESY 
spectra for parallel T4G4 quadruplex DNA (A) and T4G4 DNA with PEl 1:5 (B). 
Comparison of the imino regions of the native, parallel T4G4quadruplex and the T4G4 
quadruplex mixed with PEl 1:5 shows a reduction in the number of peaks in the presence 
ofPEI. The parallel T4G4shows at least 8 imino peaks, and possible as many as 12, with 
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multiple cross peaks. The presence ofmore than 4 imino peaks shows that there are 
some differences within the individual tetrads of the parallel quadruplex. In the presence 
of PEl, only 2 imino peaks are seen, with one cross peak between them. There are 
several possible explanations for the reduced number ofpeaks: some of the peaks may be 
broadened and undetectable, or a change in conformation may have reduced the number 
of environments. The simplest changes in conformation would be the reversal ofone or 
two strands to produce a mixed (3:1) or antiparallel quadruplex. However, even the most 
symmetric antiparallel quadruplex from T 404 would have at least 4 different imino 
environments. For true assignments, isotopically labeled guanines are typically used-
these were outside the scope ofour experiments. 
Figure 5.30: 	 Imino-imino and Imino-amino regions of the NOESY spectra for 
parallel T4G4 quadruplex DNA (A) and T4G4 quadruplex DNA with 
PEl 1:5 (8) 
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Figure 5.31 shows NOESY spectra of aromatic H61H8 to sugar HI' region for 
parallel T4G4 quadruplex DNA (A) and T4G4quadruplex DNA with PEl at 1:5 ration (B). 
One of the key areas of the NOESY spectrum for conformational analysis is that the 
aromatic (H6/H8) to sugar (HI') cross-peaks regions are showed between 7.0 - 8.0 and 
5.4 - 6.6 ppm which enabled us to assign all aromatic and anomeric protons. The 
resonance of a thymine methyl group was assigned through strong intra-residual cross­
peak with intra-residual H6 proton in 2D NOESY spectra. The conformation of the base 
with relation to the backbone can be syn or anti. Moving from 5' to 3', there are four 
possible arrangements with different cross-peak results. Anti to anti gives 3 strong cross 
peaks, syn to anti gives 3 strong and one weak cross peaks, anti to syn gives two strong 
cross peaks, and syn to syn gives two strong and one weak cross peak. In general, the 
presence of syn bases reduces the number of cross peaks. The number of cross peaks is 
in fact greatly reduced in the presence of PEl. A few are unchanged - for example 
between the aromatic peak at 7.8 and the sugar at 6.1 ppm. There are a few new ones ­
for example 7.5 to 6.25 ppm. But many have disappeared. This could be a result of 
increased syn conformations: the parallel T4G4is expected to be all anti, while a change 
to the 3: 1 or anti parallel structures would require some syn conformations. However, 
without the precise assignments from isotopic labeling, we cannot make an exact 
structural determination. 
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Figure 5.31: Aromatic H61H8 to sugar HI' region of the NOESY spectra for 
parallel T4G4 quadruplex DNA (A) and T4G4 quadruplex DNA with 
PEl 1:5 (B) 
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Figure 5.32 shows aromatic H61H8 to thymine methyl region of the NOESY spectra 
for parallel T4G4 quadruplex DNA. Parallel T4G4 quadruplex DNA alone showed in part 
A. The T4G4 DNA with PEI in 1 to 5 ratios showed in part B. We have observed the 
Finally, the methyl groups of the T tails can be used. In the parallel structure, all of the 
tails are together, and more cross-peaks are expected as compared to an antiparallel 
arrangement. In fact, when in the presence ofPEl, the number ofcross peaks between 
the thymine methyl region (1.4 2.0 ppm) and the aromatic region (6.6 - 8.0 ppm) is 
reduced. Once again, this reduction could be due to broadening of resonances or to a 
structural transition. In summary, the NOESY spectra support a structural change 
induced by PEl but are not definitive. 
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Figure 5.32: Aromatic H61H8 to thymine methyl region of the NOESY spectra for 
parallel T4G4 quadruplex DNA (A) and T4G4 DNA with PEl 1:5 (B) 
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5.8 	Circular Dichroism Experiment of the PEl and quadruplex (T4G4)DNA: 
Structural Transition Investigation. 
The NOE results caused us to re-examine our CD data, and acquire some new data 
as well. Samples were made up identical to those used for NMR study - quadruplex 
T4G4 DNA, quadruple x T4G4 with PEl 1: 1, and quadruplex T4G4 with PEl 1 :5. Figure 
5.33 shows the CD spectra of the quadruplex (T4G4) DNA alone and with PEl at 1 to 1 
and 1 to 5 molar ratio. The CD measurements were taken immediately after mixing, 
without allowing any equilibration time. In typical G-quadruplex parallel structure, 
guanines all have the same anti glycosidic conformation which exhibits a positive peak at 
260 nm and small negative peak at 240 nm. The CD spectra ofthe PEIIquadruplex DNA 
at I to I and 5 to 1 molar ratio are showed a positive peak near 260nm and a negative 
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peak near 240 run in all three sample, which are consistent with the typical parallel 
stranded G-quadruplex conformation. The CD spectra all appear similar; which indicated 
no conformational changes at the initial time point. 
Figure 5.33: 	 CD Spectra of the Quadruplex DNA alone and with PEl at 1 to 1 and 
1 to 5 Molar Ratios at the initial Time Point 
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Figure 5.34 shows the CD spectra of the PEl! T4G4 quadruplex DNA mixture (5 to 
1 molar ratio in potassium buffer) at different times following addition ofPEl to the 
DNA. We have observed the CD spectrum changing within four hours after addition. 
The two and half hours spectra showed a negative peak near 260 run. A negative peak at 
260 run has been associated with an antiparallel structure in the presence ofNa+ ions.327 
Our T4G4 quadruplex DNA without adding the polymer is a parallel quadruplex 
conformation. In typical CD spectra of G-quadruplex structures, parallel· stranded 
guanines exhibit a positive peak at 260 nm and a small negative peak at 240 nm. 328 In 
an antiparallel-stranded of G-quadruplex conformation, guanines have alternating anti 
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and syn glycosidic confonnation along each DNA strand, which generates a positive peak 
at 290 nm, a negative at 260 nm and a very small negative peak at 240 nm.329 
The time profile of the PEIIquadruplex DNA mixture (5:1) CD spectra is puzzling, 
especially after four hours, shows that is neither purely parallel or antiparalle1 - a mixed 
or hybrid confonnation. We tried to shed light on this structural transition of quadruplex 
DNA induced by PEL In a search of the literature, we have found that Smargiasso et al 
has reported the mixed/hybrid ofquadruple x DNA in different cations (K+, Na+ and 
N~J.330 The hybrid-quadruplexes DNA are the mixtures of parallel and anti-parallel 
strands in orientation. The DNA in the presence ofpotassium and ammonium cations 
mostly existed as mixtures of parallel and anti-parallel orientation. The pure anti-parallel 
structure was usually observed in the sodium ion (figure 5.35). The Dai research group 
also discovered a new confonnation, mixed hybrid structures, in the human telomeric 
intennolecular G- quadruplex structure.323 Miyoshi and his research team has report the 
structural transition from antiparallel to parallel ofG-quadruplex of d(G4T4G4) induced 
by calcium ion ( figure 5.36). 
The CD spectra ofPEIIDNA (5 to 1) initial time profile (see Figure 5.34) showed a 
positive peak at 260 nm and two negative peaks at - 240 nm and -285 nm, still a classic 
parallel quadruplex confonnation. The four hours CD spectra ofPEIIquadruplex DNA (5 
to I ratio) showed two positive peaks at - 230 nm and - 260 nm and a weak negative 
peak at - 285 nm. In comparing with the typical CD spectra of the parallel and 
antiparallel strands, the PEII (T4G4)4 DNA (5 to 1) existed some peaks in both 
confonnations (230 nm and 260 nm). 331 
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Reviewing these results, all suggest that, most probably, in the high molar ratio of 
PEl (5 to I) might induce a structural transition of the G-quadruplex (T 4G4) DNA from 
parallel (the original T4G4 is a parallel confonnation) to another confonnation (hybrid or 
antiparallel) or to a mixture of different structures. 
Figure 5.34: 	CD spectra of the PEIIquadruplex T4G4 DNA (5 to 1 molar ratio) 
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Figure 5.35: 	 CD Spectra of Hybrid G-quadruplex DNA in the presence of the 
Potassium, Sodium and Ammonium Cation 
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Image adapted from Smargiasso N., et a1. BMC Genomics 2009, 10(362), 
10.1186/1471-2164-10-362. 
CD Spectra of the Transition from the Antiparallel to the Parallel 
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As we assess the NMR and CD results, we cannot conclusively assign the 
confonnation of the G-quadruplex T4G4 structures in the presence of PEl at this point. 
The structural transitions are quite complex, and there are multiple variables: 
concentration (ratio) of PEl with respect to DNA, time, and temperature. As shown in 
figure 5.36, the nature of the cation can greatly change the quadruplex structure, however 
addition ofPEl replaces the potassium and any sodium cations with the alkyl ammonium 
ions of the PEl would induce the confonnational change. The structural rearrangements 
may be occurring slowly but continuously, with equilibration between parallel, mixed 3: I 
and antiparallel structures. There is no doubt that the temperature will strongly effect the 
structural confonnation and transition status. All the experimental data reported here 
provide some infonnation on the structural transition induced by PEl in quadruplex 
(T4G4) DNA, but significant work is required to fully elucidate the solution to this 
problem. 
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CHAPTER 6 SUMMARY, CONCULSION AND FURTHER STUDY 
6.1 Summary and Conclusion 
The purpose of this study was to discover and examine polymers which bind DNA 
for nucleic acid research. We were not entirely successful on our original plan (binding ­
crosslinking - imprinting), but have made significant advances which prepare the way for 
future work. 
We have demonstrated that cross-linking ofPEl with isophthalaldehyde occurred 
both in solution and in bulk. For solution cross-linking, the light scattering results did not 
show any increase in molecular radii. Instead, there was a trend ofa slight decrease in 
radii, which suggests that the PEl might have "shrunk" through intra-molecular cross­
linking. When isophthalaldehyde reacts with two polyethylenimine (PEl) (-NH2) groups, 
the branches of the PEl will connect through the isophthalaldehyde. 
This intra- molecular cross-linked reaction might slightly decrease the 
hydrodynamic radius of the PEl because the molecule will become more compact. The 
light scattering data showed that the PEl molecule did not develop the molecular 
aggregation behavior up to a concentration of 1.8 M. It can be concluded that intra­
molecular cross-links were formed within PEl branched polymers. Furthermore, the data 
suggested that PEl cross-linking can produce the optimal condensation effect and 
decrease the molecular radii ofthe PEl which might improve the biological application of 
polyethylenimine. 
The In Situ NMR and UV extraction data also showed that isophthalaldehyde was 
incorporated into the PEl by chemical cross-linking. This part ofthe study proves that 
isophthalaldehyde, a cross-linking agent, was found to be effective in forming 
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cross-linked with PEl. 
Our CD data agreed with the literature that quadruplex DNA (T 4G4)4 is a parallel 
conformation. CD titration results showed that by adding PEI!quadruplex (T4G4) DNA 
complex into quadruplex (T4G4) DNA at very low concentration ofPEI, the quadruplex 
DNA still maintains a parallel quadruplex structure. By adding more and more PEl into 
quadruplex DNA, however, the DNA went through a structural change. 
In response to this, we performed the CD melting study to investigate the binding 
phenomena of the (T 4G4)4. However, CD melting did not yield any conclusive data. 
Other researchers' data indicate that quadruplex (T4G4) DNA melts at a very high 
temperature (closer to 100°C). Therefore, it is difficult to observe conclusive results 
(melting data was not shown). 
As shown in the CD spectra, the initial results of the PEI! quadruplex (T 4G4) DNA 
complexes suggested that PEl might denature quadruplex DNA, and convert it into new 
structures as a result of strong interactions between the cationic PEl and anionic DNA 
chains. This impacted the possibility of whether we could template PEI by cross-linking 
it in the presence ofquadruplex DNA. This loss ofquadruplex structure questioned our 
use of the PEI!isophthalaldehyde system for imprinting on quadruplex DNA. It also 
points to the difficulties of importing any less robust DNA structure into cells using PEL 
We then examined other polymers as potential imprinting media. 
The finding ofother polymers with the capability ofmore applications in the 
biomedical field has raised some concerns. We studied the interaction of some cationic 
and neutral polymers with quadruplex (T 4G4) DNA. The cationic porphyrin (TMPyP4) 
was selected as a probe to investigate the interaction of the polymers and quadruplex 
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(T4G4) DNA. TMPyP4 has been reported to have a high affinity to quadruplex DNA due 
to its similar size with quadruplex DNA. The preliminary polymer screening results 
showed that the neutral polymers interact with quadruplex DNA without displacing the 
porphyrin. The porphyrin UV spectrum peak maximum shifts from 422nm to 433 nm 
remained after adding those polymers. 
The polyethylenimine (PEl) binds to quadruplex DNA by electrostatic attraction. 
The CD and porphyrin UV screening results showed PEl might alter the quadruplex 
DNA structures. Other researchers have shown that polyvinylpyrrolidone is able to bind 
to DNA. In contrast to free quadruplex DNA, the polyvinylpyrrolidone (PVP), some 
changes were observed in 3lp NMR ofquadruplex DNA-binding interaction. By adding a 
sufficient amount of the compounds, we have observed the 3lp NMR spectra shifted to a 
higher frequency field (down field). A slight change ofpolyvinyl pyridine N-oxide 
(PVNO) was also observed in 31p NMR ofquadruplex DNA-binding interaction. 
Diffusion NMR is a very powerful tool to study mobility ofmolecules and to 
characterize mixtures of the complex in the biochemistry fields. Our NMR data from the 
diffusion experiment has indicated that the poly(N-vinylpyrrolidone) has shown the 
binding interaction with the quadruplex (T4G4) DNA which is consistent with the 
previous finding. The poly(4-vinylpyridine N-oxide) did show a weak binding 
interaction with the quadruplex (T4G4) DNA. 
However, the interaction ofthe quadruplex DNA with PVNO is still unclear at this 
moment. Although it is not as well-defined as indicated by the lack of well resolved 
NMR peak for PVP and PVNO polymers, we still can provide some information for 
applying these polymers in further studies. 
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In attempt to better predict the binding interaction for poly( ethylenimine), poly(N­
vinylpyrrolidone), and poly(4-vinylpyridine N-oxide) with quadruplex (T4G4) DNA; we 
have conducted the DOSY NMR experiments. The DOSY data verified the same 
conclusion as the previous NMR studies for these three polymers. Moreover, we have 
discovered the binding ratio ofthe PVP and quadruplex DNA, as indicated in the 
experiment, I to I binding ratio showed very weak binding or some kinds of interaction. 
The 5 to I ratio showed the better binding affinity and 10: 1 ratio was shown many 
fragment peaks which indicated the conformational changing in quadruplexes DNA. 
A 2D NOESY experiment was performed to further investigate the conformational 
change on binding of the poly (ethylenimine) with quadruplex (T4G4) DNA. We 
therefore conclude that molar ratio ofPEl Iquadruplex DNA at 5 to 1 has stronger 
binding interaction than at a I to 1 ratio. The PEIIquadruplex DNA structural transition 
was also investigated by CD; the CD spectra show that PEl will induce the 
conformational change in quadruplex DNA structures. However, the definitive 
conformation has yet to be determined by our studies. 
A number of challenges still remain unfulfilled in fully understanding the 
importance of these materials. Further study will continue to develop the suitable 
functionalized polymers and hope to provide guidance to other researchers and for a 
better understanding and applying in using these materials in nucleic acid research. 
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6.2 Suggested Further Studies 
Building on these results, further studies in this area will seek to extend the 
structure-function relationship ofquadruplex DNA and its applications. Our research has 
revealed some preliminary fmdings about quadruplex T4G4 DNA binding to PEL 
We hope to find more specific information about the mechanism of the transition steps­
does this transition in multiple steps or is it a single step transition? Is there a single PEl 
induced structure or is there a dynamic equilibrium between a suite of structures? Is the 
structural alteration by PEl general- will all quadruplex structures be altered - or 
specific to parallel structures? Can we use the similar sequences with an antiparallel 
structure to cross-links with PEl and apply this architecture to the imprint techniques. 
We will evaluate the sequences and structures availability for the improving the binding 
specificity with G-quadruplex DNA. 
The other interests are in the modification of the porphyrin and its derivatives. Based 
on porphyrin end-stacking property with G-quadruplex, derivative of porphyrins can 
conjugate with polymers or other small molecules could possible induce quadruplex. 
Further improvement will continuously rely on a better understanding of the cellular 
and in vivo barriers in gene transfer. We anticipate that significantly improve the structure 
specificity will provide new insights into the direction of future research. 
152 

REFERENCES 

1. Bai, N.; Health & Medicine, Dec., 2008. 
2. Ledley, F.D., Pharm. Res. 1997,13, 1595-1614. 
3. Weir, B.; Zhao, X.; Meyerson, M., Cancer Cell 2004, 6 (5), 433-438. 
4. Anson, D.S.; Smith, G.J.; Parsons, D.W., Curr Gene Ther 2006,6(2), 161-179. 
5. Park, T.G.; Jeong, J.H.; Kim, S.W.; Adv. Drug Deliv Rev. 2006, 58(4),467-486. 
6. Liu, Z.; Zhang, Z.; Zhou, C.; Jiao, Y., Progress in Polymer Science, 2010, 35 (9), 
1144-1162. 
7. Kabanov, A.V., Pharm. Sci. Tech. Today, 1999,2,365-372. 
8. Nishikawa, M.; Huang, L., Hum. Gene. Ther. 2001,12,861-870. 
9. Wong, S.Y.; Pelet, J.M.; Putnam, D., Prog. Polym. Sci. 2007, 32, 799-837. 
10. Smith, A.E., Annu. Rev. Microbiol1995, 49, 807-838. 
11. Breyer, B.; Jiang, W.; Cheng, H.; Zhou, L.; Paul, R.; Feng, T.; He, T.C., Curro Gene 
Ther. 2001, 1, 149-162. 
12. Lee, M.; Kim, S.W., Pharm. Res. 2005,22,1-10. 
13. Glover, D.; Lipps, H.J.; Jans, D.A., Nat. Rev. Genet, 2005, 6, 299-310. 
14. Li, S.; Huang, L., Gene Ther. 2000, 7,31-34. 
15. Felfuer, P.L. et al., Proc. Natl. Acad. Sci. US.A.1987, 84, 7413-7417. 
16. Zelphati, 0.; Szoka, C. Jr., Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 11493-11498. 
17. Boussij, O. et al., Proc. Natl. Acad. Sci., US.A. 1995,92, 7297-7301. 
18. Pollard, H. et al., J. Bioi. Chern. 1998,273, 7507-7511. 
19. Brown, M.D.; Schatzlein, A.G.; Uchegbu, IF.,Int. J. Pharm. 2001,229, 1-21. 
20. Godbey, W.T.; Mikos, A.G. J., Control Release 2001, 72,115-125. 
21. De Smedt, S.C.; Demeester, J.; Hennink,W.E., Pharm. Res. 2000,17,113-126. 
22. Merdan, T.; Kopecek, J.; Kissel, T., Adv. Drug Del. Rev. 2002,54, 715-758. 
153 

23. Han, H.; Hurley, L.H., Trends Pharmacol. Sci. 2000,21, 136-142. 
24. Sarder, N. V., Biote. Mol. Bio. Review 2007, 2 (3),58-67. 
25. Arigita, c.; Zuidam, N.J.; Crommelin, D.J.A; Hennink, W.E., Pharm. Res. 1999,16, 
1534-1541. 
26. Bloomfield, V. A, Nucleic Acid Science 1997, 1-23. 
27. Watson, J.D.; Crick, F.H., Nature 1953,171(4356), 737-738. 
28. Capra, J.A; Paeschke, K.; Singh, M.; Zakian, V. A, PLoS Cornput. Biol.201O, 
6 (7), e1000861. doi :10.1371 
29. Wang, Y.; Patel, D. 1., Structure 1993,1,263-282. 
30. Zahler, AM.; Williamson, J.R.; Cech, T.R.; Prescott, D.M., Nature 1991,350, 718­
720. 
31. Yang, D.; Okamoto, K., Future MedChern. 2010,2(4),619-646. 
32. Neidle, S.; Parkinson, G.N., Curr.Opin. Struct. Bioi. 2003, 13,275-283. 
33. Lundblad, V.; Proc. Natl.Acad. Sci. USA 1998,95,8415-8416. 
34. Shim, J.W.; Tan, Q.; Gu, L-Q, Nucl. Acids Res. 2009, 37 (3),972-982. 
35. Vrraca, J.L.; Hall, A.J.; Moreno-Bondi, M.C.; Sellergren, B. Angew. Chern. Inter. Ed. 
2006,45,5158-5161. 
36. Miyata, T.; Jige, M.; Nakaminami, T.; Vragami, T., Proc. Natl. Acad. Sci. USA 
2006,103,1190-1193. 
37. Shi, D.-F. ; Wheelhouse, R.T.; Sun, D.; Hurley, L.H., J. Med. Chern. 2001,44,4509­
4523. 
38. (a) Mastrobattista, E.; Hennink, W.E., Nature Materials 2012,11, 10-12. (b). Castasi, 
P.; Chen, X.; Moyzis, R; Bradbury, E.; Gupta, G., J. Mol. Bioi. 1996,264,534-545. 
39. Jewell, C. M.; Lynn, D. M., Curro Opin. Colloid Interface Sci. 2008, 13 (6), 395­
402. 
40. Gao, X.; Kim, K-S; Liu, D., The AAPS Journal 2007 , 9 (l), E92-103. 
41. Boussif, 0.; Lezoualch, F.; Zanta, M.A; Mergny, M.D.; Scherman, D.; Demeneix, 
R; Behr, J.-P., Proc. Natl. Acad. Sci. USA 1995, 7297-7301. 
154 
42. Nathan, P. Q.; Pack, D. W., Biomacromolecules 2006, 7(8),2427-2435. 
43. Haq, I.; Trent, J. 0.; Chowdhry, B. Z.; Jenkins, T. C., J. A.C. S. 1999,121 (9), 1768­
1779. 
44. Polymers: The Origin and Growth of a Science, Herbert Morawetz, John Wiley & 
Sons,1985. 
45. Polymers: Chemistry and Physics ofModem Materials, Cowie, 1. M. G, Chapman & 
Hall, 1991. 
46. Su, J.; Kim, C-J.; Ciftci, K., Gene Therapy, 2002, 9(15), 1031-1036. 
47. Mumper, R. 1.; Wang, J.; Klakamp, S. L.; Nitta, H.; Anwer, K.; Tagliaferri, F.; 
Rolland, A. P., J. Controlled Release 1998, 52,191-203. 
48. Mumper, RJ. et al. Pharm Res 1996,13,701-709. 
49. Holt, P.F.; Lindsay, H.; Beck, E.G., Br. J. Pharmacol. 1970,38(1), 192-201. 
50. Walker, G. F.; Fella, C.; Pelisek, J.; Fahrmeir, J.; Boeckle, S.; Ogris, M .;Wagner, 
E., Molecular Therapy 2005, 11,418--425. 
51. Ogris, M.; Brunner, S.; Schuller, S.; Kircheis, R; Wagner, E., Gene Ther. 1999,6 
(4),595-{)05. 
52. Breunig, M.; Lungwitz, u.; Liebl, R; Fontanari, C.; Klar, J.; Kurtz, A., J. Gene 
Med2005, 7 (10), 1287-1298. 
53. Lee, H.; Jeong, J. H.; Park, T. G.; Journal ojContro//ed Release 2001, 76, 183-192. 
54. Kircheis, R; Wightman, L.; Wagner, E., Adv. Drug Deliver Rev. 2001,53,341-358. 
55. Lemkine, G. F.; Demeneix, B. A., Curro Opin. Mol. Ther. 2001, 3, 178-182. 
56. Lungwitz, U; Breuniq, M.; Blunk, T.; Gopferich, A., Eur. J. Pharm. Biopharm., 2005, 
60 (2), 247-266. 
57. Hanzlikova, M.; Soininen, P.; Lampela, P.; Mannisto, P. T.; Raasmaja, A, 
Plasmid2009, 61(1), 15-21. 
58. (a) Abdallah, 1. B.; Hassan, A.; Benoist, C.; Goula, D.; Behr, J.-P.; Demeneix, B.A., 
Hum. Gene Ther. 1996, 7, 1947-1954. (b) Boletta, A.; Benigni, A.; Lutz, J.; 
Remuzzi, G.; Soria, M.R; Monaco,L., Hum. Gene Ther.1997, 8, 243-1251. 
59. Von Harpe, A.; Petersen, H.; Li, Y.X.; Kissel, T.; J. Control Release 2000,69, 
309-322. 
155 

60. Maruyama, H.; Higuchi, N.; Kameda, S.; Nakamura, G.; Miyazaki, J.; Gejyo, F., 
Gene Ther. Mol. Bioi. 2003, 7, 221-228. 
61. Godbey, W.T.; Wu, K.K.; Hirasaki, GJ.; Mikos, A.G.; Gene Ther. 1999,6, 
1380-1388. 
62. Gosselin, M.A.; Guo, W.; Lee, R.J., Bioconjugate Chem. 2001, 12 (6), 989-994. 
63. Lungwitz, U; Breunig, M,; Blunk, T; Gopferich, A., Eur. J. Pharm. Biopharm. 2005, 
60(2),247-266. 
64. Mady, M. M.; Mohammed, W. A.; E1-Guendy, N.M.; E1sayed, A.A., International 
Journal ofPhysical Sciences 2011, 6(32), 7328 - 7334. 
65. Yanga, T.; Hussaina, A.; Baia, S.; Ikramy, A.; Harashimab, H; Ahsan, F., J. Control 
Release 2006,115,289-297. 
66. Kircheis, R.; Wightman, L.; Schreiber, A.; Robitza, B.; Rossler, V.; Kursa, M.; 
Wagner, E., Gene Ther. 2001, 8(1),28-40. 
67. De Smedt, S. C.; Demeester, J.; Hennink:, W., Pharmaceutical Research 2000, 
17(2),113-126. 
68. Needham, c.J.; Williams, A.K.; Chew, S.A.; Kasper, F.K.; Mikos, A.G., 
Biomacromolecules 2012,131429-1437. 
69. Huppert lL.; Ba1asubramanian, S., Nucleic Acids Res. 2005,33,2908-2916. 
70. Sun, H.; Zhou, Q.; Xiang, J.; Tang, Y., Bioorganic & Medicinal Chemistry 
Letters 2009, 19 (16), 4669-4672. 
71. Hershman, S.G.; Chen, Q.; Lee, lY.; Kozak, M.L.; Yue, P.; Wang, L. S.; Johnson, 
F.B., Nucleic Acids Res. 2008,36(1), 144-156. 
72. Izbicka, E,; Wheelhouse, R.T.; Raymond, E.; Davidson, K.K.; Lawrence, RA.; Sun, 
D.; Windle, B.E.; Hurley, L.R.; Von Hoff, D.D., Cancer Res. 1999, 59, 639-644. 
73. Zhang, S.; Zhao, Y.; Zhao, B.; Wang, B., Bioconjug Chem. 2010,21(6), 1003-1009. 
74. Hu, Q.; Fan, H.; Lou, W.; Wang, Q.; Tang, G.,J. Zhejiang Univ. Sci. B. 2011, 12(9), 
720-729. 
75. Tang, G.; Guo, H; Alexis, F.; Wang, X.; Zeng, S.; Lim, T.; Ding, J.; Yang, Y.; 
Wang, S., J. Gene Med. 2006,8 (6),736-744. 
76. Park, T.G.; Jeong, J.H.; Kim, S.W, Adv Drug Deliver Rev. 2006, 58,467-486. 
156 

77. Jeong, J.H.; Kim, S. W.; Park, T. G., Prog. Polym. Sci. 2007, 32, 1239-1274. 
78. Choi, Y.H.; Liu, F.; Park, J.S.; Kim, S.W., J. Control. Release 1998, 54, 39-48. 
78. Wei, C.; Han, G.; Jia, G.; Zhou, J.; Li, C., Biophysical Chem. 2008,137 (I), 19-23. 
79. Wei, C.; Jia, G.; Yuan, 1; Feng, Z.; Li, C., Biochemistry 2006,45(21),6681-6691. 
80. Munson, B. R.; Fiel, R J., Nucleic Acids Research 1992,20 (6), 1315-1319. 
81. Lubitz, I.; Borovok, N.; Kotlyar, A., Biochemistry 2007,46, 12925 -12929. 
82. Wei, C.; Wang, L.; Jia, G.; Zhou, J.; Han, G.; Li, C., Biophysical Chemistry 2009, 
143, 79-84. 
83. Wheelhouse, R.T.; Sun, D.; Han, H.; Han, F. X.; Hurley, L. H., J. Am. Chem. Soc. 
1998,120,3261-3262. 
84. Han, F. X.; Wheelhouse, R. T.; Hurley, L. H.,J. Am. Chem. Soc. 1999,121, 3561­
3570. 
85. Kim, M. Y.; Gleason-Guzman, M.; 1zbicka, E.; Nishioka, D.; Hurley, L. H., 
Cancer Res., 2003,63,3247-3256. 
86.1zbicka, E.; Wheelhouse, R. T.; Raymond, E. et aI, Cancer Research 1999, 
59 (3), 639-644. 
87. Garrett, RH., Grisham. C.M., Biochemistry 3rd ed. 2007, Thomson Brooks/Core, 
BelmontCA. 
88. Horton, RA.; Moran, L. A.; Scrimgeour, G.; Perry, M.'rawn, D., Principles of 
Biochemistry 2006, 4/e, ISBN-! 0:0 131453068, Prentice Hall. 
89. Bundschuh, R.; Gerland, U., Eur. Phys. J. E 19 2006, 319-329. 
90. Amott, S.; Chandrasekaran, R.; Selsing, E., Structure and Conformation ofNucleic 
Acids and Protein- Nucleic Acid Interactions (eds Sundaralingam, M. & Rao, 
S.T.) 1975, 477-603. 
91. Dahm, R., Developmental Bioi. 2005,278,274-288. Friedrich Miescher and the 
discovery of DNA. 
92. Levene, P., J. BioI. Chem. 1919,40 (2),415-24. 
93. (a) Astbury, W., 1947. "Nucleic acid". Symp. SOC. Exp. BbU, (66). 
(b) Astbury, W.T.; Bell, F.O., Quant Bio. 138,6, 109-121 
157 

94. Hershey, A; Chase, M., J. Gen. Physiol. 1952, 36 (I), 39-56. 
95. Watson, J.D.; Crick, F.H.C, Nature 1953, 171 (4356), 737-738. 
96. Bundschuh, R.; Gerland, V., Eur. Phys. 2006,19, 319-329. 
97. Khuu, P.; Ho, P.S., Biochemistry 2009,48(33), 7824-7832. 
98. Richards, FM., Protein Sci. 1992,1, 1721-1730. 
99. Soyfer, V.N; Potaman, V.N., Triple-Helical Nucleic Acids 1995, Springer Ver., New 
York, p360. 
100. Arnott, S.; Chandrasekaran, R.; Selsing, E., Structure and Conformation ofNucleic 
Acids and Protein- Nucleic AcidInteractions (eds Sundaralingam, M. & Rao, 
S.T.)1975,477--603. 
10 I. Ghosh, A, Bansal, M., Acta Crystallogr D Bioi. Crystallogr 2003, 59 (Pt 4), 620­
626. 
102. Zhang, H.; Yu, H.; Ren, J.; Qu, X., Biophysical Journal 2006, 90 (9), 3203-3207. 
103. Ha, S. c., Lowenhaupt, K.; Rich, A; Kim, Y.; Kim, K. K., Nature 2005, 437, 1183­
1186. 
104. Voet, D.; Voet, lG, Biochemistry, 3rd, 2004, Chapter, 5, 29 
105. Dickerson, et aI., Science 1982, 216, 475-483. 
106. Lehninger, A; Nelson, D.; Cox, M.M., Lehninger, Principles ofBiochemistry 2004 
4 ed, Chapter 12,Nucleic Acid Structure. 
107. Saenger, W., Principles ofNucleic Acid Structure 1984, Springer-Verlag, New 
York. 
108. Wang, AHl; Quigley, G.l; Kolpak, F.J.; Crawford, J.L.; van Boom, J.H.; Van 
der Marel, G.; Rich, A., 1979, Nature (London) 282 (5740), 680--686. 
109. Rich. A, Ann. NY A cad. Sci. 1994,726, 1-17. 
110. Rich, A.; Zhang S., Nature 2003, 4, 566-572. 

Ill. Maxim, D. F-K.; Sergei, M.M., Annu. Rev. Biochem. 1995, 64, 65-95. 

112. Wang, E.; Malek, S.; Feigon, J., Biochemistry 1992, 31,4838-4846. 

lB. Radhakrishnan, L; Patel, D. J., J. Am. Chem. Soc. 1992,114(17),6913--6915. 

158 

114. Heo, D.S., Genetic in Medicine 2002, 4, 52S-55S. 
115. Romano, G.; PaciUo, C.; Giordano, A, The Oncologist 1998, 3(4), 4225-4236. 
116. Campbell, N. A.; Brad, W.; Robin, J. H., Biology: exploring Life, 2006, Boston, 
Massachusetts: Pearson Prentice HalL 
117. Liaw, J.; Chang, S-F.; Hsiao, F-C., Gene Therapy 2001,8,999-1004. 
118. Touchefeu, Y.; Harrington, K. J.; Galmiche, 1. P.; Vassaux, G., Aliment Pharmacol 
The~ 2010,32,953-968. 
119. Ledley FD., Hum. Gene Ther. 1995,6(9), 1129-1144. 
120. MoriUe, M.; Passirani, C.; Vonarbourg, A; Clavreul, A; Benoit, J-P., 
Biomaterials 2008, 29, 3477-3496 
121. Radler, J.O.; Koltover, I.; Salditt, T.; Safinya, c.R., Science 1997, 275(5301), 810­
814. 
122. Editor, Segev; N., Associate Editors: Alfonso; A., Payne; G., Donaldson; J., 
Trafficking Inside Cells: Pathways, Mechanisms and Regulation, Landes 
Bioscience and Springer Science/Business Media, 2009 Madame Curie Bioscience 
Database. 
123. Burgers, P. M.J, J. o/Biological Chemistry 2008,284 (7),4041-4045. 
124. Das-bradoo; S., Bielinsky; A, Nature Education 2010,3(9),50. 
125. Berg, J.M.; Tymoczko, J.L.; Stryer, L.; Clarke, N.D., Biochemistry 2002. W. H. 
Freeman and Company. ISBN 0-7167-3051-0, Chapter 27: DNA Replication, 
Recombination, and Repair. 
126. Kong, X-P.; Onrust, R.; O'Donnell, M.; Kuriyan, J., Cell 1992, 69,425-437. 
127. (a) Alberts, 8.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P., 
Molecular Biology o/the Cell 2002, Garland Science. ISBN 0-8153-3218-1, 
Chapt 5, DNA Replication Mechanisms. (b) Buzzle.com, DNA replication steps. 
128. Muller, H.J., Collecting Net 1938, 13, 181-198. 
129. Phan, AT.; Kuryavyi, V.; Luu, K. N.; Patel, D. J., Nucleic Acids Res. 2007,35(19), 
6517-6525. 
130. Han, H.; Hurley, L.H., Trends in Pharmacological Sciences 2000,21(4),136-142. 
131. Bodnar, A.G.; Ouellette, M.; Frolkis, M.; Holt, S.E.; Chiu, C.P.; Morin, 
159 

G.B.; Harley, C.B.; Shay, IW., Lichtsteiner, S.; Wright, W.E., Science 1998, 279, 
349 -352. 
132. Aubert, G.; Lansdorp, P. M., Physiol Rev. 2008,88 (2),557-579. 
133. 	 Blackburn; E.H., Nature Struct. Bioi. 2000,7,847- 850. 
134. Meyne, J.; Ratliff, R.L.; Moyzis, R.K., PNAS 1989,86 (18), 7049-7053. 
135. Moyzis, R.K.; Buckingham, J.M.; Cram, L.S.; Dan, M.; Deaven, L.L.; Jones, M.D.; 
Meyne, J.; Ratliff, R.L.; Wu, J.-R., Proc. Natl Acad. Sci. USA 1988, 85,6622- 6626. 
136. Viglasky, V.; Bauer, L.; Tluckova, K.; Javorsky, P., J. Nuclei Acids 2010, 2010,1-8. 
137. Xu, Y.; Ishizuka, T.; Kurabayashi, K.; Komiyama, M., Angew. Chem. Int. Ed. 2009, 
48, 7833 -7836. 
138. Allsopp, R. C.; Morin, G.B.; DePinho, R.; Harley, C.B.; Weissman, I.L., Blood 
2003,102, 517-520. 
139. 	Grandin, N.; Charbonneau, M., Biochimie 2008,90,41-59. 
140. Chakhparonian, M.; Wellinger, R.J., Trends Genet. 2003,19,439-444. 
141. Smogorzewska, A.; de Lange, T.,Annu. Rev. Biochem. 2004, 73, 177-208. 
142. Viscardi, V.; Clerici, M.; Cartagena-Lirola, H.; Longhese, M.P., Biochimie 2005, 87, 
613-624. 
143. 	Sandell, L. L.; Zakian, V. A., Cell 1993, 75, 729-739. 
144. McClintock, B., Genetics 1938,23,315-376. 
145. McClintock, Barbara. A short biographical note: Barbara McClintock i983, 
Nobel Foundation biography. 
146. 	 0lovnikov, A.M., J. Theor. Bioi. 1973,41(1), 181-190. 
147. 	Blackburn, E.H.; Greider, C. W.; Szostak, J.W., The Nobel Prize in physiology 
or Medicine 2009, Nobel prize.org. 
148. Counter, C. M.; Hirte, H. W.; Bacchetti, S.; Harley, C. B., Proc. Natl. Acad. Sci. 
U.S.A., 1994, 91, 2900. 
149. 	Stewart, S. A.; Bertuch, A.A., Cancer Res. 2010,70, 7365-7371. 
150. Greider, C.W.; Blackburn; E.H., Cell 1987, 51, 887-898. 
160 

151. Blasco, M.A; Nat Rev Genet 2005,6(8),611-22. 
152. Callaway, E., Nature, 2010, doi; 1O.1038/news, 2010.635. 
153. Funk, W. D.; Wang, C. K., et aI., Exp Cell Res 2000,258(2),270-278. 
154. Hiyama, E.; Hiyama, K.; Yokoyama, T.; Shay, 1.W., Neoplasia. 2001,3(1), 17-26. 
155. Shay, 1. W.; Bacchetti, S., Eur. J. Cancer 1997, 33, 787-791. 
156. Akalin, A; Elmore, L.W.; Forsythe, H.L.; Amaker, B.A.; McCollum, E.D.; Nelson, 
P.S.; Ware, 1.L.; Holt, S.E., Cancer Res 2001,61,4791-4796. 
157. Fenton, R. G.; Longo, D.L., Harrison's Principles of Intemal Medicine 1998, 69, 
Cancer cell biology and Angiogenesis. 
158. Willeit, P.; Willeit, J., et aI., JAMA 2010, 304(1), 69-75. 
159. Vogelstein, B.; Kinzler, K.W., Trends Genet.1993, 9, 138- 141. 
160. Shay, IW.; Wright, W.E.; Werbin, H., Biochim. Biophys. Acta 1991, 1072, 1-7. 
161. Hanahan, D.; Weinberg, R.A, Cell 2000, 100, 57-70. 
162. Hahn, W.C.; Counter, C.M.; Lundberg, A.S.; Beijersbergen, R.L.; Brooks, M.W.; 
Weinberg, R.A, Nature 1999, 499,464- 468. 
163. Kim, N. W.; Piatyszek, M. A.; et aI., Science 1994, 266 (5193),2011-2015. 
164. Meyerson, M.; Counter, C. M.; Eaton, E. N.; Ellisen, L. W.; Steiner, P.; CaddIe, S. 
D.; Ziaugra, L.; Beijersbergen, R. L.; Davidoff, M. 1.; Liu, Q., Bacchetti, S.; Haber, 
D. A; Weinberg, R. A, Cell 1997, 90, 785-795. 
165. Fiedler, W.; Dahse, R.; Schlichter, A., Int. J. Oneal. 1996,9, 1227-1232. 
166. Mehle, C.; Piatyszek, M. A; Ljungberg, B.; Shay, J. W.; Ross, G., Oncogene 1996, 
13, 161-166. 
167. Cong, Y.; Wright, W.E.; Shay, J.W., Mol. Bioi. Rev. 2002,66,3408-3425. 
168. Raymond, E.; Sun, D.; Chen, S.; Windle, B.; Van Hoff, D. D., Current Opinin in 
Biotechnology 1996,7,583-591. 
169. Saretzki, G., Cancer Lett. 2003, 194(2),209-219. 
170. Shy, 1.W.; Zou, Y.; Hiya, E.,Wright; W.E., Hum. Mol. Genet. 2001, 10(7),677-685. 
161 

171. Norton, J.C.; Piatyszek, M.A; Wright, W.E.; Shay, J.W.; Corey, D.R, Nature 
Biotechnol. 1996,14,615- 619. 
172. de Lange, T.; Jacks, T., Cell 1999, 98, 273- 275. 
173. McKenzie, K.E.; Umbricht, C.B.; Sukumar, S., Mol. Med Today 1999, 5, 114- 122. 
174. White, L.; Wright, W.E.; Shay, J.W., Trends Biotechnol. 2001, 19, 114- 120. 
175. Fossel, M.B., Cells, Aging, and Human Disease, Oxford University Press 
2004, ISBN 0-19-514035-4. 
176. Sun, D.; Thompson, B.; Cathers, B.E.; et al. J. Med. Chern. 1997, 40, 2113-2116. 
177. Mergny, J.L.; Lacroix, L.; Teulade-Fichou, M-P. et aI, Proc Nat.! A cad. Sci. 2001, 
98, 3062-3067. 
178. Read, M.A ; Harrison, J.R.; Romagnoli, B., et aI, PNAS 2001, 98, 4844-4849. 
179. Gellert, M.; Li, F.; Lipsett, M. N.; Davies, D.R., Proc. Natl. Acad. Sci. U.S.A. 1962, 
48,2013-2018. 
180. Sannohe, Y.; Sugiyama, H., Current Protocols in Nucleic Acid Chemistry 2010, 
40,17.2.1-17.2.17, Overview of Fonnation ofG-Quadrup1ex Structures. 
181. Sun, D.; Guo, K.; Shin, Y-J., Nucl. Acids Res. 2011,39 (4), 1256-1265. 
182. Fukita, Y.; Mizuta,T-R.; Shirozu, M.; Ozawa, K.; Shimizu, A.; Honjo, T., J. 
Biological Chemistry 1993, 268, 17463-17470. 
183. Sinden, R.R., Am. J. Hum. Genet. 1999,64,346-353. 
184. Burge S.; Parkinson G.N.; Hazel P.; Todd, AK.; Neid1e, S.; Nucl. Acids Res. 
2006,34 (19),5402-5415. 
185. Balasubramanian, S.; Hurley, L. H.; Neid1e, S., Nat. Rev. Drug Discov. 2011, 10 (4), 
261- 275. 
186. Neidle, S.; Balasubramanian, S., Quadruplex Nucleic Acids 2006, Cambridge: RSC. 
187. Yang, D.; Okamoto, K., Future Med. Chern. 2010,2(4),619-646. 
188. Huppert, J.L., Chern. Soc. Rev. 2008, 37, 1375-1384. 
189. Lipps, H.J.; Rhodes, D, Trends in Cell Biology 2009,19(8),414-422. 
162 

190. Schaffitzel, Co; Berger, 1.; Postberg, J.; Hanes, 1.; Lipps, H.J.; Pluckthun, A., Proc 
Natl. Acad Sci. USA 2001, 98(15), 8572-8577. 
191. Yong; Q., Hurley; L. H., Biochimie. 2008,90(8),1149-1171. 
192. Mendez; M.A: Development and characterization o/novel nanomaterials using 
G- quadmplex DNA building blocks, ISBN-1O: 1244714828,2011, Pro .. Quest, 
UMI Dissertation Publishing 
193. Kaushik, M.; Kaushik, S,; Bansal, A; Saxena, S.; Kukreti, S., Curro Mol. Med. 
2011,11(9), 744-769. 
194. Yong, Q.; Hurley, L. H., Biochimie. 2008,90(8), 1149-1171. 
195. Rachewal, P A; Brown, T.; Fox, KR., Biochemistry 2007, 46(11), 3036-3044. 
196. Cang, X; Sponer J.; Cheatham, T.E., Nucleic Acids Res. 2011,39(10),4499-4512. 
197. Lee, J.Y.; Yoon, J.; Kihm, H.W.; Kim, D.S., Biochemistry 2008,47(11),3389­
3396. 
198. Sundquist, W.I; Klug, A, Nature 1989, 342(6251), 825-829. 
199._Burge, S.; Parkinson, G.N.; Hazel, P.; Todd, AK.; Neidle S, Nucleic Acids Res. 
2006,34,5402-5415. 
200. Dai, J.x.; Carver, M.; Punchihewa, C.; Jones, R.A.; Yang, D.Z., Nucl. Acids Res. 
2007,35(15),4927-4940. 
201. Gilbert, D.E.; Feigon J., Curro Opin. Stmct. Bioi. 1999, 9, 305-314. 
202. Lane AN.; Chaires, J.B.; Gray, R.D.; Trent, J.O., Nucleic Acids Res. 2008,36, 
5482-5515. 
203. Jing, N., Marchand, C.; Liu, J.; Mitra, R.; Hogan, M.E.; Pommier, Y., J. Bioi. 
Chem. 2000,27,21460-21467. 
204. Miyoshi, D.; Nakao, A; Sugimoto, N., Nucleic Acids Res., 2003, 31, 156-1163. 
205. Hazel, P.; Huppert, J.; Balasubramanian, S.; Neidle, S.,J. Am. Chem. Soc. 2004, 126 
,16405-16415. 
206. Simonsson, T., Bioi. Chem. 2001,382,621-628. 
207. Cang, X.; Sponer, J.; Cheatham, T. E.,J. Am. Chem. Soc. 2011, 133(36), 14270­
14279. 
208. Parkinson, G. N.; Lee, M. P. H.; Neidle, S., Nature, 2002, 417, 6891, 876-880. 
163 

209. Wang, Y.; Patel, D.J., 1. Mol. Bioi. 1993,234, 1171 - 1183. 
210. Marathias, V. M.; Bolton, P. H., Biochemistry 1999, 38, 4355-4364. 
211. Williamson, J. R.; Raghuraman, M.K.; Cech, T.R., Cell 1989, 59(5), 871·880. 
212. Smith, F.W.; Lau, F.W.; Feigon, J., Proc. Natl. Acad. Sci. USA 1994,91, 10546· 
10550, Biochemistry. 
213. Rachwal, PA; Findlow, IS.; Werner, JM; Brown, T.; Fox, KR., Nucl. Acids 
Res. 2007,35,4214-4222. 
214. Greene, K.L.; Wang, Y.; Live, D., 1. Biomol. NMR 1995,5(4),333-338. 
215. Clark, G. R.; Pytel, P. D.; Squire, C. J.,NucleicAcids Res. 2012, 1-8. 
216. Marusic, M. ; Sket, P.; Bauer, L.; Viglasky, V.; Plavec,)., Nucleic Acids Res. 2012 
40(14),6946-6956. 
217. Venczel, E.A.; Sen, D., Biochemistry 1993, 32, 6220-6228. 
218. Bugaut, A.;Balasubramanian, S., Biochemistry 2008, 47(2), 689-97. 
219. Risitano, A.; Fox, K.R., Nucleic Acids Res. 2004, 32, 2598· 2606. 
220. Editor, Neidle S, Authors, Hud, N.V.; Plavec, J., The role of cations in determining 
quadruplex structure and stability. Quadruplex Nucleic Acids, Royal Society of 
Chemistry, Publishing, Cambridge UK, 2006,100--130. 
221. Kang, C., Zhang, X., Ratliff, R., Moyzis, R.; Rich, A., Nature 1992, 356, 126 -131. 
222. Miyoshi D; Nakao, A.; Toda, T., Sugimoto, N., FEBS Lett. 2001,496(2-3), 128-133. 
223. Chen, F.M., Biophys. J. 1997, 73,348-356. 
224. Chen, F. M., Biochemistry 1992,31,3769-3776. 
225. Risitano, Q.; Fox. K.R., Nucleic Acids Res. 2004, 32(8), 2598-2606. 
226. Ross W. S.; Hardin C. C., 1. Am. Chem. Soc. 1994, 116 (14),6070--6080. 
227. Rawal, P.; Kummarasetti, V.B.; Ravindran J.; Kumar, N.; Halder, K.; Sharma, R.; 
Mukerji, M.; Das, S.K.; Chowdhury, S., Genome Res. 2006, 16, 644-655. 
228. Waller, Z.A.; Sewitz, S.A.; Hsu, S.T.; Balasubramanian, S. ,1. Am. Chem. Soc. 2009 
,131(35), 12628-12633. 
229. Siddiqui-Jain, A.; Grand, C. L.; Bearss, D. J.; Hurley, L. R., Proc. Natl. Acad. Sci. 
164 

U.S.A. 2002,99, 11593-11598. 
230. Rankin, S.; Reszka, A P.; Huppert, J.; Zloh, M.; Parkinson, G. N.;Todd, A. K.; 
Ladame, S.; Balasubramanian, S.; Neidle, S., J. Am. Chern. Soc. 2005, 127, 10584­
10589. 
231. Maizels, N., Nat. Struct. Mol. Bioi. 2006, 13, 1055-1059. 
232. Phan, AT.; Kuryavyi, V.; Burge, S.; Neidle, S.; Patel, D. J., J. Am. Chern. Soc. 
2007,129,4386-4392. 
233. Zhao, Y.; Du, Z.; Li, N., FEBS Lett. 2007,581, 1951-1956 
234. Dai, J.; Dexheimer, T. S.; Chen, D.; Carver, M.; Ambrus, A.; Jones,R. A.; Yang, D. 
,J. Am. Chern. Soc. 2006, 128, 1096--1098. 
235. Viglasky, V., FEBS J. 2009, 276,401- 409 
236. Gowan, S.M., et a1. Mol. Pharmacol. 2002, 61, 1154-1156. 
237. Maizels, N., Nat. Struct. Mol. BioI. 2006,13, 1055-1059. 
238. Guo, K.; Pourpak, A.; Beetz-Rogers, K.; Gokhale, V.; Sun, D.; Hurley, L. H., J. 
Am. Chern. Soc. 2007,129,10220-10228. 
239. Bates, P.; Mergny, J.L.; Yang, D., EMBO Rep.2007, 8,1003-1010. 
240. Dganesian, L.; Bryan, T.M., Bio. Essays 2007,29, 155-165. 
241. Dganesian, L.; Moon, IX.; Bryan,T. M.; Jarstfer, M.B., EMBO J. 2006, 25,1148­
1159. 
242. Kumari, S.; Bugaut, A.; Huppert, J.L.; Balasubramanian, S., Nat. Chern. Bioi. 2007, 
3,218-221. 
243. Yang, D.Z.; Hurley, L.H., Nucleoside Nucleotide Nucleic Acids 2006, 25 (8), 
951-968. 
244!...Patel, DJ.; Phan, AT.; Kuryavyi, V., Nucleic Acids Res. 2007,35, 7429-7455. 
245. Cogoi, S.; Xodo, L. E., Nucleic Acids Res. 2006,34,2536--2549. 
246. Sun, D.; Hurley, L.H., J. Moo. Chern. 2009,52,2863-2874. 
246. Riou, J.F.; Guittat, L.; Mailliet, P.; Laoui, A., Renou, E., Petitgenet, D., 
Megnin- Chanet, F.; Helene, C.; Mergny, J.L., PNAS 2002, 99 (5), 2672-2677. 
165 

247. Yang, D.; Okamoto, K., Future Med. Chem. 2010,2(4),619-646. 
248. Jiang, Y.L.; Liu, Z.P., Mini Rev. Med .Chem. 2010, 10(8), 726-36. 
249. Ou, T.-M.; Lu, Y.-J.; Tan, J.-H.; Huang, Z.-S.; Wong, K.-Y.; Gu, L.-Q., Chem. Med. 
Chem.2008,3,690-713. 
250. Lusvarghi, S.; Murphy, C.T; Roy, S.; Tanious, F. A.; Sacui, I., J. Am. Chem. Soc. 
2009,131(51), 18425-18440. 
251. Luedtke, N. W., CHIMIA 2009, 63 (3), 134-139. 
252. Drewe, W.C.; Nanjunda, R.; Gunaratnam, M.; Beltran, M.; Parkinson, G.N.; 
Reszka, A.P.; Wilson, W.D.; Neidle, S.,J. Med. Chem. 2008,51,7751-7767. 
253. Oganesian, L.; Bryan, T. M., Bioessays 2007, 29, 155-165. 
254. 	Shi, D. F.; Wheelhouse, R. T.; Sun, D. Y.; Hurley, L. H., J. Med Chem. 2001,44, 
4509-4523. 
255. Grand, C. L; Han, H.; Munoz, R.M.; Weitman, S.; Von Hoff, L.H.; Hurley, L.H.; 
Bearss, D. J., Mol. Cancer Ther. 2002,1,565-573. 
256. 	Vicente, M. G., Curro Med. Chem., 2001, 1, 175-194 
257. Ding, L.; Balzarini, D.; Schols, D.; Meunier, B.; Clercq, E. Biochem.Pharmacol. 
1992,44,1675-1679. 
258. Makundan, N.E.; Petho, G.; Dixon, D.W.; Marzilli, L.G., lnorg. Chem. 1995,34, 
3677-3687. 
259. Sehlstedt, U.; Kim, S.K.; Carter, P.; Goodisman, J.; Vollano, J.F.; Norde'n, R; 
Dabrowiak, J.C., Biochemistry 1994, 33, 417- 426. 
260. Nagesb, N.; Sharma, V. K.; Kumara. G.; Lewis, E.A., J. Nucleic Acids 2012, 2012, 
1-12. 
261. Marzilli, L. G.; Banville, L. D.; Zon, G.; Wilson, W. D. J. Am. Chem. Soc. 1986, 
108,4188-4192. 
262. Fiel, R.J.; Howard, J.C.; Mark, E.H.; Datta Gupta, N., Nucleic Acids Res. 1979, 6, 
3093-3118. 
263. 	Arthanari, H.; Basu, S.; Kawano, T. L. ;Bolton, P. H., Nucleic Acids Res. 1998,26, 
3724-3728. 
166 

264. Fiel, R. J., J. Biomol. Struct. Dyn. 1989,6, 1259-1275. 
265. Gibbs, E. J.; Tinoco, I. Jr.; Maestre , M. F.; Ellinas, P. A; Pasternack, R. F., 
Biochem. Biophys. Res. Commun. 1988,157,350-358. 
266. Guliaev, A B.; Leontis, N. B., Biochemistry 1999, 38, 15425-15437. 
267. Lee, y'-A.; Lee, S.; Cho, T.-S.; Kim, C.; Han, S. W.; Kim, S. K., J. Phys. Chem. B. 
2002,106,11351-11355. 
268. Strickland, J. A; Marzilli, L. G.; Wilson, W. D., Biopolymers 1990, 29, 1307-1323. 
269. Kuroda, R.; Tanaka, H., J. Chem. Soc. Chem. Commun. 1994,157,5-1576. 
270. Schneider, H.-J.; Wang, M. ,J. Org. Chem. 1994,59, 7473-7478. 
271. Sehlstedt, U.; Kim, S. K.; Carter, P.; Goodisman, J.; Vollano, J. F.; Norde'n, B.; 
Dabrowiak, J. C., Biochemistry 1994,33,417-426. 
272. Pasternack, R. F.; Goldsmith, J. 1; Gibbs, E., 1., Biophys. J. 1998, 75, 1024-1031. 
273. Yun, B. H.; Jeon, S. H.; Cho, T.-S.; Yi, S. Y.; Sehlstedt, U.; Kim, S. K., Biophys. 
Chem. 1998, 70, 1-10. 
274. Lee, S.; Jeon, S. H.; Kim, B.-J.; Han, S. W.; Jang, H. G.; Kim,S. K. ,Biophys. 
Chem. 2001,92,35-45. 
275. Park, T.; Kim, J. M.; Han, S. W.; Lee, D.-J.; Kim, S. K. ,Biochim.Biophys. Acta 
2005, 1726, 287-292. 
276. Jin, B.; Lee, H. M.; Lee, Y.-A; Ko, J. H.; Kim, C. Kim, S. K., J. Am. Chem. Soc. 
2005,127,2417-2424. 
277. Carvlin, M. J.; Datta-Gupta, N.; Fiel, R., J. Biochem. Piophys. Res. Commun. 1982, 
108,66-73. 
278. Carvlin, M. J.; Fiel, R. J., Nucleic Acids Res. 1983,11,6121-6139. 
279. Banville, D. L.; Marzilli, J. A; Strickland, J. A; Wilson, W. D., Biopolymers 1986, 
25, 1837-1858. 
280. Yamashita, T.; Uno, T.; Ishikawa, Y., Bioorganic & Medicinal Chemistry 2005,13, 
2423-2430. 
281. Han, H.; Langley, D.R.; Rangan, A; Hurley, L. H., J. Am. Chem. Soc. 2001,123, 
8902-8913 
167 

282. Dixon, 1M. ; Lopez, F.; Esteve, J.P., Tejera, AM.; Blasco, MA; Pratviel, G; 
Meunier, B., Chem.biochem. 2005, 6(1), 123-132. 
283. Yang, D.; Okamoto, K., Future Med Chem. 2010,2(4),619-646. 
284. Lee, Y.-A.; Kim, J.-O.; Cho, T.-S.; Song, R.; Kim, S. K. J. Am. Chem. Soc. 2003, 
125,8106-8107. 
285. Granville, D. J.; McManus, B. M.; Hunt, D. W. Histol. Histopathol. 2001, 16, 
309-317. 
286. Dalla, V. L; Marciani, M. S., Curro Med.Chem. 2001,8(12), 1405-1418. 
287. Earnshaw, J.C.; Steer, M.W., The application ofLaser Light Scattering to the Study 
OfBiological Motion 1982, Plenum Press, New York and London. 
288. Kerker, M., The scattering oflight and other electromagnetic radiation. 

Academic, New York, 1969. 

289. van de Hulst, H.C., Light scattering by small particles. John Wiley & Sons, New 
York, 1957. (Paperback by Dover Publications, New York, 1981) 
290. Bohren, C.F.; Huffman, D. R, Absorption and scattering oflight by small 
particles. John Wiley & Sons, New York, 1983. (Paperback by Wily Science 
Paperback Series, 1998) 
291. Berne, B. J.; Pecora, R, Dnamic Light Scattering: With Applications to Chemistry, 
Biology, and Physics. 1975, Dover Publications, Inc., Mineola. New York. 
292. Kerker, M., Scattering of Light & Other Electromagnetic Radiation 1969, 
Academic Press Inc. 
293. Wyatt Technology, http://www.wyatt.com. 
294. Edited by Gorenstein, D.G., Phosphorus-31 NMR Principles and Application 1984. 
Academic Press Inc. 
295. Gorenstein, D.G., Annu. Rev. Biophys. Bioehg. 1981,10,355-386. 
296. Canet, D. and D'ecorps, M., Applications ofField Gradients in NMR in 
Dynamics ofSolutions and Fluid Mixtures, Editor, Delpuech, J-J., Wiley, New 
York, 1995, 309-343. 
297. Packer, K. J., Diffusion & Flow in Liquids in Encyclopedia ofNuclear 
Magnetic Resonance. Editor: Grant, D. M.; Harris ,R. K., Wiley, New York, 1996, 
168 

1615-1626. 
298. Price, W. S., Gradient NMR, in Annual Reports on NMR Spectroscopy. Editor: 
Webb, G.A. Academic Press, London, 1996, 51-142. 
299. Karger, 1.; Ruthven, D. M., Diffusion in Zeolites and Other Microporous Solids, 

Wiley, NewYork,1992. 

300. Nose, T., Annu. Rep. NMR Spectrosc. 1993,27,218 253. 
301. Price, W. S., Concepts Magn. Reson. 1997,9,299 336 
302. Editor: Young, 1. R., Methods 0/Magnetic Resonance Imaging and Spectroscopy. 

Wiley, Chichester, 2000. 

303. (a) Basser, P. 1., NMR Biomed 1995, 8,333-344. (b) Basser, P. J.; Mattiello, 1.; 

Bihan, D. L, Biophys. J. 1994,66,259 - 267. 

304. Brand, T.; Cabrita, E. 1.; Berge, S., Progress in nuclear magnetic. 2005, 46(4), 159­
196. 
305. Johnson, C. S. Jr., Diffusion Measurements by Magnetic Field Gradient 
Methods, in Encyclopedia of Nuc1ear Magnetic Resonance. Editor: Grant, D. M. 
Harris, R. K., Wiley, New York, 1996,1626-1644. 
306. Hawlicka, E., Chern. Soc. Rev. 1995,34, 13743-13750. 
307. Hunter, R. J., Foundations o/Colloid Science, Oxford University Press, Oxford, 
1986. 
308. Ernst, R.R.; Bodenhausen, B.; Wokaun, A., Principles o/Nuclear Magnetic 
Resonances in One or Two Dimesnions 1992, Oxford University Press. 
309. Jones, J. A.; Wilkins, D. K. ; Smith, L. 1.; Dobson, C. M. ; J. Biomol. NMR 1997, 
10, 199 - 203. 
310. Crank, J., The Mathematics o/Diffusion, 2nd ed., Claxendon Press, Oxford, 1975. 
311. Cohen, Y.; Avram, L.; Frish, L.,Angew. Chem. Int. Ed. 2005,44,520 - 554. 
312. De Graaf, R.A., In vivo NMR spectroscopy: principles and techniques. John Wiley 
& Sons Ltd, 2007. 
313. Price, W.S., Concepts Magn. Reson. 1997,9,299-336. 
314. Keeler, J., Understanding NMR Spectroscopy 2010 (2nd ed.).Wiley ISBN978-0­
470-74608-0. 
169 
315. Mumenthaler, C.; Braun, W.,J. Mol. Bioi. 1995,254,465-480. 
316. Sherman, R.E., Analytical Instrumentation 1996, Cp 31, ISA, 
ISBN 978-1-55617-581-7, 566-592. 
317. Sreerama, N.; Woody, R. W., Meth. Enzymol. 2004,383,318-351. 
318. Alder, A.J.; Greenfield, N.J.; Fasman, G.D., Meth. Enzymology 1973, 27 (675), 
Circular Dichroism and Optical Rotary Dispersion of Proteins and Polypeptides. 
319. Woody, R.W.; Berova, N.; Nakanishi, K. (editors), Circular dichroism and the 
conformational analysis ofBiomolecules, 2nd, 2000, Wi 1ey-VCH. 
320. Wyatt Technology http://www.wyatt.com 
321. Wu, et. al. J. Magn. Reson. 1995, A 115,260-264. 
322. Utsuno, K.; U1udag, H, Biophys. J. 2010,99(1),201-207. 
323. Dai, Z.; Wu, C., Macromolecules 2012,45 (10), 4346-4353 
324. Mady, M.M.; Mohammed, W. A.; E1-Guendy, N. M.; E1sayed, A. A., Romanian J. 
Biophys. 2011,21 (2), 151-165. 
325. Lugo-Ponce, P.; McMillin, D. R., Coordination Chemistry Reviews 2000, 208, 
169-191. 
326. Saba, K; Agasti, S.S.; Kim, c.; Li, X.; Rotello, V. M., Chern. Rev. 2012, 112(5), 
2739- 2779. 
327. Kypr, J.; Kejnovska, I.; Renciuk, D.; Vorlickova, M., Nucleic Acids Res. 2009 
,37(6), 1713-1725. 
328. Ambrus, A.; Chen, D.; Dai, J.; Bialis, T.; Jones, R. A.; Yang, D., Nucleic Acids 

Res. 200634(9), 2723-2735. 

329. Dai, J.; Carver, M.; Yang, D., Biochimie. 2008, 90(8), 1172-1183. 
330. Smargiasso, N.; Rosu, F., et aI, JACS. 2008,130 (31), 10208-10216. 
331. Miyoshi, D.; Nakao, A.; Sugimoto, N., Nucl. Acids Res. 2003,31(4), 1156-1163. 
170 

